Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status
GRCh38/hg38 11p15.5-15.4(chr11:61793-10727969)x3	DENND5A|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FAM99A|FAM99B|FHIP1B|GATD1|GATD1-DT|H19|H19-ICR|HBB|HBB-3'HS1|HBB-HS-107|HBB-HS-111|HBB-LCR|HBD|HBE1|HBG1|HBG2|HOTS|HPX|HRAS|HS-E1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IPO7|IRAG1|IRAG1-AS1|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01001|LINC01150|LINC01219|LINC02688|LINC02708|LINC02709|LINC02749|LMNTD2|LMNTD2-AS1|LMO1|LOC101927708|LOC101928008|LOC105274310|LOC105369149|LOC105376526|LOC106099062|LOC106099063|LOC106099064|LOC106099065|LOC106783508|LOC106799843|LOC106865369|LOC107133510|LOC109623489|LOC109951029|LOC110006319|LOC110008579|LOC110011217|LOC110013311|LOC110121378|LOC110121453|LOC111718490|LOC112067719|LOC112067720|LOC112081391|LOC112081400|LOC112081404|LOC112081405|LOC112136080|LOC112136081|LOC112136092|LOC112136094|LOC113939920|LOC113939924|LOC113939927|LOC113939928|LOC114827852|LOC116216126|LOC116216127|LOC116216128|LOC116216129|LOC121392887|LOC121392888|LOC121392889|LOC121392890|LOC121832782|LOC121832783|LOC121832784|LOC121832785|LOC121832786|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC124418422|LOC124418423|LOC124418426|LOC124421482|LOC124421483|LOC124421484|LOC124421485|LOC124421486|LOC124902806|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC126861117|LOC126861118|LOC126861119|LOC126861120|LOC126861121|LOC126861122|LOC126861123|LOC126861124|LOC126861125|LOC126861126|LOC126861127|LOC126861128|LOC126861129|LOC126861130|LOC126861131|LOC126861132|LOC126861133|LOC126861134|LOC126861135|LOC126861136|LOC126861137|LOC126861138|LOC126861139|LOC129388416|LOC129388417|LOC129390245|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC129390252|LOC129390253|LOC129390254|LOC129390255|LOC129390256|LOC129390257|LOC129390258|LOC130005037|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163|LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC130005179|LOC130005180|LOC130005181|LOC130005182|LOC130005183|LOC130005184|LOC130005185|LOC130005186|LOC130005187|LOC130005188|LOC130005189|LOC130005190|LOC130005191|LOC130005192|LOC130005193|LOC130005194|LOC130005195|LOC130005196|LOC130005197|LOC130005198|LOC130005199|LOC130005200|LOC130005201|LOC130005202|LOC130005203|LOC130005204|LOC130005205|LOC130005206|LOC130005207|LOC130005208|LOC130005209|LOC130005210|LOC130005211|LOC130005212|LOC130005213|LOC130005214|LOC130005215|LOC130005216|LOC130005217|LOC130005218|LOC130005219|LOC130005220|LOC130005221|LOC130005222|LOC130005223|LOC130005224|LOC130005225|LOC130005226|LOC130005227|LOC130005228|LOC130005229|LOC130005230|LOC130005231|LOC130005232|LOC130005233|LOC130005234|LOC130005235|LOC130005236|LOC130005237|LOC130005238|LOC130005239|LOC130005240|LOC130005241|LOC130005242|LOC130005243|LOC130005244|LOC130005245|LOC130005246|LOC130005247|LOC130005248|LOC130005249|LOC130005250|LOC130005251|LOC130005252|LOC130005253|LOC130005254|LOC130005255|LOC130005256|LOC130005257|LOC130005258|LOC130005259|LOC130005260|LOC130005261|LOC130005262|LOC130005263|LOC130005264|LOC130005265|LOC130005266|LOC130005267|LOC130005268|LOC130005269|LOC130005270|LOC130005271|LOC130005272|LOC130005273|LOC130005274|LOC130005275|LOC130005276|LOC130005277|LOC130005278|LOC130005279|LOC130005280|LOC130005281|LOC130005282|LOC130005283|LOC130005284|LOC130005285|LOC130005286|LOC130005287|LOC130005288|LOC130005289|LOC130005290|LOC130005291|LOC130005292|LOC130005293|LOC130005294|LOC130005295|LOC130005296|LOC130005297|LOC130005298|LOC130005299|LOC130005300|LOC130005301|LOC130005302|LOC130005303|LOC130005304|LOC130005305|LOC130005306|LOC130005307|LOC130005308|LOC130005309|LOC130005310|LOC130005311|LOC130005312|LOC130005313|LOC130005314|LOC130005315|LOC130005316|LOC130005317|LOC130005318|LOC130005319|LOC130005320|LOC130005321|LOC130005322|LOC130005323|LOC130005324|LOC130005325|LOC130005326|LOC130005327|LOC130005328|LOC130005329|LOC130005330|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LOC283299|LRRC56|LSP1|LYVE1|MIR210|MIR210HG|MIR302E|MIR4298|MIR4485|MIR4686|MIR4687|MIR483|MIR5691|MIR6743|MIR6744|MIR675|MIR7847|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL17|MRPL23|MRPL23-AS1|MTRNR2L8|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NRIP3|NRIP3-DT|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|A-GAMMA3'E|ADM|ADM-DT|AKIP1|AMPD3|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BET1L|BGLT3|BRSK2|C11orf16|C11orf21|C11orf40|C11orf42|CAND1.11|CARS1|CARS1-AS1|CASC23|CAVIN3|CCKBR|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DENND2B-AS1|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51C1P|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51J1|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E1|OR52E2|OR52E4|OR52E5|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52P1|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B2P|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PANO1|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PRADX|PRR33|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RIC3-DT|RIC8A|RNF141|RNH1|RPL27A|RPLP2|RRM1|RRP8|SBF2|SBF2-AS1|SCGB1C1|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA23|SNORA3A|SNORA3B|SNORA52|SNORA54|SNORD131|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|STK33|SWAP70|SYT8|SYT9|SYT9-AS1|TAF10|TALDO1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TMEM9B-AS1|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRL-CAA5-1|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|TUB-AS1|UBQLN3|UBQLNL|WEE1|ZNF143|ZNF143-AS1|ZNF195|ZNF214|ZNF215		See cases	VCV000151263	11	61793 - 10749516	11	61793 - 10727969	151263	161014			copy number gain		Pathogenic	Apr 30, 2011	no assertion criteria provided						
GRCh38/hg38 11p15.5(chr11:196855-2116185)x3	ANO9|AP2A2|B4GALNT4|BET1L|BRSK2|CD151|CDHR5|CEND1|CHID1|CIMAP1A|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|FAM99A|FAM99B|GATD1|GATD1-DT|H19|H19-ICR|HOTS|IRF7|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01150|LINC01219|LINC02688|LINC02708|LMNTD2|LMNTD2-AS1|LOC105274310|LOC110121378|LOC111718490|LOC116216126|LOC121392887|LOC121392888|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC129390246|LOC129390247|LOC130005037|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC132090831|LOC143666|LRRC56|LSP1|MIR210|MIR210HG|MIR4298|MIR6743|MIR6744|MIR675|MIR7847|MOB2|MRPL23|MRPL23-AS1|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NLRP6|PANO1|PGGHG|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PRADX|PRR33|PSMD13|PTDSS2|RASSF7|RIC8A|RNH1|RPLP2|SCT|SIGIRR|SIRT3|SLC25A22|SNORA52|SNORD131|SYT8|TALDO1|TMEM80|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TSPAN4		See cases	VCV000154856	11	196855 - 2137415	11	196855 - 2116185	154856	164610			copy number gain		Pathogenic	Aug 13, 2012	no assertion criteria provided						
GRCh38/hg38 11p15.5-15.4(chr11:196855-5321874)x3	A-GAMMA3'E|ANO9|AP2A2|ART1|ART5|ASCL2|B4GALNT4|BET1L|BGLT3|BRSK2|C11orf21|C11orf40|CARS1|CARS1-AS1|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|FAM99A|FAM99B|GATD1|GATD1-DT|H19|H19-ICR|HBB|HBB-3'HS1|HBB-LCR|HBD|HBE1|HBG1|HBG2|HOTS|HRAS|HS-E1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01150|LINC01219|LINC02688|LINC02708|LINC02749|LMNTD2|LMNTD2-AS1|LOC101927708|LOC105274310|LOC105376526|LOC106099062|LOC106099063|LOC106099064|LOC106099065|LOC106783508|LOC106799843|LOC106865369|LOC107133510|LOC109623489|LOC109951029|LOC110006319|LOC110008579|LOC110011217|LOC110013311|LOC110121378|LOC111718490|LOC112067719|LOC112067720|LOC112081391|LOC113939920|LOC116216126|LOC116216127|LOC116216128|LOC121392887|LOC121392888|LOC121832782|LOC121832783|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC126861117|LOC126861118|LOC129388416|LOC129388417|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC130005037|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163|LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC130005179|LOC130005180|LOC130005181|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LRRC56|LSP1|MIR210|MIR210HG|MIR4298|MIR4686|MIR4687|MIR483|MIR6743|MIR6744|MIR675|MIR7847|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL23|MRPL23-AS1|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NLRP6|NUP98|OR51A2|OR51A4|OR51A7|OR51B4|OR51C1P|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51L1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B4|OR52E1|OR52E2|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52M1|OR52R1|OSBPL5|PANO1|PGAP2|PGGHG|PRADX|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PRR33|PSMD13|PTDSS2|RASSF7|RHOG|RIC8A|RNH1|RPLP2|RRM1|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SNORA52|SNORA54|SNORD131|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TRIM21|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195		See cases	VCV000154823	11	196855 - 5343104	11	196855 - 5321874	154823	164577			copy number gain		Pathogenic	Aug 13, 2012	no assertion criteria provided						
GRCh38/hg38 11p15.5-15.4(chr11:196966-3377077)x3	ANO9|AP2A2|ASCL2|B4GALNT4|BET1L|BRSK2|C11orf21|CARS1|CARS1-AS1|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CIMAP1A|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|FAM99A|FAM99B|GATD1|GATD1-DT|IFITM10|H19|H19-ICR|HOTS|HRAS|IFITM1|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|KCNQ1DN|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01150|LINC01219|LINC02688|LINC02708|LMNTD2|LMNTD2-AS1|LOC105274310|LOC106783508|LOC106799843|LOC109623489|LOC110121378|LOC111718490|LOC112067719|LOC113939920|LOC116216126|LOC116216127|LOC121392887|LOC121392888|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC130005037|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LRRC56|LSP1|MIR210|MIR210HG|MIR4298|MIR4686|MIR483|MIR6743|MIR6744|MIR675|MIR7847|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL23|MRPL23-AS1|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NLRP6|OSBPL5|PANO1|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PRADX|PRR33|PSMD13|PTDSS2|RASSF7|RIC8A|RNH1|RPLP2|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SNORA52|SNORA54|SNORD131|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195		See cases	VCV000057274	11	196966 - 3398307	11	196966 - 3377077	57274	71869			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter						
GRCh38/hg38 11p15.5-15.4(chr11:196966-4435344)x3	LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LRRC56|LSP1|MIR210|MIR210HG|MIR4298|MIR4686|MIR4687|MIR483|MIR6743|MIR6744|MIR675|MIR7847|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL23|MRPL23-AS1|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NLRP6|NUP98|OR52B4|OSBPL5|PANO1|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PRADX|PRR33|PSMD13|PTDSS2|RASSF7|RHOG|RIC8A|RNH1|RPLP2|RRM1|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SNORA52|SNORA54|SNORD131|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TRIM21|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195|ANO9|AP2A2|ART1|ART5|ASCL2|B4GALNT4|BET1L|BRSK2|C11orf21|CARS1|CARS1-AS1|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|FAM99A|FAM99B|GATD1|GATD1-DT|H19|H19-ICR|HOTS|LINC02688|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01150|LINC01219|LINC02708|LINC02749|LMNTD2|LMNTD2-AS1|LOC101927708|LOC105274310|LOC105376526|LOC106783508|LOC106799843|LOC106865369|LOC109623489|LOC110121378|LOC111718490|LOC112067719|LOC112067720|LOC112081391|LOC113939920|LOC116216126|LOC116216127|LOC121392887|LOC121392888|LOC121832782|LOC121832783|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC129388416|LOC129388417|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC130005037|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163		See cases	VCV000057258	11	196966 - 4456574	11	196966 - 4435344	57258	71853			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter						
GRCh38/hg38 11p15.5-15.4(chr11:218365-3377077)x3	ANO9|AP2A2|ASCL2|B4GALNT4|BRSK2|C11orf21|CARS1|CARS1-AS1|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|FAM99A|FAM99B|GATD1|GATD1-DT|IFITM10|H19|H19-ICR|HOTS|HRAS|IFITM1|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|KCNQ1DN|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01150|LINC01219|LINC02688|LINC02708|LMNTD2|LMNTD2-AS1|LOC105274310|LOC106783508|LOC106799843|LOC109623489|LOC110121378|LOC111718490|LOC112067719|LOC113939920|LOC116216126|LOC116216127|LOC121392887|LOC121392888|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LRRC56|LSP1|MIR210|MIR210HG|MIR4298|MIR4686|MIR483|MIR6744|MIR675|MIR7847|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL23|MRPL23-AS1|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NLRP6|OSBPL5|PANO1|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PRADX|PRR33|PSMD13|PTDSS2|RASSF7|RNH1|RPLP2|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SNORA52|SNORA54|SNORD131|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195		See cases	VCV000059748	11	218365 - 3398307	11	218365 - 3377077	59748	74343			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter						
GRCh38/hg38 11p15.5(chr11:313988-723647)	ANO9|B4GALNT4|CDHR5|DEAF1|DRD4|EPS8L2|HRAS|IFITM1|IFITM3|IRF7|LMNTD2|LMNTD2-AS1|LOC116216126|LOC124418409|LOC124418411|LOC126861108|LOC126861109|LOC129390246|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC132090831|LOC143666|LRRC56|MIR210|MIR210HG|PHRF1|PKP3|PTDSS2|RASSF7|RNH1|SCT|SIGIRR|TMEM80		Autism spectrum disorder	VCV003024365			11	313988 - 723647	3024365	3184637			copy number loss		Uncertain significance		no assertion criteria provided						
GRCh38/hg38 11p15.5-15.1(chr11:446754-18904742)x3	TRIM22|TRIM3|TUB-AS1|UBQLN3|TRIM34|TRIM5|UBQLNL|UEVLD|TRIM66|TRIM68|TRIM6|TSG101|TSPAN32|TSSC4|TUB|WEE1|ZBED5|ZBED5-AS1|ZNF143|ZNF143-AS1|USH1C|USP47|ZNF195|ZNF214|ZNF215|TPP1|TRIM21|TMEM9B|TMEM9B-AS1|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TPH1|TRL-CAA5-1|TRPM5|TSPAN4|A-GAMMA3'E|ABCC8|ADM|ADM-DT|AKIP1|AMPD3|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|BGLT3|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CAND1.11|CARS1|CARS1-AS1|CASC23|CAVIN3|CCKBR|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CTR9|CTSD|CYB5R2|CYP2R1|DCHS1|DEAF1|DENND2B|DENND2B-AS1|DENND5A|DKK3|DNHD1|DRD4|DUSP8|EIF3F|EIF4G2|EPS8L2|FAM99A|FAM99B|FAR1|FHIP1B|GALNT18|GATD1|GATD1-DT|GTF2H1|H19|H19-ICR|HBB|HBB-3'HS1|HBB-HS-107|HBB-HS-111|HBB-LCR|HBD|HBE1|HBG1|HBG2|HOTS|HPS5|HPX|HRAS|HS-E1|IFITM10|IGF2|IGF2-AS|IGSF22|IGSF22-AS1|ILK|INS|INS-IGF2|INSC|IPO7|IRAG1|IRAG1-AS1|IRF7|KCNC1|KCNJ11|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LDHA|LDHAL6A|LDHC|LINC00958|LINC01150|LINC01219|LINC02545|LINC02547|LINC02548|LINC02682|LINC02683|LINC02688|LINC02708|LINC02709|LINC02729|LINC02749|LINC02751|LINC02752|LINC02989|LMNTD2|LMNTD2-AS1|LMO1|LOC101927708|LOC101928008|LOC101928053|LOC105274310|LOC105369149|LOC105376526|LOC106099062|LOC106099063|LOC106099064|LOC106099065|LOC106736470|LOC106783508|LOC106799843|LOC106865369|LOC107133510|LOC107988023|LOC108254681|LOC108281125|LOC109623489|LOC109951029|LOC110006319|LOC110008579|LOC110011217|LOC110013311|LOC110120848|LOC110120922|LOC110120926|LOC110120947|LOC110121340|LOC110121343|LOC110121378|LOC110121434|LOC110121453|LOC110121471|LOC110121483|LOC111413037|LOC111718490|LOC111982890|LOC112042781|LOC112042782|LOC112067712|LOC112067713|LOC112067714|LOC112067715|LOC112067716|LOC112067719|LOC112067720|LOC112081391|LOC112081400|LOC112081404|LOC112081405|LOC112136080|LOC112136081|LOC112136092|LOC112136094|LOC113939920|LOC113939924|LOC113939927|LOC113939928|LOC114827852|LOC116216127|LOC116216128|LOC116216129|LOC121392887|LOC121392888|LOC121392889|LOC121392890|LOC121392891|LOC121392892|LOC121832782|LOC121832783|LOC121832784|LOC121832785|LOC121832786|LOC121832787|LOC121832788|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC124418422|LOC124418423|LOC124418426|LOC124421482|LOC124421483|LOC124421484|LOC124421485|LOC124421486|LOC124421487|LOC124421488|LOC124421489|LOC124421490|LOC124421491|LOC124421492|LOC124421493|LOC124421494|LOC124421495|LOC124421496|LOC124421497|LOC124421498|LOC124421499|LOC124421500|LOC124421501|LOC124421502|LOC124421503|LOC124902806|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC126861117|LOC126861118|LOC126861119|LOC126861120|LOC126861121|LOC126861122|LOC126861123|LOC126861124|LOC126861125|LOC126861126|LOC126861127|LOC126861128|LOC126861129|LOC126861130|LOC126861131|LOC126861132|LOC126861133|LOC126861134|LOC126861135|LOC126861136|LOC126861137|LOC126861138|LOC126861139|LOC126861140|LOC126861141|LOC126861142|LOC126861143|LOC126861144|LOC126861145|LOC126861146|LOC126861147|LOC126861148|LOC126861149|LOC126861150|LOC126861151|LOC126861152|LOC126861153|LOC126861154|LOC128772342|LOC128772343|LOC128772344|LOC128772345|LOC128772346|LOC129388416|LOC129388417|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC129390252|LOC129390253|LOC129390254|LOC129390255|LOC129390256|LOC129390257|LOC129390258|LOC129390259|LOC129390260|LOC129390261|LOC129390262|LOC129390263|LOC129390264|LOC129390265|LOC129390266|LOC129390267|LOC129390268|LOC129390269|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163|LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC130005179|LOC130005180|LOC130005181|LOC130005182|LOC130005183|LOC130005184|LOC130005185|LOC130005186|LOC130005187|LOC130005188|LOC130005189|LOC130005190|LOC130005191|LOC130005192|LOC130005193|LOC130005194|LOC130005195|LOC130005196|LOC130005197|LOC130005198|LOC130005199|LOC130005200|LOC130005201|LOC130005202|LOC130005203|LOC130005204|LOC130005205|LOC130005206|LOC130005207|LOC130005208|LOC130005209|LOC130005210|LOC130005211|LOC130005212|LOC130005213|LOC130005214|LOC130005215|LOC130005216|LOC130005217|LOC130005218|LOC130005219|LOC130005220|LOC130005221|LOC130005222|LOC130005223|LOC130005224|LOC130005225|LOC130005226|LOC130005227|LOC130005228|LOC130005229|LOC130005230|LOC130005231|LOC130005232|LOC130005233|LOC130005234|LOC130005235|LOC130005236|LOC130005237|LOC130005238|LOC130005239|LOC130005240|LOC130005241|LOC130005242|LOC130005243|LOC130005244|LOC130005245|LOC130005246|LOC130005247|LOC130005248|LOC130005249|LOC130005250|LOC130005251|LOC130005252|LOC130005253|LOC130005254|LOC130005255|LOC130005256|LOC130005257|LOC130005258|LOC130005259|LOC130005260|LOC130005261|LOC130005262|LOC130005263|LOC130005264|LOC130005265|LOC130005266|LOC130005267|LOC130005268|LOC130005269|LOC130005270|LOC130005271|LOC130005272|LOC130005273|LOC130005274|LOC130005275|LOC130005276|LOC130005277|LOC130005278|LOC130005279|LOC130005280|LOC130005281|LOC130005282|LOC130005283|LOC130005284|LOC130005285|LOC130005286|LOC130005287|LOC130005288|LOC130005289|LOC130005290|LOC130005291|LOC130005292|LOC130005293|LOC130005294|LOC130005295|LOC130005296|LOC130005297|LOC130005298|LOC130005299|LOC130005300|LOC130005301|LOC130005302|LOC130005303|LOC130005304|LOC130005305|LOC130005306|LOC130005307|LOC130005308|LOC130005309|LOC130005310|LOC130005311|LOC130005312|LOC130005313|LOC130005314|LOC130005315|LOC130005316|LOC130005317|LOC130005318|LOC130005319|LOC130005320|LOC130005321|LOC130005322|LOC130005323|LOC130005324|LOC130005325|LOC130005326|LOC130005327|LOC130005328|LOC130005329|LOC130005330|LOC130005331|LOC130005332|LOC130005333|LOC130005334|LOC130005335|LOC130005336|LOC130005337|LOC130005338|LOC130005339|LOC130005340|LOC130005341|LOC130005342|LOC130005343|LOC130005344|LOC130005345|LOC130005346|LOC130005347|LOC130005348|LOC130005349|LOC130005350|LOC130005351|LOC130005352|LOC130005353|LOC130005354|LOC130005355|LOC130005356|LOC130005357|LOC130005358|LOC130005359|LOC130005360|LOC130005361|LOC130005362|LOC130005363|LOC130005364|LOC130005365|LOC130005366|LOC130005367|LOC130005368|LOC130005369|LOC130005370|LOC130005371|LOC130005372|LOC130005373|LOC130005374|LOC130005375|LOC130005376|LOC130005377|LOC130005378|LOC130005379|LOC130005380|LOC130005381|LOC130005382|LOC130005383|LOC130005384|LOC130005385|LOC130005386|LOC130005387|LOC130005388|LOC130005389|LOC130005390|LOC130005391|LOC130005392|LOC130005393|LOC130005394|LOC130005395|LOC130005396|LOC130005397|LOC130005398|LOC130005399|LOC130005400|LOC130005401|LOC130005402|LOC130005403|LOC130005404|LOC130005405|LOC130005406|LOC130005407|LOC130005408|LOC130005409|LOC130005410|LOC130005411|LOC130005412|LOC130005413|LOC130005414|LOC130005415|LOC130005416|LOC130005417|LOC130005418|LOC130005419|LOC132089897|LOC132089898|LOC132089899|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC132090833|LOC143666|LOC283299|LRRC56|LSP1|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MIR302E|MIR3159|MIR4298|MIR4299|MIR4485|MIR4686|MIR4687|MIR483|MIR5691|MIR6073|MIR6124|MIR6744|MIR675|MIR7847|MIR8070|MISFA|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MRPL23-AS1|MTRNR2L8|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|MYOD1|NAP1L4|NCR3LG1|NLRP10|NLRP14|NRIP3|NRIP3-DT|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51C1P|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51J1|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E1|OR52E2|OR52E4|OR52E5|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52P1|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B2P|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PANO1|PARVA|PDE3B|PGAP2|PHLDA2|PHRF1|PIDD1|PIK3C2A|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PRADX|PRR33|PSMA1|PTDSS2|PTH|PTPN5|RASSF10|RASSF10-DT|RASSF7|RBMXL2|RHOG|RIC3|RIC3-DT|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SBF2|SBF2-AS1|SCT|SCUBE2|SERGEF|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA23|SNORA3A|SNORA3B|SNORA52|SNORA54|SNORD131|SNORD147|SNORD14A|SNORD14B|SNORD97|SOX6|SPON1|SPTY2D1|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|STK33|SWAP70|SYT8|SYT9|SYT9-AS1|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A		See cases	VCV000144515	11	446754 - 18926289	11	446754 - 18904742	144515	154266			copy number gain		Pathogenic	Apr 30, 2010	no assertion criteria provided						
NC_000011.10:g.(499700_4999400)_(5279346_5279697)del	ASCL2|BGLT3|CD81|CD81-AS1|CDHR5|DRD4|HBG2|HOTS|HBE1|HBG1|CTSD|DEAF1|CRACR2B|BRSK2|C11orf21|C11orf40|CDKN1C|CEND1|CHID1|CHRNA10|CARS1|CARS1-AS1|CD151|ART5|A-GAMMA3'E|AP2A2|ART1|DUSP8|EPS8L2|FAM99A|FAM99B|GATD1|GATD1-DT|H19|H19-ICR|HBB|HBB-3'HS1|HBB-LCR|HBD|HRAS|HS-E1|IFITM10|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01150|LINC01219|LINC02688|LINC02708|LINC02749|LMNTD2|LMNTD2-AS1|LOC101927708|LOC105274310|LOC105376526|LOC106099062|LOC106099063|LOC106099064|LOC106099065|LOC106783508|LOC106799843|LOC106865369|LOC107133510|LOC109623489|LOC109951029|LOC110006319|LOC110008579|LOC110011217|LOC110013311|LOC110121378|LOC111718490|LOC112067719|LOC112067720|LOC112081391|LOC113939920|LOC116216127|LOC116216128|LOC121392887|LOC121392888|LOC121832782|LOC121832783|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC126861117|LOC126861118|LOC129388416|LOC129388417|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163|LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC130005179|LOC130005180|LOC130005181|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LRRC56|LSP1|MIR210|MIR210HG|MIR4298|MIR4686|MIR4687|MIR483|MIR6744|MIR675|MIR7847|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL23|MRPL23-AS1|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NUP98|OR51A2|OR51A4|OR51A7|OR51C1P|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51L1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B4|OR52E1|OR52E2|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52M1|OR52R1|OSBPL5|PANO1|PGAP2|PHLDA2|PHRF1|PIDD1|PNPLA2|POLR2L|PRADX|PRR33|RASSF7|RHOG|RNH1|RPLP2|RRM1|SCT|SLC22A18|SLC22A18AS|SLC25A22|SNORA52|SNORA54|SNORD131|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TRIM21|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195		Thalassemia, gamma-delta-beta	VCV000014445			11	499700 - 5279697	14445	29484			Deletion		Pathogenic	Oct 1, 1989	no assertion criteria provided						
NC_000011.10:g.528639C>T	HRAS|LRRC56		not provided	VCV002641054	11	528639	11	528639	2641054	2806368		NC_000011.10:528638:C:T	single nucleotide variant	genic upstream transcript variant	Likely benign	Jan 1, 2023	criteria provided, single submitter						
NC_000011.10:g.528669C>T	HRAS|LRRC56		not provided	VCV002641055	11	528669	11	528669	2641055	2806369		NC_000011.10:528668:C:T	single nucleotide variant	genic upstream transcript variant	Likely benign	Feb 1, 2023	criteria provided, single submitter						
NC_000011.10:g.529719C>G	HRAS|LRRC56		not provided	VCV002641057	11	529719	11	529719	2641057	2806371		NC_000011.10:529718:C:G	single nucleotide variant		Likely benign	Jan 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530428_530483del	HRAS|LRRC56		not provided	VCV002570780	11	530419 - 530474	11	530419 - 530474	2570780	2735738			Deletion		Likely benign	Apr 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530428_530455del	HRAS|LRRC56		not provided	VCV001711268	11	530420 - 530447	11	530420 - 530447	1711268	1709684		NC_000011.10:530419:AGTGTGGCATTCCCTGGACAGAAGGGCAAGTGTGGC:AGTGTGGC	Deletion		Likely benign	Jun 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530447_530474del	HRAS|LRRC56		not provided	VCV002641058	11	530439 - 530466	11	530439 - 530466	2641058	2806372		NC_000011.10:530438:AGAAGGGCAAGTGTGGCGTCCCCTGGAGAGAAGGGC:AGAAGGGC	Deletion		Benign	Jan 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530444G>A	HRAS|LRRC56		not provided	VCV002641059	11	530444	11	530444	2641059	2806373		NC_000011.10:530443:G:A	single nucleotide variant		Likely benign	Jun 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530447A>G	HRAS|LRRC56		not provided	VCV001675437	11	530447	11	530447	1675437	1666821	rs199711118	NC_000011.10:530446:A:G	single nucleotide variant		Likely benign	Apr 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530466G>C	HRAS|LRRC56		not provided	VCV001694576	11	530466	11	530466	1694576	1687008	rs569269635	NC_000011.10:530465:G:C	single nucleotide variant		Likely benign	Jun 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530475G>A	HRAS|LRRC56		not provided	VCV001694577	11	530475	11	530475	1694577	1687009	rs111377659	NC_000011.10:530474:G:A	single nucleotide variant		Likely benign	Jun 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530522G>C	HRAS|LRRC56		not provided	VCV002641060	11	530522	11	530522	2641060	2806374		NC_000011.10:530521:G:C	single nucleotide variant		Likely benign	Mar 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530587G>C	HRAS|LRRC56		not provided	VCV002641061	11	530587	11	530587	2641061	2806375		NC_000011.10:530586:G:C	single nucleotide variant		Benign	May 1, 2022	criteria provided, single submitter						
NC_000011.10:g.530614G>C	HRAS|LRRC56		not provided	VCV002641062	11	530614	11	530614	2641062	2806376		NC_000011.10:530613:G:C	single nucleotide variant		Likely benign	May 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530894G>C	HRAS|LRRC56		not provided	VCV002641063	11	530894	11	530894	2641063	2806377		NC_000011.10:530893:G:C	single nucleotide variant		Likely benign	May 1, 2023	criteria provided, single submitter						
NC_000011.10:g.530895G>C	HRAS|LRRC56		not provided	VCV002641064	11	530895	11	530895	2641064	2806378		NC_000011.10:530894:G:C	single nucleotide variant		Benign	Oct 1, 2022	criteria provided, single submitter						
NC_000011.10:g.531047C>T	HRAS|LRRC56		not provided	VCV002641065	11	531047	11	531047	2641065	2806379		NC_000011.10:531046:C:T	single nucleotide variant		Benign	Aug 1, 2022	criteria provided, single submitter						
NC_000011.10:g.531063G>C	HRAS|LRRC56		not provided	VCV002641066	11	531063	11	531063	2641066	2806380		NC_000011.10:531062:G:C	single nucleotide variant		Likely benign	May 1, 2023	criteria provided, single submitter						
NC_000011.10:g.531065G>A	HRAS|LRRC56		not provided	VCV002641067	11	531065	11	531065	2641067	2806381		NC_000011.10:531064:G:A	single nucleotide variant		Benign	Mar 1, 2022	criteria provided, single submitter						
NC_000011.10:g.531070G>A	HRAS|LRRC56		not provided	VCV001694578	11	531070	11	531070	1694578	1687010	rs534235694	NC_000011.10:531069:G:A	single nucleotide variant		Likely benign	Jun 1, 2023	criteria provided, single submitter						
NC_000011.10:g.531072G>A	HRAS|LRRC56		not provided	VCV002498476	11	531072	11	531072	2498476	2476453		NC_000011.10:531071:G:A	single nucleotide variant		Likely benign	May 1, 2023	criteria provided, single submitter						
NC_000011.10:g.531174C>G	HRAS|LRRC56		not provided	VCV002570781	11	531174	11	531174	2570781	2735739		NC_000011.10:531173:C:G	single nucleotide variant		Likely benign	Jun 1, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.*76G>C	HRAS|LRRC56		not provided	VCV001182954	11	532452	11	532452	1182954	1172267	rs45565838	NC_000011.10:532451:C:G	single nucleotide variant	3 prime UTR variant	Likely benign	Aug 15, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.*6-2A>C	HRAS|LRRC56		not specified	VCV000040450	11	532524	11	532524	40450	48920	rs730880459	NC_000011.10:532523:T:G	single nucleotide variant	3 prime UTR variant|splice acceptor variant	Likely benign	Feb 24, 2012	criteria provided, single submitter						
NM_005343.4(HRAS):c.*6-48G>A	HRAS|LRRC56		not provided	VCV001291002	11	532570	11	532570	1291002	48919	rs1851166964	NC_000011.10:532569:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Mar 3, 2015	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-59_*6-51del	HRAS|LRRC56		Costello syndrome	VCV000976046	11	532573 - 534003	11	532573 - 534003	976046	964672			Deletion	splice acceptor variant|splice donor variant|initiator_codon_variant	Uncertain significance	Dec 20, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.*5+35C>T	LRRC56|HRAS		not provided	VCV001269148	11	532596	11	532596	1269148	1260291	rs45524036	NC_000011.10:532595:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Dec 13, 2019	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.*5+29C>T	HRAS|LRRC56		not provided	VCV001247559	11	532602	11	532602	1247559	1234938	rs200714754	NC_000011.10:532601:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Dec 18, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.*5+24C>T	HRAS|LRRC56		not provided	VCV001251694	11	532607	11	532607	1251694	1240788	rs375219797	NC_000011.10:532606:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Feb 23, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.*5+20C>T	HRAS|LRRC56		not specified|not provided	VCV000377968	11	532611	11	532611	377968	371481	rs756277885	NC_000011.10:532610:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Mar 10, 2015	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.*5+14C>G	HRAS|LRRC56		not provided	VCV000561343	11	532617	11	532617	561343	552658	rs587780953	NC_000011.10:532616:G:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	May 23, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.*5+14C>A	HRAS|LRRC56		not specified	VCV000137558	11	532617	11	532617	137558	141261	rs587780953	NC_000011.10:532616:G:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	May 18, 2012	criteria provided, single submitter						
NC_000011.9:g.(?_532626)_(534332_?)dup	HRAS|LRRC56		Costello syndrome	VCV000656817	11	532626 - 534332	11	532626 - 534332	656817	652098			Duplication		Uncertain significance	Jul 1, 2019	criteria provided, single submitter						
NC_000011.9:g.(?_532631)_(532755_?)dup	HRAS|LRRC56		Costello syndrome	VCV000417510	11	532631 - 532755	11	532631 - 532755	417510	398125			Duplication		Uncertain significance	Aug 31, 2016	criteria provided, single submitter						
NC_000011.9:g.(?_532631)_(534375_?)dup	HRAS|LRRC56		not specified	VCV000179613	11	532631 - 534375	11	532631 - 534375	179613	175336			Duplication		Uncertain significance	Jul 31, 2014	criteria provided, single submitter						
NM_005343.4(HRAS):c.*1C>T	HRAS|LRRC56		not provided|not specified	VCV000137557	11	532635	11	532635	137557	141260	rs730880327	NC_000011.10:532634:G:A	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jul 5, 2016	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.566_568del (p.Ser189del)	HRAS|LRRC56	S110del, S189del	Costello syndrome	VCV002089966	11	532638 - 532640	11	532638 - 532640	2089966	2155636		NC_000011.10:532637:AGGAG:AG	Deletion	inframe_deletion|3 prime UTR variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.567C>T (p.Ser189=)	HRAS|LRRC56		Costello syndrome	VCV001910052	11	532639	11	532639	1910052	1972862		NC_000011.10:532638:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.567C>G (p.Ser189=)	HRAS|LRRC56		Costello syndrome	VCV001131323	11	532639	11	532639	1131323	1121538	rs1324657141	NC_000011.10:532638:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jan 31, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.566C>T (p.Ser189Phe)	HRAS|LRRC56	S110F, S189F	Costello syndrome	VCV000940755	11	532640	11	532640	940755	935593	rs1851173218	NC_000011.10:532639:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.565T>G (p.Ser189Ala)	HRAS|LRRC56	S189A, S110A	Costello syndrome	VCV000856240	11	532641	11	532641	856240	838558	rs1851173462	NC_000011.10:532640:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.564C>G (p.Leu188=)	HRAS|LRRC56		Costello syndrome	VCV001656757	11	532642	11	532642	1656757	1562141	rs2133981970	NC_000011.10:532641:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 17, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.560T>C (p.Val187Ala)	HRAS|LRRC56	V108A, V187A	Costello syndrome	VCV001011612	11	532646	11	532646	1011612	994565	rs1851173673	NC_000011.10:532645:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 21, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.559G>A (p.Val187Met)	HRAS|LRRC56	V108M, V187M	Costello syndrome	VCV001713318	11	532647	11	532647	1713318	1777213		NC_000011.10:532646:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.555G>A (p.Lys185=)	HRAS|LRRC56		Costello syndrome	VCV001606869	11	532651	11	532651	1606869	1658732	rs1230514063	NC_000011.10:532650:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 1, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.552dup (p.Lys185fs)	HRAS|LRRC56	K185fs, K106fs	Costello syndrome	VCV000531191	11	532653 - 532654	11	532653 - 532654	531191	526481	rs1554884418	NC_000011.10:532653:G:GG	Duplication	frameshift variant|3 prime UTR variant	Uncertain significance	Oct 22, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.551G>C (p.Cys184Ser)	HRAS|LRRC56	C105S, C184S	Costello syndrome	VCV001407404	11	532655	11	532655	1407404	1483613	rs2133982018	NC_000011.10:532654:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 26, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.551G>A (p.Cys184Tyr)	HRAS|LRRC56	C105Y, C184Y	Costello syndrome	VCV001369069	11	532655	11	532655	1369069	1417959	rs2133982018	NC_000011.10:532654:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.548G>A (p.Ser183Asn)	HRAS|LRRC56	S104N, S183N	Costello syndrome	VCV000836160	11	532658	11	532658	836160	838559		NC_000011.10:532657:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.546G>A (p.Met182Ile)	HRAS|LRRC56	M182I, M103I	not specified|Costello syndrome	VCV000240138	11	532660	11	532660	240138	241153	rs748639813	NC_000011.10:532659:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Feb 19, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.545T>C (p.Met182Thr)	HRAS|LRRC56	M103T, M182T	Costello syndrome	VCV001038544	11	532661	11	532661	1038544	1030297	rs1851174858	NC_000011.10:532660:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 1, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.544A>C (p.Met182Leu)	HRAS|LRRC56	M103L, M182L	Costello syndrome	VCV000946957	11	532662	11	532662	946957	926270	rs730880465	NC_000011.10:532661:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.544A>G (p.Met182Val)	HRAS|LRRC56	M182V, M103V	not provided|Costello syndrome	VCV000180853	11	532662	11	532662	180853	179411	rs730880465	NC_000011.10:532661:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 19, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.543C>T (p.Cys181=)	HRAS|LRRC56		Costello syndrome	VCV001447107	11	532663	11	532663	1447107	1410600	rs2133982060	NC_000011.10:532662:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Uncertain significance	Aug 30, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.542G>A (p.Cys181Tyr)	HRAS|LRRC56	C102Y, C181Y	Costello syndrome	VCV001042310	11	532664	11	532664	1042310	1030298	rs1187682907	NC_000011.10:532663:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.540C>A (p.Gly180=)	HRAS|LRRC56		Costello syndrome	VCV002027966	11	532666	11	532666	2027966	2078177		NC_000011.10:532665:G:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 30, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.540C>T (p.Gly180=)	HRAS|LRRC56		Costello syndrome	VCV001535136	11	532666	11	532666	1535136	1531848	rs976055009	NC_000011.10:532665:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Apr 9, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.539G>A (p.Gly180Asp)	HRAS|LRRC56	G101D, G180D	Costello syndrome	VCV000948441	11	532667	11	532667	948441	926271	rs1851175904	NC_000011.10:532666:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 1, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.538G>C (p.Gly180Arg)	HRAS|LRRC56	G101R, G180R	Costello syndrome	VCV002700340	11	532668	11	532668	2700340	2855339		NC_000011.10:532667:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.538G>A (p.Gly180Ser)	HRAS|LRRC56	G101S, G180S	Costello syndrome|not provided	VCV000654278	11	532668	11	532668	654278	640150	rs772602067	NC_000011.10:532667:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.537C>T (p.Pro179=)	HRAS|LRRC56		not provided|Costello syndrome	VCV000415878	11	532669	11	532669	415878	398222	rs371316832	NC_000011.10:532668:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 2, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.536C>T (p.Pro179Leu)	HRAS|LRRC56	P100L, P179L	Costello syndrome|not provided	VCV001052272	11	532670	11	532670	1052272	1047282	rs760429548	NC_000011.10:532669:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.535C>T (p.Pro179Ser)	HRAS|LRRC56	P179S, P100S	Costello syndrome|not provided|Cardiovascular phenotype	VCV001422549	11	532671	11	532671	1422549	1416320	rs1201430199	NC_000011.10:532670:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 30, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.535C>G (p.Pro179Ala)	HRAS|LRRC56	P100A, P179A	Costello syndrome	VCV000724759	11	532671	11	532671	724759	738027	rs1201430199	NC_000011.10:532670:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Dec 2, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.534C>T (p.Gly178=)	HRAS|LRRC56		Costello syndrome	VCV001984566	11	532672	11	532672	1984566	2036019		NC_000011.10:532671:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 11, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.534C>G (p.Gly178=)	HRAS|LRRC56		Cardiovascular phenotype|not provided|Costello syndrome|not specified	VCV000415883	11	532672	11	532672	415883	398316	rs770431635	NC_000011.10:532671:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.532G>A (p.Gly178Ser)	HRAS|LRRC56	G99S, G178S	Costello syndrome	VCV002709469	11	532674	11	532674	2709469	2878215		NC_000011.10:532673:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 24, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.532G>C (p.Gly178Arg)	HRAS|LRRC56	G178R, G99R	Costello syndrome	VCV000660554	11	532674	11	532674	660554	640151	rs1445835026	NC_000011.10:532673:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 2, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.529_531del (p.Ser177del)	HRAS|LRRC56	S98del, S177del	Costello syndrome	VCV002014533	11	532675 - 532677	11	532675 - 532677	2014533	2075029		NC_000011.10:532674:ACT:	Deletion	inframe_deletion|3 prime UTR variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.531T>C (p.Ser177=)	HRAS|LRRC56		Costello syndrome	VCV001896875	11	532675	11	532675	1896875	1952810		NC_000011.10:532674:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.529_530del (p.Ser177fs)	HRAS|LRRC56	S98fs, S177fs	Costello syndrome	VCV002160269	11	532676 - 532677	11	532676 - 532677	2160269	1883952		NC_000011.10:532675:CTCTC:CTC	Microsatellite	frameshift variant|3 prime UTR variant	Uncertain significance	May 9, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.530G>C (p.Ser177Thr)	LRRC56|HRAS	S177T, S98T	Costello syndrome	VCV001720993	11	532676	11	532676	1720993	1774975		NC_000011.10:532675:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.530G>A (p.Ser177Asn)	HRAS|LRRC56	S98N, S177N	Costello syndrome	VCV001376888	11	532676	11	532676	1376888	1479752	rs1191074796	NC_000011.10:532675:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 7, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.522T>C (p.Pro174=)	HRAS|LRRC56		Costello syndrome	VCV002975056	11	532684	11	532684	2975056	3130255		NC_000011.10:532683:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 10, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.521C>A (p.Pro174His)	HRAS|LRRC56	P174H, P95H	Noonan syndrome and Noonan-related syndrome	VCV001334241	11	532685	11	532685	1334241	1325101	rs2133982181	NC_000011.10:532684:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 12, 2016	criteria provided, single submitter						
NM_005343.4(HRAS):c.520C>G (p.Pro174Ala)	HRAS|LRRC56	P174A, P95A	Costello syndrome	VCV000643338	11	532686	11	532686	643338	640152		NC_000011.10:532685:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.520C>T (p.Pro174Ser)	HRAS|LRRC56	P174S, P95S	RASopathy	VCV000040448	11	532686	11	532686	40448	48918	rs397517144	NC_000011.10:532685:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.519T>G (p.Pro173=)	HRAS|LRRC56		Costello syndrome	VCV000415881	11	532687	11	532687	415881	398657	rs759004302	NC_000011.10:532686:A:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jan 17, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.518C>G (p.Pro173Arg)	HRAS|LRRC56	P173R, P94R	Costello syndrome	VCV002005751	11	532688	11	532688	2005751	2072697		NC_000011.10:532687:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 23, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.518C>T (p.Pro173Leu)	HRAS|LRRC56	P173L, P94L	Costello syndrome|Intellectual disability	VCV000462156	11	532688	11	532688	462156	461199	rs1171786943	NC_000011.10:532687:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 27, 2021	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.517C>T (p.Pro173Ser)	HRAS|LRRC56	P173S, P94S	Costello syndrome|not provided	VCV001024818	11	532689	11	532689	1024818	1009736	rs1851178613	NC_000011.10:532688:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 30, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.516C>A (p.Asn172Lys)	HRAS|LRRC56	N93K, N172K	Costello syndrome	VCV002820359	11	532690	11	532690	2820359	2981445		NC_000011.10:532689:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.516C>T (p.Asn172=)	HRAS|LRRC56		not specified|Costello syndrome	VCV000415885	11	532690	11	532690	415885	398318	rs765180494	NC_000011.10:532689:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 16, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.515A>G (p.Asn172Ser)	HRAS|LRRC56	N172S, N93S	Costello syndrome	VCV001055387	11	532691	11	532691	1055387	1047283	rs913523409	NC_000011.10:532690:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.511C>G (p.Leu171Val)	HRAS|LRRC56	L92V, L171V	Costello syndrome	VCV002693094	11	532695	11	532695	2693094	2857078		NC_000011.10:532694:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.482_511del (p.Arg161_Lys170del)	HRAS|LRRC56		Costello syndrome	VCV001372348	11	532695 - 532724	11	532695 - 532724	1372348	1443593	rs2133982236	NC_000011.10:532694:GCTTCCGCAGCTTGTGCTGCCGGATCTCACGC:GC	Deletion	inframe_deletion|3 prime UTR variant	Uncertain significance	Aug 4, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.510G>A (p.Lys170=)	HRAS|LRRC56		RASopathy	VCV000045305	11	532696	11	532696	45305	54472	rs397517143	NC_000011.10:532695:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 17, 2024	reviewed by expert panel						
NM_005343.4(HRAS):c.508A>T (p.Lys170Ter)	HRAS|LRRC56	K170*, K91*	Costello syndrome	VCV000040447	11	532698	11	532698	40447	48917	rs372936166	NC_000011.10:532697:T:A	single nucleotide variant	nonsense|3 prime UTR variant	Uncertain significance	Jun 27, 2019	reviewed by expert panel						
NM_005343.4(HRAS):c.506G>T (p.Arg169Leu)	HRAS|LRRC56	R169L, R90L	Costello syndrome	VCV001035699	11	532700	11	532700	1035699	1030299	rs142218590	NC_000011.10:532699:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.506G>A (p.Arg169Gln)	HRAS|LRRC56	R169Q, R90Q	Large congenital melanocytic nevus|Malignant tumor of urinary bladder|Epidermal nevus|Costello syndrome|Thyroid cancer, nonmedullary, 2|Linear nevus sebaceous syndrome|not provided|HRAS-related disorder|Costello syndrome|Hereditary cancer-predisposing syndrome	VCV000180856	11	532700	11	532700	180856	179412	rs142218590	NC_000011.10:532699:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 14, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.505C>T (p.Arg169Trp)	HRAS|LRRC56	R169W, R90W	Costello syndrome|Large congenital melanocytic nevus|Malignant tumor of urinary bladder|Epidermal nevus|Costello syndrome|Thyroid cancer, nonmedullary, 2|Linear nevus sebaceous syndrome|Cardiovascular phenotype|not specified	VCV000177918	11	532701	11	532701	177918	174801	rs151229168	NC_000011.10:532700:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.503T>C (p.Leu168Pro)	HRAS|LRRC56	L168P, L89P	not provided|Costello syndrome|Noonan syndrome and Noonan-related syndrome	VCV000935131	11	532703	11	532703	935131	935594	rs756367459	NC_000011.10:532702:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.498C>A (p.His166Gln)	HRAS|LRRC56	H166Q, H87Q	Costello syndrome	VCV000240136	11	532708	11	532708	240136	241154	rs878854760	NC_000011.10:532707:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Dec 28, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.497A>G (p.His166Arg)	HRAS|LRRC56	H166R, H87R	Costello syndrome|HRAS-related disorder	VCV001019189	11	532709	11	532709	1019189	1009737	rs1851180327	NC_000011.10:532708:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 21, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.496C>T (p.His166Tyr)	HRAS|LRRC56	H166Y, H87Y	Costello syndrome	VCV001408362	11	532710	11	532710	1408362	1422009	rs1439562437	NC_000011.10:532709:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.495G>A (p.Gln165=)	HRAS|LRRC56		Costello syndrome	VCV001569234	11	532711	11	532711	1569234	1603782	rs2133982327	NC_000011.10:532710:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 29, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.493C>A (p.Gln165Lys)	HRAS|LRRC56	Q165K, Q86K	Costello syndrome	VCV002821352	11	532713	11	532713	2821352	2988428		NC_000011.10:532712:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.492G>A (p.Arg164=)	HRAS|LRRC56		Costello syndrome	VCV000775476	11	532714	11	532714	775476	701802	rs1461319720	NC_000011.10:532713:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.491G>A (p.Arg164Gln)	HRAS|LRRC56	R164Q, R85Q	Costello syndrome|not provided|HRAS-related disorder	VCV000948223	11	532715	11	532715	948223	926272	rs753977266	NC_000011.10:532714:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.491G>C (p.Arg164Pro)	HRAS|LRRC56	R164P, R85P	Costello syndrome|Large congenital melanocytic nevus|Costello syndrome|Thyroid cancer, nonmedullary, 2|Linear nevus sebaceous syndrome|Malignant tumor of urinary bladder|Epidermal nevus	VCV000850426	11	532715	11	532715	850426	838560	rs753977266	NC_000011.10:532714:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.490C>T (p.Arg164Trp)	HRAS|LRRC56	R164W, R85W	Hereditary cancer-predisposing syndrome|Costello syndrome	VCV000579709	11	532716	11	532716	579709	564738	rs779101895	NC_000011.10:532715:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 17, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.489C>G (p.Ile163Met)	HRAS|LRRC56	I163M, I84M	Costello syndrome	VCV002416982	11	532717	11	532717	2416982	1944141		NC_000011.10:532716:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.489C>A (p.Ile163=)	HRAS|LRRC56		Costello syndrome	VCV001122767	11	532717	11	532717	1122767	1121539	rs2133982379	NC_000011.10:532716:G:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 2, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.487A>T (p.Ile163Phe)	HRAS|LRRC56	I163F, I84F	Costello syndrome	VCV000580753	11	532719	11	532719	580753	567334	rs1564787934	NC_000011.10:532718:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.486G>C (p.Glu162Asp)	HRAS|LRRC56	E162D, E83D	Costello syndrome	VCV002098197	11	532720	11	532720	2098197	2147053		NC_000011.10:532719:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.484G>C (p.Glu162Gln)	HRAS|LRRC56	E162Q, E83Q	Costello syndrome	VCV001713326	11	532722	11	532722	1713326	1777221		NC_000011.10:532721:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 22, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.484G>A (p.Glu162Lys)	HRAS|LRRC56	E162K, E83K	Costello syndrome|not provided	VCV001034833	11	532722	11	532722	1034833	1030300	rs1564787942	NC_000011.10:532721:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.483T>G (p.Arg161=)	HRAS|LRRC56		not provided	VCV002641068	11	532723	11	532723	2641068	2806382		NC_000011.10:532722:A:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 1, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.483T>C (p.Arg161=)	HRAS|LRRC56		Costello syndrome	VCV001091737	11	532723	11	532723	1091737	1078337	rs2133982410	NC_000011.10:532722:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.482G>A (p.Arg161His)	HRAS|LRRC56	R161H, R82H	not specified|Costello syndrome	VCV000517437	11	532724	11	532724	517437	497621	rs748729430	NC_000011.10:532723:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.481C>G (p.Arg161Gly)	HRAS|LRRC56	R161G, R82G	Hereditary cancer-predisposing syndrome	VCV001692890	11	532725	11	532725	1692890	1685330	rs758956556	NC_000011.10:532724:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 8, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.481C>T (p.Arg161Cys)	HRAS|LRRC56	R161C, R82C	not provided|Costello syndrome|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Linear nevus sebaceous syndrome|Large congenital melanocytic nevus|Malignant tumor of urinary bladder|Costello syndrome	VCV000644041	11	532725	11	532725	644041	640153	rs758956556	NC_000011.10:532724:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 4, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.480G>C (p.Val160=)	HRAS|LRRC56		Costello syndrome	VCV001631844	11	532726	11	532726	1631844	1597646	rs2133982437	NC_000011.10:532725:C:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 7, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.479T>G (p.Val160Gly)	HRAS|LRRC56	V81G, V160G	Costello syndrome	VCV001938886	11	532727	11	532727	1938886	2004213		NC_000011.10:532726:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.479T>C (p.Val160Ala)	HRAS|LRRC56	V160A, V81A	Costello syndrome	VCV001019983	11	532727	11	532727	1019983	1009738	rs1851181776	NC_000011.10:532726:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 8, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.478G>C (p.Val160Leu)	HRAS|LRRC56	V160L, V81L	Cardiovascular phenotype	VCV003284768	11	532728	11	532728	3284768	3433919		NC_000011.10:532727:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 3, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.477G>T (p.Leu159Phe)	HRAS|LRRC56	L159F, L80F	Costello syndrome	VCV002128760	11	532729	11	532729	2128760	2178783		NC_000011.10:532728:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 21, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.477G>A (p.Leu159=)	HRAS|LRRC56		RASopathy	VCV000040446	11	532729	11	532729	40446	48916	rs140060409	NC_000011.10:532728:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.476T>C (p.Leu159Ser)	HRAS|LRRC56	L159S, L80S	Costello syndrome	VCV001347756	11	532730	11	532730	1347756	1391672	rs2133982455	NC_000011.10:532729:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.473_475delinsG (p.Thr158fs)	HRAS|LRRC56	T158fs, T79fs	Costello syndrome	VCV003010191	11	532731 - 532733	11	532731 - 532733	3010191	3176927		NC_000011.10:532730:ACG:C	Indel	frameshift variant|3 prime UTR variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.474G>C (p.Thr158=)	HRAS|LRRC56		Costello syndrome	VCV002884864	11	532732	11	532732	2884864	3050208		NC_000011.10:532731:C:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 9, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.474G>A (p.Thr158=)	HRAS|LRRC56		Costello syndrome	VCV000462155	11	532732	11	532732	462155	461200	rs747269683	NC_000011.10:532731:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 8, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.473C>A (p.Thr158Lys)	HRAS|LRRC56	T158K, T79K	Costello syndrome	VCV003015521	11	532733	11	532733	3015521	3174498		NC_000011.10:532732:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 19, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.473C>G (p.Thr158Arg)	HRAS|LRRC56	T158R, T79R	Costello syndrome	VCV002146977	11	532733	11	532733	2146977	1870627		NC_000011.10:532732:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.473C>T (p.Thr158Met)	HRAS|LRRC56	T158M, T79M	Costello syndrome|not provided	VCV000134514	11	532733	11	532733	134514	138253	rs587778400	NC_000011.10:532732:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.469T>C (p.Tyr157His)	HRAS|LRRC56	Y157H, Y78H	Costello syndrome	VCV001008068	11	532737	11	532737	1008068	994566	rs1851182643	NC_000011.10:532736:A:G	single nucleotide variant	3 prime UTR variant|missense variant	Uncertain significance	Oct 9, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.468C>G (p.Phe156Leu)	LRRC56|HRAS	F156L, F77L	not provided	VCV001198752	11	532738	11	532738	1198752	1187757	rs770648642	NC_000011.10:532737:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Apr 23, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.468C>T (p.Phe156=)	LRRC56|HRAS		Costello syndrome|not specified	VCV000227430	11	532738	11	532738	227430	230220	rs770648642	NC_000011.10:532737:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 13, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.466T>C (p.Phe156Leu)	HRAS|LRRC56	F156L, F77L	Costello syndrome	VCV001327492	11	532740	11	532740	1327492	1318065	rs2133982557	NC_000011.10:532739:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Dec 8, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.465C>T (p.Ala155=)	HRAS|LRRC56		Costello syndrome	VCV001146773	11	532741	11	532741	1146773	1142405	rs375878504	NC_000011.10:532740:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.464C>T (p.Ala155Val)	HRAS|LRRC56	A76V, A155V	Costello syndrome	VCV000964643	11	532742	11	532742	964643	956531	rs1269551105	NC_000011.10:532741:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.463G>A (p.Ala155Thr)	HRAS|LRRC56	A155T, A76T	Costello syndrome	VCV001063343	11	532743	11	532743	1063343	1047284	rs1171537215	NC_000011.10:532742:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 27, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.463G>T (p.Ala155Ser)	HRAS|LRRC56	A76S, A155S	Costello syndrome	VCV000936794	11	532743	11	532743	936794	935595	rs1171537215	NC_000011.10:532742:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.462T>C (p.Asp154=)	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype	VCV001566597	11	532744	11	532744	1566597	1569121	rs1412169294	NC_000011.10:532743:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 3, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.461A>T (p.Asp154Val)	HRAS|LRRC56	D154V, D75V	Costello syndrome	VCV000578573	11	532745	11	532745	578573	567338	rs1434040739	NC_000011.10:532744:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.460G>T (p.Asp154Tyr)	HRAS|LRRC56	D154Y, D75Y	Costello syndrome	VCV002817156	11	532746	11	532746	2817156	2980814		NC_000011.10:532745:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Nov 29, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.460G>A (p.Asp154Asn)	HRAS|LRRC56	D154N, D75N	not provided|Costello syndrome	VCV000040445	11	532746	11	532746	40445	48915	rs745497215	NC_000011.10:532745:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Feb 13, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.459G>A (p.Glu153=)	HRAS|LRRC56		Costello syndrome	VCV001557364	11	532747	11	532747	1557364	1627807	rs2133982634	NC_000011.10:532746:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	May 2, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.457G>T (p.Glu153Ter)	HRAS|LRRC56	E153*, E74*	Costello syndrome	VCV002810889	11	532749	11	532749	2810889	2975403		NC_000011.10:532748:C:A	single nucleotide variant	nonsense|3 prime UTR variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.454G>A (p.Val152Met)	HRAS|LRRC56	V152M, V73M	not provided|Costello syndrome	VCV001321132	11	532752	11	532752	1321132	1311376	rs1851183840	NC_000011.10:532751:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 20, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.452G>C (p.Gly151Ala)	HRAS|LRRC56	G151A, G72A	Costello syndrome	VCV000462154	11	532754	11	532754	462154	461709	rs1362209698	NC_000011.10:532753:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451G>C (p.Gly151Arg)	HRAS|LRRC56	G151R, G72R	Costello syndrome	VCV002156214	11	532755	11	532755	2156214	1889813		NC_000011.10:532754:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451G>A (p.Gly151Arg)	HRAS|LRRC56	G151R, G72R	Costello syndrome	VCV002093477	11	532755	11	532755	2093477	2156557		NC_000011.10:532754:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 24, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-3C>T	HRAS|LRRC56		Costello syndrome	VCV000648589	11	532758	11	532758	648589	652212	rs1158205210	NC_000011.10:532757:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-4C>G	HRAS|LRRC56		Costello syndrome	VCV002093523	11	532759	11	532759	2093523	2152727		NC_000011.10:532758:G:C	single nucleotide variant	intron variant	Likely benign	Feb 5, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-4C>T	HRAS|LRRC56		Costello syndrome	VCV000666417	11	532759	11	532759	666417	653976	rs1589789708	NC_000011.10:532758:G:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-5C>T	HRAS|LRRC56		Cardiovascular phenotype|not provided|Costello syndrome	VCV000514968	11	532760	11	532760	514968	503676	rs370181298	NC_000011.10:532759:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.451-5C>G	HRAS|LRRC56		not provided|Costello syndrome	VCV000415886	11	532760	11	532760	415886	398664	rs370181298	NC_000011.10:532759:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.451-6T>C	HRAS|LRRC56		Costello syndrome	VCV001615748	11	532761	11	532761	1615748	1547690	rs1480423930	NC_000011.10:532760:A:G	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-6T>G	HRAS|LRRC56		Costello syndrome	VCV000955868	11	532761	11	532761	955868	959992	rs1480423930	NC_000011.10:532760:A:C	single nucleotide variant	intron variant	Uncertain significance	Sep 10, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-22_451-8dup	HRAS|LRRC56		Costello syndrome	VCV001609012	11	532762 - 532763	11	532762 - 532763	1609012	1573882	rs1159599721	NC_000011.10:532762:AGGAGGGATGGGATCAGGAGGGA:AGGAGGGATGGGATCAGGAGGGATGGGATCAGGAGGGA	Duplication	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-8T>C	HRAS|LRRC56		Costello syndrome	VCV000706417	11	532763	11	532763	706417	695528	rs373444310	NC_000011.10:532762:A:G	single nucleotide variant	intron variant	Likely benign	Nov 10, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-9C>T	HRAS|LRRC56		Costello syndrome	VCV001537689	11	532764	11	532764	1537689	1649968	rs763872424	NC_000011.10:532763:G:A	single nucleotide variant	intron variant	Likely benign	Oct 15, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-10C>T	HRAS|LRRC56		Costello syndrome	VCV000721681	11	532765	11	532765	721681	744533	rs1589789759	NC_000011.10:532764:G:A	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-12C>T	HRAS|LRRC56		Costello syndrome	VCV001568532	11	532767	11	532767	1568532	1570622	rs1204923566	NC_000011.10:532766:G:A	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-13C>A	HRAS|LRRC56		Costello syndrome	VCV001661581	11	532768	11	532768	1661581	1607942	rs761468352	NC_000011.10:532767:G:T	single nucleotide variant	intron variant	Likely benign	Sep 29, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-13C>T	HRAS|LRRC56		Costello syndrome	VCV001638681	11	532768	11	532768	1638681	1624367	rs761468352	NC_000011.10:532767:G:A	single nucleotide variant	intron variant	Likely benign	Nov 5, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-14C>A	HRAS|LRRC56		Costello syndrome	VCV003011061	11	532769	11	532769	3011061	3170095		NC_000011.10:532768:G:T	single nucleotide variant	intron variant	Likely benign	Jul 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-14C>T	HRAS|LRRC56		Costello syndrome	VCV001570422	11	532769	11	532769	1570422	1536917	rs367678988	NC_000011.10:532768:G:A	single nucleotide variant	intron variant	Likely benign	Sep 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-15T>C	HRAS|LRRC56		Costello syndrome	VCV001632968	11	532770	11	532770	1632968	1545362	rs1644141623	NC_000011.10:532769:A:G	single nucleotide variant	intron variant	Likely benign	Jan 6, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-16A>G	HRAS|LRRC56		Costello syndrome	VCV002704050	11	532771	11	532771	2704050	2856476		NC_000011.10:532770:T:C	single nucleotide variant	intron variant	Likely benign	Aug 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-17C>T	HRAS|LRRC56		Costello syndrome	VCV001577800	11	532772	11	532772	1577800	1522228	rs754150592	NC_000011.10:532771:G:A	single nucleotide variant	intron variant	Likely benign	Jul 30, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-19C>T	HRAS|LRRC56		Costello syndrome	VCV002161739	11	532774	11	532774	2161739	1887518		NC_000011.10:532773:G:A	single nucleotide variant	intron variant	Likely benign	Aug 4, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-20T>G	HRAS|LRRC56		Costello syndrome	VCV002031953	11	532775	11	532775	2031953	2086013		NC_000011.10:532774:A:C	single nucleotide variant	intron variant	Likely benign	Sep 27, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-48C>T	HRAS|LRRC56		not provided	VCV000561443	11	532803	11	532803	561443	552659	rs45607337	NC_000011.10:532802:G:A	single nucleotide variant	intron variant	Likely benign	Jun 19, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-168T>G	HRAS|LRRC56		not provided	VCV000561388	11	532923	11	532923	561388	552660	rs35601764	NC_000011.10:532922:A:C	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-224G>A	HRAS|LRRC56		not provided	VCV001236387	11	532979	11	532979	1236387	1228096	rs114143453	NC_000011.10:532978:C:T	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-282C>T	HRAS|LRRC56		not provided	VCV000561855	11	533037	11	533037	561855	552661	rs45626636	NC_000011.10:533036:G:A	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.451-341G>A	LRRC56|HRAS		not provided	VCV000561445	11	533096	11	533096	561445	552662	rs45489193	NC_000011.10:533095:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+181G>A	HRAS|LRRC56		Epidermolytic nevus	VCV002672093	11	533272	11	533272	2672093	2839621		NC_000011.10:533271:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+174G>A	HRAS|LRRC56	A71T	not provided	VCV000379346	11	533279	11	533279	379346	371486	rs371117417	NC_000011.10:533278:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Apr 1, 2016	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+171C>T	HRAS|LRRC56	R70C	not specified	VCV000179859	11	533282	11	533282	179859	175213	rs376091236	NC_000011.10:533281:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	not provided	Jul 1, 2014	no classification provided						
NM_005343.4(HRAS):c.450+170T>G	HRAS|LRRC56		HRAS-related disorder	VCV003048018	11	533283	11	533283	3048018	3209588		NC_000011.10:533282:A:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Mar 1, 2023	no assertion criteria provided						
NM_176795.5(HRAS):c.488_507del (p.Leu163fs)	HRAS|LRRC56	L163fs, S57fs	RASopathy	VCV000830080	11	533302 - 533321	11	533302 - 533321	830080	818441	rs776060230	NC_000011.10:533301:GGGTCCCGGGGGGTCCCAGAGGGTCCCGG:GGGTCCCGG	Deletion	frameshift variant|intron variant	Benign	Nov 4, 2019	reviewed by expert panel						
NM_176795.5(HRAS):c.501G>A (p.Pro167=)	HRAS|LRRC56	R61Q	not provided	VCV001198269	11	533308	11	533308	1198269	1187758	rs764211685	NC_000011.10:533307:C:T	single nucleotide variant	missense variant|synonymous variant|intron variant	Likely benign	Mar 26, 2019	criteria provided, single submitter						
NM_176795.5(HRAS):c.500dup (p.Pro169fs)	HRAS|LRRC56	P169fs, R61fs	Congenital fibrosis of extraocular muscles|Costello syndrome	VCV000522672	11	533308 - 533309	11	533308 - 533309	522672	513316	rs35613389	NC_000011.10:533308:GGGGGG:GGGGGGG	Duplication	frameshift variant|intron variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts						
NM_176795.5(HRAS):c.500C>T (p.Pro167Leu)	HRAS|LRRC56	P167L, R61W	not specified	VCV000040444	11	533309	11	533309	40444	48914	rs730880457	NC_000011.10:533308:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 26, 2012	criteria provided, single submitter						
NM_176795.5(HRAS):c.498C>G (p.Pro166=)	HRAS|LRRC56	P60R	not provided	VCV001267195	11	533311	11	533311	1267195	1254518	rs377676071	NC_000011.10:533310:G:C	single nucleotide variant	missense variant|synonymous variant|intron variant	Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_176795.5(HRAS):c.488_497del (p.Leu163fs)	HRAS|LRRC56	L163fs, S57fs	Costello syndrome	VCV001321186	11	533312 - 533321	11	533312 - 533321	1321186	1311425	rs764755556	NC_000011.10:533311:GGGTCCCAGAGGGTCCC:GGGTCCC	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Nov 2, 2021	criteria provided, multiple submitters, no conflicts						
NM_176795.5(HRAS):c.481G>A (p.Gly161Arg)	HRAS|LRRC56	G161R	not provided	VCV001319799	11	533328	11	533328	1319799	1310048	rs750721065	NC_000011.10:533327:C:T	single nucleotide variant	synonymous variant|missense variant|intron variant	Uncertain significance	Dec 20, 2022	criteria provided, multiple submitters, no conflicts						
NM_176795.5(HRAS):c.480C>T (p.Ser160=)	HRAS|LRRC56	P54L	not provided	VCV000384895	11	533329	11	533329	384895	372230	rs1057522069	NC_000011.10:533328:G:A	single nucleotide variant	missense variant|synonymous variant|intron variant	Likely benign	Mar 17, 2016	criteria provided, single submitter						
NM_176795.5(HRAS):c.463_468dup (p.Gly155_Ser156dup)	HRAS|LRRC56		Noonan syndrome	VCV000981548	11	533340 - 533341	11	533340 - 533341	981548	969663		NC_000011.10:533340:AGAGCCAGAGC:AGAGCCAGAGCCAGAGC	Duplication	inframe_insertion|intron variant	Uncertain significance		no assertion criteria provided						
NM_176795.5(HRAS):c.457C>T (p.Arg153Cys)	HRAS|LRRC56	R153C	HRAS-related disorder	VCV003040518	11	533352	11	533352	3040518	3214047		NC_000011.10:533351:G:A	single nucleotide variant	synonymous variant|missense variant|intron variant	Likely benign	Nov 21, 2019	no assertion criteria provided						
NM_176795.5(HRAS):c.451-12_451del	HRAS|LRRC56		not specified	VCV001677298	11	533358 - 533370	11	533358 - 533370	1677298	1668956	rs2133985401	NC_000011.10:533357:CCTGTGTCAAGGG:	Deletion	intron variant|splice acceptor variant	Uncertain significance		no assertion criteria provided						
NM_005343.4(HRAS):c.450+84C>A	HRAS|LRRC56		not specified	VCV000179526	11	533369	11	533369	179526	174802	rs727504926	NC_000011.10:533368:G:T	single nucleotide variant	intron variant	Uncertain significance	Feb 4, 2014	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+49G>A	HRAS|LRRC56		not provided	VCV001264485	11	533404	11	533404	1264485	1256106	rs568602129	NC_000011.10:533403:C:T	single nucleotide variant	intron variant	Benign	Jan 2, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+38dup	HRAS|LRRC56		Squamous cell lung carcinoma	VCV000873189	11	533414 - 533415	11	533414 - 533415	873189	861315	rs1851232069	NC_000011.10:533414:GGG:GGGG	Duplication	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided						
NM_005343.4(HRAS):c.450+38C>T	HRAS|LRRC56		not provided	VCV001223994	11	533415	11	533415	1223994	1214267	rs201986435	NC_000011.10:533414:G:A	single nucleotide variant	intron variant	Benign	Dec 19, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+35A>C	HRAS|LRRC56		Squamous cell lung carcinoma	VCV000873190	11	533418	11	533418	873190	861316	rs749486358	NC_000011.10:533417:T:G	single nucleotide variant	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided						
NM_005343.4(HRAS):c.450+31A>G	HRAS|LRRC56		Squamous cell lung carcinoma	VCV000873191	11	533422	11	533422	873191	861317	rs1300614609	NC_000011.10:533421:T:C	single nucleotide variant	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided						
NM_005343.4(HRAS):c.450+20C>T	HRAS|LRRC56		Costello syndrome	VCV001901998	11	533433	11	533433	1901998	1954038		NC_000011.10:533432:G:A	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+20C>G	HRAS|LRRC56		Costello syndrome	VCV001552555	11	533433	11	533433	1552555	1586634	rs201524241	NC_000011.10:533432:G:C	single nucleotide variant	intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+20C>A	HRAS|LRRC56		not specified|Costello syndrome	VCV000929129	11	533433	11	533433	929129	917487	rs201524241	NC_000011.10:533432:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 21, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.450+19C>T	HRAS|LRRC56		Costello syndrome	VCV002758716	11	533434	11	533434	2758716	2921187		NC_000011.10:533433:G:A	single nucleotide variant	intron variant	Likely benign	Sep 15, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+18C>A	HRAS|LRRC56		Costello syndrome	VCV001954748	11	533435	11	533435	1954748	2014890		NC_000011.10:533434:G:T	single nucleotide variant	intron variant	Likely benign	Apr 24, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+18C>T	LRRC56|HRAS		not provided|Costello syndrome	VCV000385544	11	533435	11	533435	385544	371488	rs1057522255	NC_000011.10:533434:G:A	single nucleotide variant	intron variant	Likely benign	Aug 28, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.450+17C>T	HRAS|LRRC56		not specified|Costello syndrome	VCV000917726	11	533436	11	533436	917726	906055	rs367869009	NC_000011.10:533435:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 27, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.440_450+16del	HRAS|LRRC56		Costello syndrome	VCV002853311	11	533437 - 533463	11	533437 - 533463	2853311	3016782		NC_000011.10:533436:TGGAGAGCTGCCTCACCTGCCGGGTCTTGG:TGG	Deletion	splice donor variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+16A>G	HRAS|LRRC56		Costello syndrome	VCV001546935	11	533437	11	533437	1546935	1645911	rs754589455	NC_000011.10:533436:T:C	single nucleotide variant	intron variant	Likely benign	Aug 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+15C>T	HRAS|LRRC56		Costello syndrome	VCV001587080	11	533438	11	533438	1587080	1629020	rs1851235106	NC_000011.10:533437:G:A	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+14C>T	HRAS|LRRC56		Costello syndrome	VCV001946318	11	533439	11	533439	1946318	2002596		NC_000011.10:533438:G:A	single nucleotide variant	intron variant	Likely benign	Sep 17, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+13T>C	HRAS|LRRC56		Costello syndrome	VCV001588800	11	533440	11	533440	1588800	1641126	rs752168787	NC_000011.10:533439:A:G	single nucleotide variant	intron variant	Likely benign	Oct 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+9G>A	HRAS|LRRC56		Costello syndrome	VCV002175134	11	533444	11	533444	2175134	1901273		NC_000011.10:533443:C:T	single nucleotide variant	intron variant	Likely benign	Sep 13, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+7C>T	HRAS|LRRC56		Costello syndrome	VCV002161724	11	533446	11	533446	2161724	1887503		NC_000011.10:533445:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.450+4A>C	HRAS|LRRC56		Costello syndrome	VCV002963846	11	533449	11	533449	2963846	3127260		NC_000011.10:533448:T:G	single nucleotide variant	intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.448C>T (p.Gln150Ter)	HRAS|LRRC56	Q150*	not provided	VCV000424493	11	533455	11	533455	424493	408384	rs1064796999	NC_000011.10:533454:G:A	single nucleotide variant	nonsense|synonymous variant	Uncertain significance	Oct 13, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.447G>A (p.Arg149=)	HRAS|LRRC56	G43D	Costello syndrome	VCV001659502	11	533456	11	533456	1659502	1543231	rs2133986135	NC_000011.10:533455:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.445dup (p.Arg149fs)	HRAS|LRRC56	G43fs, R149fs	not provided	VCV003252223	11	533457 - 533458	11	533457 - 533458	3252223	3411019		NC_000011.10:533457:GGG:GGGG	Duplication	frameshift variant	Uncertain significance	Sep 30, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.446G>A (p.Arg149Gln)	HRAS|LRRC56	R149Q, G43S	Costello syndrome|HRAS-related disorder	VCV002037387	11	533457	11	533457	2037387	2097878		NC_000011.10:533456:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.445C>A (p.Arg149=)	HRAS|LRRC56		Costello syndrome	VCV002978950	11	533458	11	533458	2978950	3141479		NC_000011.10:533457:G:T	single nucleotide variant	synonymous variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.445del (p.Arg149fs)	HRAS|LRRC56	R149fs, G43fs	Costello syndrome	VCV001390411	11	533458	11	533458	1390411	1396584	rs2133986181	NC_000011.10:533457:GGG:GG	Deletion	frameshift variant	Uncertain significance	Oct 31, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.445C>T (p.Arg149Trp)	LRRC56|HRAS	R149W	Costello syndrome|not provided|not specified	VCV000503536	11	533458	11	533458	503536	494969	rs1554884750	NC_000011.10:533457:G:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.443C>G (p.Thr148Ser)	HRAS|LRRC56	P42A, T148S	Costello syndrome	VCV002893865	11	533460	11	533460	2893865	3045797		NC_000011.10:533459:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.441G>A (p.Lys147=)	HRAS|LRRC56	R41K	not provided|Cardiovascular phenotype|Costello syndrome	VCV000462153	11	533462	11	533462	462153	462038	rs777386438	NC_000011.10:533461:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 7, 2021	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.177_433dup (p.Glu98Ter)	HRAS|LRRC56	E98*	Costello syndrome	VCV002044453	11	533463 - 533464	11	533463 - 533464	2044453	2095878			Duplication	nonsense|splice acceptor variant|splice donor variant|initiator_codon_variant	Uncertain significance	Dec 16, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.438C>T (p.Ala146=)	HRAS|LRRC56	P40L	Costello syndrome	VCV002162148	11	533465	11	533465	2162148	1884536		NC_000011.10:533464:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	May 31, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.438C>A (p.Ala146=)	HRAS|LRRC56	P40Q	Costello syndrome	VCV001107363	11	533465	11	533465	1107363	1100055	rs1851236604	NC_000011.10:533464:G:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Jun 27, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.437C>T (p.Ala146Val)	HRAS|LRRC56	A146V, P40S	Costello syndrome	VCV000012611	11	533466	11	533466	12611	27650	rs121917759	NC_000011.10:533465:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 29, 2018	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.436G>A (p.Ala146Thr)	HRAS|LRRC56	A146T	Costello syndrome	VCV000012607	11	533467	11	533467	12607	27646	rs104894231	NC_000011.10:533466:C:T	single nucleotide variant	missense variant|synonymous variant	Pathogenic	Mar 1, 2007	no assertion criteria provided						
NM_005343.4(HRAS):c.435G>C (p.Ser145=)	HRAS|LRRC56	R39P	Costello syndrome	VCV001159352	11	533468	11	533468	1159352	1142406	rs747008553	NC_000011.10:533467:C:G	single nucleotide variant	synonymous variant|missense variant	Likely benign	Jun 1, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.435G>A (p.Ser145=)	HRAS|LRRC56	R39Q	Cardiovascular phenotype|Costello syndrome	VCV000462152	11	533468	11	533468	462152	461203	rs747008553	NC_000011.10:533467:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Dec 12, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.434C>T (p.Ser145Leu)	LRRC56|HRAS	R39W, S145L	HRAS-related disorder	VCV003029345	11	533469	11	533469	3029345	3194421		NC_000011.10:533468:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	no assertion criteria provided						
NM_005343.4(HRAS):c.432C>T (p.Thr144=)	HRAS|LRRC56	P38L	Cardiovascular phenotype	VCV002565161	11	533471	11	533471	2565161	2732135		NC_000011.10:533470:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Apr 24, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.412_431del (p.Gly138fs)	HRAS|LRRC56	G138fs, A32fs	Costello syndrome	VCV000951790	11	533472 - 533491	11	533472 - 533491	951790	926273	rs1851237302	NC_000011.10:533471:GTCTCGATGTAGGGGATGCCGT:GT	Deletion	frameshift variant	Uncertain significance	Aug 16, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.429G>A (p.Glu143=)	HRAS|LRRC56	R37K	Costello syndrome	VCV002893617	11	533474	11	533474	2893617	3049003		NC_000011.10:533473:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Oct 29, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.429G>C (p.Glu143Asp)	HRAS|LRRC56	R37T, E143D	Costello syndrome	VCV001505329	11	533474	11	533474	1505329	1436896	rs1226399807	NC_000011.10:533473:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.427G>A (p.Glu143Lys)	HRAS|LRRC56	E143K	Costello syndrome	VCV001021116	11	533476	11	533476	1021116	1009739	rs909222512	NC_000011.10:533475:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.427G>C (p.Glu143Gln)	HRAS|LRRC56	E143Q	not provided|Costello syndrome	VCV000954226	11	533476	11	533476	954226	947499	rs909222512	NC_000011.10:533475:C:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Oct 31, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.424_426del (p.Ile142del)	HRAS|LRRC56	I142del, S36del	Costello syndrome	VCV002737254	11	533477 - 533479	11	533477 - 533479	2737254	2901931		NC_000011.10:533476:GATG:G	Deletion	inframe_deletion	Uncertain significance	Apr 28, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.426C>A (p.Ile142=)	HRAS|LRRC56	S36*	Costello syndrome	VCV001024308	11	533477	11	533477	1024308	1009740	rs533567288	NC_000011.10:533476:G:T	single nucleotide variant	synonymous variant|nonsense	Uncertain significance	Aug 26, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.426C>G (p.Ile142Met)	HRAS|LRRC56	S36W, I142M	Costello syndrome|Cardiovascular phenotype	VCV000936167	11	533477	11	533477	936167	935596	rs533567288	NC_000011.10:533476:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.426C>T (p.Ile142=)	HRAS|LRRC56	S36L	not provided|Costello syndrome|Cardiovascular phenotype	VCV000378902	11	533477	11	533477	378902	371489	rs533567288	NC_000011.10:533476:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Feb 14, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.425T>C (p.Ile142Thr)	HRAS|LRRC56	I142T, S36P	Costello syndrome	VCV001385979	11	533478	11	533478	1385979	1360987	rs2133986466	NC_000011.10:533477:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.424A>T (p.Ile142Phe)	HRAS|LRRC56	I142F	Costello syndrome	VCV002416003	11	533479	11	533479	2416003	1937351		NC_000011.10:533478:T:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.424A>G (p.Ile142Val)	HRAS|LRRC56	I142V	Costello syndrome	VCV001047151	11	533479	11	533479	1047151	1030301	rs1564788848	NC_000011.10:533478:T:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.424A>C (p.Ile142Leu)	HRAS|LRRC56	I142L	Costello syndrome	VCV000574796	11	533479	11	533479	574796	567341	rs1564788848	NC_000011.10:533478:T:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jul 13, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.423C>T (p.Tyr141=)	LRRC56|HRAS	T35I	Costello syndrome|Cardiovascular phenotype	VCV000757785	11	533480	11	533480	757785	768485	rs1589791513	NC_000011.10:533479:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Apr 4, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.422A>G (p.Tyr141Cys)	HRAS|LRRC56	T35A, Y141C	Costello syndrome|Hereditary cancer-predisposing syndrome	VCV000838341	11	533481	11	533481	838341	838561	rs372048612	NC_000011.10:533480:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.420C>T (p.Pro140=)	HRAS|LRRC56	P34L	Costello syndrome	VCV001092016	11	533483	11	533483	1092016	1078338	rs2133986528	NC_000011.10:533482:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Jun 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.419C>T (p.Pro140Leu)	HRAS|LRRC56	P140L, P34S	Costello syndrome|Cardiovascular phenotype	VCV000959406	11	533484	11	533484	959406	947500	rs745637518	NC_000011.10:533483:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.418C>T (p.Pro140Ser)	LRRC56|HRAS	P140S	Costello syndrome|not specified	VCV000177861	11	533485	11	533485	177861	175214	rs144001095	NC_000011.10:533484:G:A	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.417C>T (p.Ile139=)	HRAS|LRRC56	S33F	Costello syndrome	VCV001106261	11	533486	11	533486	1106261	1100056	rs2133986571	NC_000011.10:533485:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Oct 21, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.415A>T (p.Ile139Phe)	HRAS|LRRC56	I139F	Costello syndrome	VCV001430912	11	533488	11	533488	1430912	1467589	rs2133986598	NC_000011.10:533487:T:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jul 5, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.414C>T (p.Gly138=)	HRAS|LRRC56	A32V	Costello syndrome	VCV001442022	11	533489	11	533489	1442022	1474888	rs2133986610	NC_000011.10:533488:G:A	single nucleotide variant	synonymous variant|missense variant	Uncertain significance	Oct 19, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.414C>A (p.Gly138=)	HRAS|LRRC56	A32E	Costello syndrome	VCV001116345	11	533489	11	533489	1116345	1100057	rs2133986610	NC_000011.10:533488:G:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Feb 11, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.413G>T (p.Gly138Val)	HRAS|LRRC56	A32S, G138V	Costello syndrome	VCV001518179	11	533490	11	533490	1518179	1512450	rs1554884772	NC_000011.10:533489:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.413G>A (p.Gly138Asp)	HRAS|LRRC56	G138D, A32T	Costello syndrome	VCV000462151	11	533490	11	533490	462151	461389	rs1554884772	NC_000011.10:533489:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.412G>C (p.Gly138Arg)	HRAS|LRRC56	G138R	Costello syndrome	VCV002896174	11	533491	11	533491	2896174	3066855		NC_000011.10:533490:C:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	May 2, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.412G>A (p.Gly138Ser)	HRAS|LRRC56	G138S	RASopathy	VCV000045304	11	533491	11	533491	45304	54471	rs397517142	NC_000011.10:533490:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jul 25, 2019	reviewed by expert panel						
NM_005343.4(HRAS):c.411C>T (p.Tyr137=)	HRAS|LRRC56	T31M	Costello syndrome	VCV000531194	11	533492	11	533492	531194	526483	rs1471385417	NC_000011.10:533491:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Nov 15, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.410A>C (p.Tyr137Ser)	HRAS|LRRC56	T31P, Y137S	Cardiovascular phenotype|Linear nevus sebaceous syndrome|Epidermal nevus|Malignant tumor of urinary bladder|Large congenital melanocytic nevus|Costello syndrome|Thyroid cancer, nonmedullary, 2|Costello syndrome	VCV000835903	11	533493	11	533493	835903	838562	rs1180561549	NC_000011.10:533492:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.408C>T (p.Ser136=)	HRAS|LRRC56	A30V	Costello syndrome	VCV001655381	11	533495	11	533495	1655381	1615731	rs2133986691	NC_000011.10:533494:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Nov 24, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.407G>C (p.Ser136Thr)	HRAS|LRRC56	S136T, A30P	Costello syndrome	VCV002705867	11	533496	11	533496	2705867	2857004		NC_000011.10:533495:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.407G>A (p.Ser136Asn)	HRAS|LRRC56	A30T, S136N	Costello syndrome	VCV000939384	11	533496	11	533496	939384	935597	rs748289593	NC_000011.10:533495:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.406A>G (p.Ser136Gly)	HRAS|LRRC56	S136G	Costello syndrome	VCV002007771	11	533497	11	533497	2007771	2073432		NC_000011.10:533496:T:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jun 17, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.404G>A (p.Arg135Gln)	HRAS|LRRC56	E29K, R135Q	Costello syndrome	VCV001002072	11	533499	11	533499	1002072	994567	rs1473091760	NC_000011.10:533498:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.403C>G (p.Arg135Gly)	HRAS|LRRC56	R135G	not provided	VCV003371962	11	533500	11	533500	3371962	3531152		NC_000011.10:533499:G:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.403C>T (p.Arg135Ter)	HRAS|LRRC56	R135*	Costello syndrome	VCV002161363	11	533500	11	533500	2161363	1891072		NC_000011.10:533499:G:A	single nucleotide variant	nonsense|synonymous variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.401_402insAAGACCTCGC (p.Ser136fs)	HRAS|LRRC56	S136fs, P28fs	Costello syndrome	VCV002036547	11	533501 - 533502	11	533501 - 533502	2036547	2090603		NC_000011.10:533501:GCGAGGTC:GCGAGGTCTTGCGAGGTC	Insertion	frameshift variant	Uncertain significance	Oct 23, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.402C>T (p.Ala134=)	HRAS|LRRC56	P28L	Costello syndrome	VCV001949071	11	533501	11	533501	1949071	2006639		NC_000011.10:533500:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Feb 1, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.402C>G (p.Ala134=)	HRAS|LRRC56	P28R	Costello syndrome	VCV001156385	11	533501	11	533501	1156385	1142407	rs773270401	NC_000011.10:533500:G:C	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 4, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.401C>T (p.Ala134Val)	HRAS|LRRC56	A134V, P28S	not specified|Costello syndrome	VCV000045303	11	533502	11	533502	45303	54470	rs397517141	NC_000011.10:533501:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.400G>A (p.Ala134Thr)	HRAS|LRRC56	A134T	Costello syndrome	VCV001398877	11	533503	11	533503	1398877	1427942	rs1389157073	NC_000011.10:533502:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.399C>T (p.Leu133=)	HRAS|LRRC56	S27L	Costello syndrome	VCV001083789	11	533504	11	533504	1083789	1078339	rs761180869	NC_000011.10:533503:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Jun 30, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.398T>A (p.Leu133His)	HRAS|LRRC56	L133H, S27T	Cardiovascular phenotype|Costello syndrome|not provided	VCV000409951	11	533505	11	533505	409951	398759	rs766801436	NC_000011.10:533504:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.397C>T (p.Leu133Phe)	HRAS|LRRC56	L133F	Cardiovascular phenotype|Costello syndrome	VCV000531190	11	533506	11	533506	531190	526759	rs776888712	NC_000011.10:533505:G:A	single nucleotide variant	missense variant|synonymous variant	Conflicting classifications of pathogenicity	Sep 25, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.396C>T (p.Asp132=)	HRAS|LRRC56	T26I	Costello syndrome	VCV001123955	11	533507	11	533507	1123955	1121540	rs975107534	NC_000011.10:533506:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.395A>G (p.Asp132Gly)	HRAS|LRRC56	D132G, T26A	Costello syndrome	VCV002853575	11	533508	11	533508	2853575	3013374		NC_000011.10:533507:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.394G>A (p.Asp132Asn)	HRAS|LRRC56	D132N	not provided|Costello syndrome|not specified	VCV000567281	11	533509	11	533509	567281	564743	rs759893630	NC_000011.10:533508:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.393G>A (p.Gln131=)	HRAS|LRRC56	R25K	Costello syndrome	VCV001133616	11	533510	11	533510	1133616	1121541	rs2133986872	NC_000011.10:533509:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Jan 1, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.391C>G (p.Gln131Glu)	HRAS|LRRC56	Q131E	Costello syndrome	VCV001022017	11	533512	11	533512	1022017	1009741	rs376688893	NC_000011.10:533511:G:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	May 5, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.391C>T (p.Gln131Ter)	HRAS|LRRC56	Q131*	not provided|Costello syndrome	VCV000409949	11	533512	11	533512	409949	398678	rs376688893	NC_000011.10:533511:G:A	single nucleotide variant	nonsense|synonymous variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.390T>G (p.Ala130=)	HRAS|LRRC56	L24R	Costello syndrome	VCV001085417	11	533513	11	533513	1085417	1078340	rs2133986915	NC_000011.10:533512:A:C	single nucleotide variant	synonymous variant|missense variant	Likely benign	Feb 25, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.389C>T (p.Ala130Val)	HRAS|LRRC56	A130V, L24F	not provided	VCV003252346	11	533514	11	533514	3252346	3411142		NC_000011.10:533513:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.388G>C (p.Ala130Pro)	LRRC56|HRAS	A130P, R23S	Costello syndrome	VCV000583295	11	533515	11	533515	583295	564745	rs1564788957	NC_000011.10:533514:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 22, 2022	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.387G>A (p.Gln129=)	HRAS|LRRC56	R23K	Cardiovascular phenotype	VCV003284769	11	533516	11	533516	3284769	3433920		NC_000011.10:533515:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	May 23, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.386A>G (p.Gln129Arg)	HRAS|LRRC56	Q129R, R23G	Costello syndrome	VCV001028366	11	533517	11	533517	1028366	1017461	rs1851242529	NC_000011.10:533516:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 8, 2022	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.383G>T (p.Arg128Leu)	HRAS|LRRC56	G22C, R128L	Costello syndrome	VCV001487521	11	533520	11	533520	1487521	1485414	rs1554884794	NC_000011.10:533519:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.383G>A (p.Arg128Gln)	HRAS|LRRC56	R128Q, G22S	Costello syndrome	VCV000961076	11	533520	11	533520	961076	947501	rs1554884794	NC_000011.10:533519:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.383G>C (p.Arg128Pro)	HRAS|LRRC56	R128P, G22R	Costello syndrome	VCV000531192	11	533520	11	533520	531192	526484	rs1554884794	NC_000011.10:533519:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.382C>T (p.Arg128Trp)	HRAS|LRRC56	R128W	Costello syndrome	VCV000639168	11	533521	11	533521	639168	640154	rs1350889077	NC_000011.10:533520:G:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Apr 28, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.379T>C (p.Ser127Pro)	HRAS|LRRC56	S127P	Costello syndrome|Cardiovascular phenotype	VCV001045905	11	533524	11	533524	1045905	1030302	rs1221709596	NC_000011.10:533523:A:G	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.378A>G (p.Glu126=)	HRAS|LRRC56	N20S	RASopathy	VCV000040442	11	533525	11	533525	40442	48912	rs397517140	NC_000011.10:533524:T:C	single nucleotide variant	synonymous variant|missense variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.376G>T (p.Glu126Ter)	HRAS|LRRC56	E126*, W19C	Costello syndrome	VCV002421729	11	533527	11	533527	2421729	1945090		NC_000011.10:533526:C:A	single nucleotide variant	nonsense|missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.376G>C (p.Glu126Gln)	HRAS|LRRC56	E126Q, W19C	Costello syndrome	VCV001438088	11	533527	11	533527	1438088	1510825	rs763754805	NC_000011.10:533526:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.375G>A (p.Val125=)	HRAS|LRRC56	W19*	Costello syndrome	VCV001472323	11	533528	11	533528	1472323	1385471	rs1851243465	NC_000011.10:533527:C:T	single nucleotide variant	synonymous variant|nonsense	Likely benign	Nov 15, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.375G>C (p.Val125=)	HRAS|LRRC56	W19S	Costello syndrome	VCV001089010	11	533528	11	533528	1089010	1078341	rs1851243465	NC_000011.10:533527:C:G	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 31, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.374T>G (p.Val125Gly)	HRAS|LRRC56	V125G, W19G	Costello syndrome	VCV002889884	11	533529	11	533529	2889884	3054995		NC_000011.10:533528:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.374T>C (p.Val125Ala)	HRAS|LRRC56	V125A, W19R	Costello syndrome	VCV000981547	11	533529	11	533529	981547	969664		NC_000011.10:533528:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.373del (p.Val125fs)	HRAS|LRRC56	V125fs, W19fs	Costello syndrome	VCV002816042	11	533530	11	533530	2816042	2976712		NC_000011.10:533529:C:	Deletion	frameshift variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.370A>G (p.Thr124Ala)	HRAS|LRRC56	T124A	Costello syndrome|not provided	VCV001046957	11	533533	11	533533	1046957	1030303	rs1851243906	NC_000011.10:533532:T:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.369C>T (p.Arg123=)	HRAS|LRRC56	A17V	RASopathy	VCV000259747	11	533534	11	533534	259747	254209	rs200945755	NC_000011.10:533533:G:A	single nucleotide variant	synonymous variant|missense variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.368G>A (p.Arg123His)	HRAS|LRRC56	R123H, A17T	Costello syndrome	VCV001520643	11	533535	11	533535	1520643	1356002	rs730880464	NC_000011.10:533534:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.368G>C (p.Arg123Pro)	HRAS|LRRC56	R123P, A17P	Costello syndrome|Hereditary cancer-predisposing syndrome	VCV000180852	11	533535	11	533535	180852	179413	rs730880464	NC_000011.10:533534:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.367C>G (p.Arg123Gly)	HRAS|LRRC56	H16Q, R123G	Costello syndrome	VCV001443090	11	533536	11	533536	1443090	1371977	rs369106578	NC_000011.10:533535:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.367C>T (p.Arg123Cys)	HRAS|LRRC56	R123C	not specified|Costello syndrome|not provided	VCV000180851	11	533536	11	533536	180851	179414	rs369106578	NC_000011.10:533535:G:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.366A>G (p.Ala122=)	HRAS|LRRC56	H16R	Costello syndrome	VCV001126979	11	533537	11	533537	1126979	1121542	rs755980627	NC_000011.10:533536:T:C	single nucleotide variant	synonymous variant|missense variant	Likely benign	May 7, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.365C>T (p.Ala122Val)	LRRC56|HRAS	A122V, H16Y	Costello syndrome	VCV001415726	11	533538	11	533538	1415726	1371354	rs779711606	NC_000011.10:533537:G:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.364G>A (p.Ala122Thr)	HRAS|LRRC56	A122T	Costello syndrome	VCV001435264	11	533539	11	533539	1435264	1422238	rs1851244921	NC_000011.10:533538:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.363T>C (p.Ala121=)	HRAS|LRRC56	L15P	not provided|Costello syndrome|not specified|Cardiovascular phenotype|Noonan syndrome and Noonan-related syndrome	VCV000045302	11	533540	11	533540	45302	54469	rs146440188	NC_000011.10:533539:A:G	single nucleotide variant	synonymous variant|missense variant	Benign/Likely benign	Dec 25, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.362C>A (p.Ala121Asp)	HRAS|LRRC56	L15M, A121D	Costello syndrome	VCV001523512	11	533541	11	533541	1523512	1346809	rs376667492	NC_000011.10:533540:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.362C>T (p.Ala121Val)	HRAS|LRRC56	A121V	Costello syndrome|not provided	VCV000180855	11	533541	11	533541	180855	179415	rs376667492	NC_000011.10:533540:G:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	May 6, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.361G>A (p.Ala121Thr)	HRAS|LRRC56	W14*, A121T	Ovarian cancer|Costello syndrome	VCV001035777	11	533542	11	533542	1035777	1030304	rs1851245429	NC_000011.10:533541:C:T	single nucleotide variant	missense variant|nonsense	Conflicting classifications of pathogenicity	Jan 1, 2022	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.360G>C (p.Leu120=)	HRAS|LRRC56	W14S	Cardiovascular phenotype|Costello syndrome	VCV001149109	11	533543	11	533543	1149109	1142408	rs1851245565	NC_000011.10:533542:C:G	single nucleotide variant	synonymous variant|missense variant	Likely benign	Dec 7, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.358C>G (p.Leu120Val)	LRRC56|HRAS	L120V	Costello syndrome	VCV001024545	11	533545	11	533545	1024545	1009742	rs397517139	NC_000011.10:533544:G:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.358C>T (p.Leu120=)	HRAS|LRRC56		Cardiovascular phenotype|not specified|Costello syndrome	VCV000045301	11	533545	11	533545	45301	54468	rs397517139	NC_000011.10:533544:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.357C>T (p.Asp119=)	LRRC56|HRAS	T13I	RASopathy	VCV000040441	11	533546	11	533546	40441	48911	rs111352454	NC_000011.10:533545:G:A	single nucleotide variant	synonymous variant|missense variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.351G>A (p.Lys117=)	HRAS|LRRC56	S11N	Costello syndrome	VCV002126974	11	533552	11	533552	2126974	2178287		NC_000011.10:533551:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Apr 23, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.350A>G (p.Lys117Arg)	HRAS|LRRC56	K117R, S11G	Costello syndrome	VCV000012605	11	533553	11	533553	12605	27644	rs104894227	NC_000011.10:533552:T:C	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.347A>G (p.Asn116Ser)	HRAS|LRRC56	T10A, N116S	Costello syndrome	VCV002961373	11	533556	11	533556	2961373	3119991		NC_000011.10:533555:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.345G>A (p.Gly115=)	HRAS|LRRC56	G9E	Costello syndrome	VCV001161875	11	533558	11	533558	1161875	1142409	rs2133987449	NC_000011.10:533557:C:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Jul 13, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.343G>A (p.Gly115Arg)	HRAS|LRRC56	G115R, W8*	Costello syndrome	VCV002983589	11	533560	11	533560	2983589	3152949		NC_000011.10:533559:C:T	single nucleotide variant	missense variant|nonsense	Uncertain significance	Jul 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.342G>A (p.Val114=)	HRAS|LRRC56	W8*	Costello syndrome	VCV002724775	11	533561	11	533561	2724775	2888703		NC_000011.10:533560:C:T	single nucleotide variant	synonymous variant|nonsense	Likely benign	Jun 15, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.342G>C (p.Val114=)	HRAS|LRRC56	W8S	Costello syndrome	VCV001614016	11	533561	11	533561	1614016	1536771	rs2133987502	NC_000011.10:533560:C:G	single nucleotide variant	synonymous variant|missense variant	Likely benign	Sep 4, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.339G>A (p.Leu113=)	HRAS|LRRC56	W7*	Costello syndrome	VCV000240135	11	533564	11	533564	240135	241155	rs878854759	NC_000011.10:533563:C:T	single nucleotide variant	synonymous variant|nonsense	Likely benign	Jun 23, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.332T>C (p.Met111Thr)	LRRC56|HRAS	M111T, W5R	Costello syndrome	VCV000568861	11	533571	11	533571	568861	564747	rs1564789063	NC_000011.10:533570:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.331A>T (p.Met111Leu)	HRAS|LRRC56	M111L	Cardiovascular phenotype|Costello syndrome	VCV002958767	11	533572	11	533572	2958767	3126074		NC_000011.10:533571:T:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.331A>G (p.Met111Val)	HRAS|LRRC56	M111V	Costello syndrome	VCV001491189	11	533572	11	533572	1491189	1508424	rs771447288	NC_000011.10:533571:T:C	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.330C>A (p.Pro110=)	HRAS|LRRC56	P4Q	Costello syndrome	VCV002150089	11	533573	11	533573	2150089	1881555		NC_000011.10:533572:G:T	single nucleotide variant	synonymous variant|missense variant	Likely benign	Dec 21, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.330C>T (p.Pro110=)	HRAS|LRRC56	P4L	Noonan syndrome and Noonan-related syndrome|not specified|Cardiovascular phenotype|Costello syndrome|Large congenital melanocytic nevus|Malignant tumor of urinary bladder|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Linear nevus sebaceous syndrome|Costello syndrome	VCV000045300	11	533573	11	533573	45300	54467	rs200747280	NC_000011.10:533572:G:A	single nucleotide variant	synonymous variant|missense variant	Benign/Likely benign	Jan 19, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.329C>T (p.Pro110Leu)	HRAS|LRRC56	P110L, P4S	Costello syndrome	VCV001063136	11	533574	11	533574	1063136	1047285	rs1204223913	NC_000011.10:533573:G:A	single nucleotide variant	missense variant	Uncertain significance	May 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.325G>T (p.Val109Leu)	HRAS|LRRC56	V109L	Costello syndrome	VCV001716699	11	533578	11	533578	1716699	1778380		NC_000011.10:533577:C:A	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Feb 9, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.325G>A (p.Val109Met)	HRAS|LRRC56	V109M	Costello syndrome	VCV001403670	11	533578	11	533578	1403670	1467036	rs1342261234	NC_000011.10:533577:C:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Apr 20, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.324C>T (p.Asp108=)	HRAS|LRRC56	T2M	Costello syndrome	VCV001622570	11	533579	11	533579	1622570	1561416	rs770260347	NC_000011.10:533578:G:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	Aug 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.323A>G (p.Asp108Gly)	HRAS|LRRC56	D108G, T2A	Costello syndrome	VCV001906088	11	533580	11	533580	1906088	1965025		NC_000011.10:533579:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.319G>A (p.Asp107Asn)	HRAS|LRRC56	D107N	Costello syndrome	VCV002121275	11	533584	11	533584	2121275	2180457		NC_000011.10:533583:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.318G>A (p.Ser106=)	HRAS|LRRC56		Costello syndrome	VCV001114424	11	533585	11	533585	1114424	1100058	rs1053376922	NC_000011.10:533584:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 17, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.317C>T (p.Ser106Leu)	HRAS|LRRC56	S106L	Costello syndrome	VCV000409948	11	533586	11	533586	409948	398760	rs730880462	NC_000011.10:533585:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.317C>G (p.Ser106Trp)	HRAS|LRRC56	S106W	not provided|Costello syndrome|Cardiovascular phenotype	VCV000180850	11	533586	11	533586	180850	179416	rs730880462	NC_000011.10:533585:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 23, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.315C>T (p.Asp105=)	HRAS|LRRC56		Costello syndrome	VCV001649504	11	533588	11	533588	1649504	1567358	rs1229925274	NC_000011.10:533587:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 29, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.313G>C (p.Asp105His)	HRAS|LRRC56	D105H	Costello syndrome	VCV002119240	11	533590	11	533590	2119240	2183587		NC_000011.10:533589:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.313G>A (p.Asp105Asn)	HRAS|LRRC56	D105N	Costello syndrome	VCV001430538	11	533590	11	533590	1430538	1471072	rs1274939921	NC_000011.10:533589:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.312G>A (p.Lys104=)	HRAS|LRRC56		not provided|Costello syndrome	VCV000415887	11	533591	11	533591	415887	398766	rs1060504682	NC_000011.10:533590:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 12, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.309G>A (p.Val103=)	HRAS|LRRC56		RASopathy	VCV000040440	11	533594	11	533594	40440	48910	rs575789207	NC_000011.10:533593:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.307G>C (p.Val103Leu)	HRAS|LRRC56	V103L	Costello syndrome	VCV001508857	11	533596	11	533596	1508857	1451974	rs1213269684	NC_000011.10:533595:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 19, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.307G>A (p.Val103Met)	HRAS|LRRC56	V103M	Costello syndrome	VCV001021863	11	533596	11	533596	1021863	1009743	rs1213269684	NC_000011.10:533595:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.306G>C (p.Arg102=)	HRAS|LRRC56		HRAS-related disorder	VCV003058014	11	533597	11	533597	3058014	3193128		NC_000011.10:533596:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 10, 2021	no assertion criteria provided						
NM_005343.4(HRAS):c.306G>A (p.Arg102=)	HRAS|LRRC56		Costello syndrome	VCV002920418	11	533597	11	533597	2920418	3077857		NC_000011.10:533596:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 11, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.305G>A (p.Arg102Gln)	HRAS|LRRC56	R102Q	Costello syndrome	VCV002826339	11	533598	11	533598	2826339	2989560		NC_000011.10:533597:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 23, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.304C>A (p.Arg102=)	HRAS|LRRC56		Costello syndrome	VCV001624162	11	533599	11	533599	1624162	1563001	rs1057517913	NC_000011.10:533598:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.304C>T (p.Arg102Trp)	HRAS|LRRC56	R102W	not specified|Costello syndrome	VCV000372666	11	533599	11	533599	372666	360035	rs1057517913	NC_000011.10:533598:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.302A>T (p.Lys101Ile)	HRAS|LRRC56	K101I	Cardiovascular phenotype	VCV001799008	11	533601	11	533601	1799008	1856277		NC_000011.10:533600:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.302A>G (p.Lys101Arg)	LRRC56|HRAS	K101R	Costello syndrome|not provided	VCV000430506	11	533601	11	533601	430506	421862	rs1131691997	NC_000011.10:533600:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.300C>T (p.Ile100=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV001652369	11	533603	11	533603	1652369	1664282	rs2133987967	NC_000011.10:533602:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 7, 2021	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.297G>A (p.Gln99=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV001138050	11	533606	11	533606	1138050	1121543	rs199656012	NC_000011.10:533605:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.297G>T (p.Gln99His)	HRAS|LRRC56	Q99H	Costello syndrome	VCV000957979	11	533606	11	533606	957979	947502	rs199656012	NC_000011.10:533605:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.295C>T (p.Gln99Ter)	HRAS|LRRC56	Q99*	Costello syndrome	VCV002875840	11	533608	11	533608	2875840	3041355		NC_000011.10:533607:G:A	single nucleotide variant	nonsense|5 prime UTR variant	Uncertain significance	May 19, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.295C>G (p.Gln99Glu)	HRAS|LRRC56	Q99E	Costello syndrome	VCV000966039	11	533608	11	533608	966039	956532	rs1851251123	NC_000011.10:533607:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 6, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.294G>A (p.Glu98=)	HRAS|LRRC56		Costello syndrome	VCV002194923	11	533609	11	533609	2194923	1932766		NC_000011.10:533608:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.292G>A (p.Glu98Lys)	HRAS|LRRC56	E98K	Costello syndrome	VCV001437033	11	533611	11	533611	1437033	1435603	rs751137946	NC_000011.10:533610:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.291G>A (p.Arg97=)	HRAS|LRRC56		Costello syndrome	VCV002035240	11	533612	11	533612	2035240	2100898		NC_000011.10:533611:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 10, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-3C>T	HRAS|LRRC56		Hereditary cancer-predisposing syndrome|Costello syndrome	VCV001007992	11	533615	11	533615	1007992	994568	rs1851251687	NC_000011.10:533614:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 7, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.291-4_291-3del	HRAS|LRRC56		Costello syndrome	VCV000789383	11	533615 - 533616	11	533615 - 533616	789383	779542	rs1589791952	NC_000011.10:533614:GAGAG:GAG	Microsatellite	intron variant	Likely benign	Aug 4, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-5C>G	HRAS|LRRC56		Costello syndrome	VCV002756750	11	533617	11	533617	2756750	2910151		NC_000011.10:533616:G:C	single nucleotide variant	intron variant	Likely benign	Dec 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-6T>G	HRAS|LRRC56		RASopathy	VCV000448926	11	533618	11	533618	448926	442535	rs766909143	NC_000011.10:533617:A:C	single nucleotide variant	intron variant	Benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.291-8C>T	HRAS|LRRC56		Costello syndrome|not provided	VCV000387956	11	533620	11	533620	387956	374139	rs1057522962	NC_000011.10:533619:G:A	single nucleotide variant	intron variant	Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.291-9del	HRAS|LRRC56		Costello syndrome	VCV001161396	11	533621	11	533621	1161396	1142410	rs749335082	NC_000011.10:533620:T:	Deletion	intron variant	Likely benign	Mar 19, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-9A>G	HRAS|LRRC56		Costello syndrome|not specified	VCV000633268	11	533621	11	533621	633268	621820	rs1564789180	NC_000011.10:533620:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 25, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.291-10C>T	HRAS|LRRC56		Costello syndrome	VCV001113100	11	533622	11	533622	1113100	1100059	rs1397119284	NC_000011.10:533621:G:A	single nucleotide variant	intron variant	Likely benign	Dec 11, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-11C>T	HRAS|LRRC56		Costello syndrome	VCV003023375	11	533623	11	533623	3023375	3183978		NC_000011.10:533622:G:A	single nucleotide variant	intron variant	Likely benign	Mar 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-13T>G	HRAS|LRRC56		Costello syndrome	VCV001586081	11	533625	11	533625	1586081	1593726	rs755995550	NC_000011.10:533624:A:C	single nucleotide variant	intron variant	Likely benign	Dec 21, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-15C>A	HRAS|LRRC56		Costello syndrome	VCV001669529	11	533627	11	533627	1669529	1665783	rs1404106769	NC_000011.10:533626:G:T	single nucleotide variant	intron variant	Likely benign	Oct 28, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-15C>T	HRAS|LRRC56		Costello syndrome	VCV001617867	11	533627	11	533627	1617867	1614720	rs1404106769	NC_000011.10:533626:G:A	single nucleotide variant	intron variant	Likely benign	Jul 15, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-16G>C	HRAS|LRRC56		Costello syndrome	VCV001542971	11	533628	11	533628	1542971	1523246	rs779917193	NC_000011.10:533627:C:G	single nucleotide variant	intron variant	Likely benign	Nov 15, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-16G>A	HRAS|LRRC56		Costello syndrome	VCV001534290	11	533628	11	533628	1534290	1647858	rs779917193	NC_000011.10:533627:C:T	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-17C>T	HRAS|LRRC56		Costello syndrome	VCV001577166	11	533629	11	533629	1577166	1640023	rs753558541	NC_000011.10:533628:G:A	single nucleotide variant	intron variant	Likely benign	Sep 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-17C>G	HRAS|LRRC56		not specified|Costello syndrome	VCV000511469	11	533629	11	533629	511469	503876	rs753558541	NC_000011.10:533628:G:C	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.291-18T>C	HRAS|LRRC56		Costello syndrome	VCV001658207	11	533630	11	533630	1658207	1594208	rs758646567	NC_000011.10:533629:A:G	single nucleotide variant	intron variant	Likely benign	Jul 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.291-30C>T	HRAS|LRRC56		not provided	VCV001178973	11	533642	11	533642	1178973	1168241	rs375983338	NC_000011.10:533641:G:A	single nucleotide variant	intron variant	Benign	Dec 30, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+19G>T	HRAS|LRRC56		Costello syndrome	VCV002814086	11	533747	11	533747	2814086	2966200		NC_000011.10:533746:C:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+19G>C	HRAS|LRRC56		Costello syndrome	VCV001970500	11	533747	11	533747	1970500	2029213		NC_000011.10:533746:C:G	single nucleotide variant	intron variant	Likely benign	Jul 15, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+16C>T	HRAS|LRRC56		Costello syndrome	VCV002700226	11	533750	11	533750	2700226	2859078		NC_000011.10:533749:G:A	single nucleotide variant	intron variant	Likely benign	Dec 1, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+15G>C	HRAS|LRRC56		Costello syndrome	VCV002749082	11	533751	11	533751	2749082	2915442		NC_000011.10:533750:C:G	single nucleotide variant	intron variant	Likely benign	Jan 11, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+15G>A	HRAS|LRRC56		Costello syndrome	VCV002726454	11	533751	11	533751	2726454	2889088		NC_000011.10:533750:C:T	single nucleotide variant	intron variant	Likely benign	Mar 17, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+14G>A	HRAS|LRRC56		Costello syndrome	VCV001549069	11	533752	11	533752	1549069	1573184	rs780757384	NC_000011.10:533751:C:T	single nucleotide variant	intron variant	Likely benign	Sep 21, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+11T>C	LRRC56|HRAS		Costello syndrome	VCV003005591	11	533755	11	533755	3005591	3158182		NC_000011.10:533754:A:G	single nucleotide variant	intron variant	Likely benign	Sep 6, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+10G>C	HRAS|LRRC56		Costello syndrome	VCV001669416	11	533756	11	533756	1669416	1665670	rs769212136	NC_000011.10:533755:C:G	single nucleotide variant	intron variant	Likely benign	Sep 10, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+10G>A	HRAS|LRRC56		not specified|Costello syndrome	VCV000929127	11	533756	11	533756	929127	917488	rs769212136	NC_000011.10:533755:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.290+9C>G	HRAS|LRRC56		Costello syndrome	VCV000647934	11	533757	11	533757	647934	652331	rs747854581	NC_000011.10:533756:G:C	single nucleotide variant	intron variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+9C>T	HRAS|LRRC56		Costello syndrome	VCV000462150	11	533757	11	533757	462150	461205	rs747854581	NC_000011.10:533756:G:A	single nucleotide variant	intron variant	Likely benign	Oct 25, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+7C>G	HRAS|LRRC56		Costello syndrome	VCV002837428	11	533759	11	533759	2837428	2995985		NC_000011.10:533758:G:C	single nucleotide variant	intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+7C>T	HRAS|LRRC56		Costello syndrome	VCV001936560	11	533759	11	533759	1936560	1993285		NC_000011.10:533758:G:A	single nucleotide variant	intron variant	Likely benign	Apr 20, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+6C>A	HRAS|LRRC56		Costello syndrome	VCV000240134	11	533760	11	533760	240134	241156	rs878854758	NC_000011.10:533759:G:T	single nucleotide variant	intron variant	Uncertain significance	Nov 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+3G>A	HRAS|LRRC56		Costello syndrome	VCV002733049	11	533763	11	533763	2733049	2890509		NC_000011.10:533762:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.290+3G>T	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype	VCV001797443	11	533763	11	533763	1797443	1854361		NC_000011.10:533762:C:A	single nucleotide variant	intron variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.290+1G>C	HRAS|LRRC56		not specified	VCV000929126	11	533765	11	533765	929126	917489	rs1851270546	NC_000011.10:533764:C:G	single nucleotide variant	splice donor variant	Uncertain significance	Feb 11, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.288C>T (p.Tyr96=)	HRAS|LRRC56		Costello syndrome	VCV001117140	11	533768	11	533768	1117140	1100060	rs367794954	NC_000011.10:533767:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 17, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.285G>C (p.Gln95His)	HRAS|LRRC56	Q95H	Costello syndrome	VCV001416167	11	533771	11	533771	1416167	1382991	rs925794740	NC_000011.10:533770:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.284A>G (p.Gln95Arg)	HRAS|LRRC56	Q95R	Costello syndrome	VCV001561537	11	533772	11	533772	1561537	1554962	rs2133989835	NC_000011.10:533771:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Jan 14, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.282C>G (p.His94Gln)	HRAS|LRRC56	H94Q	Cardiovascular phenotype|Costello syndrome	VCV000852174	11	533774	11	533774	852174	838563	rs375893752	NC_000011.10:533773:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 10, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.282C>T (p.His94=)	HRAS|LRRC56		not specified|Costello syndrome|Cardiovascular phenotype	VCV000045299	11	533774	11	533774	45299	54466	rs375893752	NC_000011.10:533773:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 28, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.280C>T (p.His94Tyr)	HRAS|LRRC56	H94Y	Costello syndrome	VCV000862852	11	533776	11	533776	862852	838564	rs144718261	NC_000011.10:533775:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.279C>T (p.Ile93=)	HRAS|LRRC56		Costello syndrome	VCV001109487	11	533777	11	533777	1109487	1100061	rs2133989886	NC_000011.10:533776:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 10, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.278T>C (p.Ile93Thr)	HRAS|LRRC56	I93T	Hypophosphatemic rickets|Parathyroid gland adenoma	VCV001339457	11	533778	11	533778	1339457	1330556	rs2133989896	NC_000011.10:533777:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.277A>G (p.Ile93Val)	HRAS|LRRC56	I93V	RASopathy	VCV000040439	11	533779	11	533779	40439	48909	rs587782949	NC_000011.10:533778:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 17, 2024	reviewed by expert panel						
NM_005343.4(HRAS):c.276C>T (p.Asp92=)	HRAS|LRRC56		Cardiovascular phenotype	VCV001795784	11	533780	11	533780	1795784	1853143		NC_000011.10:533779:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 23, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.275A>C (p.Asp92Ala)	HRAS|LRRC56	D92A	Costello syndrome	VCV000665374	11	533781	11	533781	665374	640155	rs1589792495	NC_000011.10:533780:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.274G>A (p.Asp92Asn)	HRAS|LRRC56	D92N	Costello syndrome	VCV000940277	11	533782	11	533782	940277	935598	rs1851271948	NC_000011.10:533781:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 16, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.273G>A (p.Glu91=)	HRAS|LRRC56		Costello syndrome	VCV001151401	11	533783	11	533783	1151401	1142411	rs1851272074	NC_000011.10:533782:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 29, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.270dup (p.Glu91Ter)	HRAS|LRRC56	E91*	Costello syndrome	VCV000958564	11	533785 - 533786	11	533785 - 533786	958564	947503	rs1851272209	NC_000011.10:533785:AAAA:AAAAA	Duplication	nonsense|5 prime UTR variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.269T>C (p.Phe90Ser)	HRAS|LRRC56	F90S	Costello syndrome|not provided	VCV001010014	11	533787	11	533787	1010014	994569	rs1589792507	NC_000011.10:533786:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 3, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.266C>G (p.Ser89Cys)	HRAS|LRRC56	S89C	not provided	VCV000040438	11	533790	11	533790	40438	48908	rs755322824	NC_000011.10:533789:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 4, 2014	criteria provided, single submitter						
NM_005343.4(HRAS):c.263A>G (p.Lys88Arg)	HRAS|LRRC56	K88R	Costello syndrome	VCV000935657	11	533793	11	533793	935657	935599	rs1851272638	NC_000011.10:533792:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 26, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.262A>G (p.Lys88Glu)	HRAS|LRRC56	K88E	Costello syndrome	VCV002015677	11	533794	11	533794	2015677	2064605		NC_000011.10:533793:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 10, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.262A>T (p.Lys88Ter)	HRAS|LRRC56	K88*	not provided	VCV001710887	11	533794	11	533794	1710887	1709298		NC_000011.10:533793:T:A	single nucleotide variant	nonsense|5 prime UTR variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.261C>T (p.Thr87=)	HRAS|LRRC56		not provided|Cardiovascular phenotype|Costello syndrome	VCV001094546	11	533795	11	533795	1094546	1078342	rs1851272766	NC_000011.10:533794:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 3, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.260C>T (p.Thr87Ile)	HRAS|LRRC56	T87I	Costello syndrome	VCV001043469	11	533796	11	533796	1043469	1030305	rs1851272986	NC_000011.10:533795:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 21, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.260C>A (p.Thr87Asn)	HRAS|LRRC56	T87N	Costello syndrome	VCV000952111	11	533796	11	533796	952111	926274	rs1851272986	NC_000011.10:533795:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 18, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.258C>T (p.Asn86=)	HRAS|LRRC56		Costello syndrome	VCV001121809	11	533798	11	533798	1121809	1121544	rs765849763	NC_000011.10:533797:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 29, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.257A>C (p.Asn86Thr)	HRAS|LRRC56	N86T	RASopathy	VCV000040437	11	533799	11	533799	40437	48907	rs138272051	NC_000011.10:533798:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Apr 3, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.255C>T (p.Asn85=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV001132096	11	533801	11	533801	1132096	1121545	rs759463996	NC_000011.10:533800:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 27, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.253A>G (p.Asn85Asp)	HRAS|LRRC56	N85D	Costello syndrome	VCV001993499	11	533803	11	533803	1993499	2049286		NC_000011.10:533802:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 12, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.250A>G (p.Ile84Val)	HRAS|LRRC56	I84V	Costello syndrome	VCV001895526	11	533806	11	533806	1895526	1952324		NC_000011.10:533805:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.249C>G (p.Ala83=)	HRAS|LRRC56		Costello syndrome	VCV001576711	11	533807	11	533807	1576711	1587042	rs111372582	NC_000011.10:533806:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Aug 9, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.249C>T (p.Ala83=)	HRAS|LRRC56		not provided|Cardiovascular phenotype|not specified|Hereditary cancer-predisposing syndrome|Costello syndrome	VCV000045298	11	533807	11	533807	45298	54465	rs111372582	NC_000011.10:533806:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.247G>A (p.Ala83Thr)	HRAS|LRRC56	A83T	Costello syndrome	VCV002087469	11	533809	11	533809	2087469	2137530		NC_000011.10:533808:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 25, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.245T>C (p.Phe82Ser)	HRAS|LRRC56	F82S	Costello syndrome	VCV001008810	11	533811	11	533811	1008810	994570	rs1851274209	NC_000011.10:533810:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.245T>G (p.Phe82Cys)	HRAS|LRRC56	F82C	Costello syndrome	VCV000937347	11	533811	11	533811	937347	935600	rs1851274209	NC_000011.10:533810:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 28, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.243G>A (p.Val81=)	HRAS|LRRC56		Costello syndrome	VCV001906366	11	533813	11	533813	1906366	1961851		NC_000011.10:533812:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 10, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.243G>T (p.Val81=)	HRAS|LRRC56		Prostate cancer, hereditary, 1	VCV001711129	11	533813	11	533813	1711129	1709540		NC_000011.10:533812:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	no assertion criteria provided						
NM_005343.4(HRAS):c.238T>A (p.Cys80Ser)	HRAS|LRRC56	C80S	Costello syndrome	VCV000580944	11	533818	11	533818	580944	570706	rs1370566417	NC_000011.10:533817:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.237G>T (p.Leu79=)	HRAS|LRRC56		Costello syndrome	VCV001574906	11	533819	11	533819	1574906	1585229	rs767586105	NC_000011.10:533818:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.237G>A (p.Leu79=)	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype	VCV000705514	11	533819	11	533819	705514	693059	rs767586105	NC_000011.10:533818:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 4, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.236T>A (p.Leu79Gln)	HRAS|LRRC56	L79Q	Costello syndrome	VCV001013777	11	533820	11	533820	1013777	1009744	rs1851275137	NC_000011.10:533819:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 1, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.235C>T (p.Leu79=)	HRAS|LRRC56		Costello syndrome	VCV001126877	11	533821	11	533821	1126877	1121546	rs193163027	NC_000011.10:533820:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 1, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.234C>T (p.Phe78=)	HRAS|LRRC56		Costello syndrome|not provided	VCV000387714	11	533822	11	533822	387714	371490	rs1057522882	NC_000011.10:533821:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 8, 2021	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.203_232dup (p.Gly77_Phe78insTrpAspGlnTyrMetArgThrGlyGluGly)	HRAS|LRRC56		HRAS-related disorder	VCV003340440	11	533823 - 533824	11	533823 - 533824	3340440	3495431		NC_000011.10:533823:AGCCCTCCCCGGTGCGCATGTACTGGTCCC:AGCCCTCCCCGGTGCGCATGTACTGGTCCCAGCCCTCCCCGGTGCGCATGTACTGGTCCC	Duplication	inframe_insertion|5 prime UTR variant	Pathogenic		criteria provided, single submitter						
NM_005343.4(HRAS):c.231C>T (p.Gly77=)	HRAS|LRRC56		Costello syndrome	VCV000735934	11	533825	11	533825	735934	752702	rs1182602668	NC_000011.10:533824:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 6, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.188_230dup (p.Phe78fs)	HRAS|LRRC56	F78fs	Costello syndrome	VCV000666416	11	533825 - 533826	11	533825 - 533826	666416	653975	rs1589792614	NC_000011.10:533825:CCCTCCCCGGTGCGCATGTACTGGTCCCGCATGGCGCTGTACTCC:CCCTCCCCGGTGCGCATGTACTGGTCCCGCATGGCGCTGTACTCCCTCCCCGGTGCGCATGTACTGGTCCCGCATGGCGCTGTACTCC	Duplication	frameshift variant|5 prime UTR variant	Uncertain significance		no assertion criteria provided						
NM_005343.4(HRAS):c.230G>A (p.Gly77Asp)	HRAS|LRRC56	G77D	Costello syndrome	VCV002178513	11	533826	11	533826	2178513	1912390		NC_000011.10:533825:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.228G>A (p.Glu76=)	HRAS|LRRC56		Costello syndrome|not provided	VCV000386770	11	533828	11	533828	386770	372231	rs1057522598	NC_000011.10:533827:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.225G>C (p.Gly75=)	HRAS|LRRC56		Costello syndrome	VCV002080164	11	533831	11	533831	2080164	2135397		NC_000011.10:533830:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 2, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.223G>A (p.Gly75Arg)	HRAS|LRRC56	G75R	Costello syndrome	VCV001362265	11	533833	11	533833	1362265	1376890	rs756190012	NC_000011.10:533832:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.222C>G (p.Thr74=)	HRAS|LRRC56		Costello syndrome	VCV001105388	11	533834	11	533834	1105388	1100062	rs372223975	NC_000011.10:533833:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 11, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.222C>T (p.Thr74=)	HRAS|LRRC56		Cardiovascular phenotype|not provided|Costello syndrome	VCV000496283	11	533834	11	533834	496283	487566	rs372223975	NC_000011.10:533833:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Jan 6, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.221C>G (p.Thr74Ser)	HRAS|LRRC56	T74S	Costello syndrome	VCV002885653	11	533835	11	533835	2885653	3043658		NC_000011.10:533834:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 10, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.221C>T (p.Thr74Ile)	HRAS|LRRC56	T74I	Costello syndrome|Hereditary cancer-predisposing syndrome	VCV001692888	11	533835	11	533835	1692888	1685328	rs1291306227	NC_000011.10:533834:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 21, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.191_220dup (p.Arg73_Thr74insAsnSerAlaMetArgAspGlnTyrMetArg)	HRAS|LRRC56		not provided	VCV001691376	11	533835 - 533836	11	533835 - 533836	1691376	1683855	rs2133990531	NC_000011.10:533835:TGCGCATGTACTGGTCCCGCATGGCGCTGT:TGCGCATGTACTGGTCCCGCATGGCGCTGTTGCGCATGTACTGGTCCCGCATGGCGCTGT	Duplication	inframe_insertion|5 prime UTR variant	Likely pathogenic	Mar 1, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.220A>G (p.Thr74Ala)	HRAS|LRRC56	T74A	Costello syndrome	VCV002416915	11	533836	11	533836	2416915	1944075		NC_000011.10:533835:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.219C>T (p.Arg73=)	HRAS|LRRC56		not provided|Costello syndrome|Cardiovascular phenotype	VCV000415879	11	533837	11	533837	415879	398226	rs749870259	NC_000011.10:533836:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.197_217dup (p.Met72_Arg73insProMetArgAspGlnTyrMet)	HRAS|LRRC56		HRAS-related disorder	VCV003340437	11	533838 - 533839	11	533838 - 533839	3340437	3495427		NC_000011.10:533838:GCATGTACTGGTCCCGCATGG:GCATGTACTGGTCCCGCATGGGCATGTACTGGTCCCGCATGG	Duplication	inframe_insertion|5 prime UTR variant	Pathogenic		criteria provided, single submitter						
NM_005343.4(HRAS):c.218G>A (p.Arg73His)	HRAS|LRRC56	R73H	Costello syndrome	VCV002134374	11	533838	11	533838	2134374	2187093		NC_000011.10:533837:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 5, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.191_217dup (p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet)	HRAS|LRRC56		not provided	VCV001691375	11	533838 - 533839	11	533838 - 533839	1691375	1683854	rs2133990580	NC_000011.10:533838:GCATGTACTGGTCCCGCATGGCGCTGT:GCATGTACTGGTCCCGCATGGCGCTGTGCATGTACTGGTCCCGCATGGCGCTGT	Duplication	inframe_insertion|5 prime UTR variant	Likely pathogenic	Jan 17, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.217C>T (p.Arg73Cys)	HRAS|LRRC56	R73C	Costello syndrome	VCV002973421	11	533839	11	533839	2973421	3129917		NC_000011.10:533838:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.215_216insCTCCAGCGCCATGCGGGACCAGTACAT (p.Tyr71_Met72insIleSerSerAlaMetArgAspGlnTyr)	HRAS|LRRC56		Vascular malformation	VCV003238637	11	533840 - 533841	11	533840 - 533841	3238637	3397747		NC_000011.10:533840:ATGTACTGGTCCCGCATGGCGCTG:ATGTACTGGTCCCGCATGGCGCTGGAGATGTACTGGTCCCGCATGGCGCTG	Insertion	5 prime UTR variant	Likely pathogenic	Apr 8, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.215T>C (p.Met72Thr)	HRAS|LRRC56	M72T	Costello syndrome	VCV002061405	11	533841	11	533841	2061405	2124097		NC_000011.10:533840:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 26, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.214A>C (p.Met72Leu)	HRAS|LRRC56	M72L	not provided	VCV000618166	11	533842	11	533842	618166	609793	rs1564789500	NC_000011.10:533841:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 11, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.211T>C (p.Tyr71His)	HRAS|LRRC56	Y71H	Costello syndrome	VCV001060724	11	533845	11	533845	1060724	1047286	rs2133990650	NC_000011.10:533844:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.210G>A (p.Gln70=)	HRAS|LRRC56		Costello syndrome	VCV001532004	11	533846	11	533846	1532004	1582924	rs1371974169	NC_000011.10:533845:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 21, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.187_207dup (p.Glu63_Asp69dup)	LRRC56|HRAS		Costello syndrome	VCV000120223	11	533848 - 533849	11	533848 - 533849	120223	125817	rs587777239	NC_000011.10:533848:GTCCCGCATGGCGCTGTACTC:GTCCCGCATGGCGCTGTACTCGTCCCGCATGGCGCTGTACTC	Duplication	inframe_insertion|5 prime UTR variant	Pathogenic	Apr 15, 2013	no assertion criteria provided						
NM_005343.4(HRAS):c.186_206dup (p.Glu62_Arg68dup)	HRAS|LRRC56		Costello syndrome	VCV000462149	11	533849 - 533850	11	533849 - 533850	462149	461391	rs1554884966	NC_000011.10:533849:TCCCGCATGGCGCTGTACTCCTCC:TCCCGCATGGCGCTGTACTCCTCCCGCATGGCGCTGTACTCCTCC	Duplication	inframe_insertion|5 prime UTR variant	Pathogenic	Nov 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.179_205dup (p.Arg68_Asp69insGlyGlnGluGluTyrSerAlaMetArg)	HRAS|LRRC56		HRAS-related disorder	VCV002633786	11	533850 - 533851	11	533850 - 533851	2633786	2799113		NC_000011.10:533850:CCCGCATGGCGCTGTACTCCTCCTGGCC:CCCGCATGGCGCTGTACTCCTCCTGGCCCCGCATGGCGCTGTACTCCTCCTGGCC	Duplication	inframe_insertion|5 prime UTR variant	Likely pathogenic	May 20, 2024	no assertion criteria provided						
NM_005343.4(HRAS):c.203G>T (p.Arg68Leu)	HRAS|LRRC56	R68L	Costello syndrome	VCV001021434	11	533853	11	533853	1021434	1009745	rs730880461	NC_000011.10:533852:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.203G>A (p.Arg68Gln)	HRAS|LRRC56	R68Q	not provided|Costello syndrome|not specified	VCV000180849	11	533853	11	533853	180849	179417	rs730880461	NC_000011.10:533852:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 24, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.202C>T (p.Arg68Trp)	HRAS|LRRC56	R68W	Costello syndrome|not provided	VCV001406399	11	533854	11	533854	1406399	1408420	rs1370690781	NC_000011.10:533853:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 14, 2022	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.202C>A (p.Arg68=)	HRAS|LRRC56		Costello syndrome	VCV001155930	11	533854	11	533854	1155930	1142412	rs1370690781	NC_000011.10:533853:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Aug 5, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.202C>G (p.Arg68Gly)	LRRC56|HRAS	R68G	Costello syndrome|Cardiovascular phenotype	VCV001062564	11	533854	11	533854	1062564	1047287	rs1370690781	NC_000011.10:533853:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.201G>A (p.Met67Ile)	HRAS|LRRC56	M67I	Costello syndrome	VCV002840656	11	533855	11	533855	2840656	3000479		NC_000011.10:533854:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.199A>T (p.Met67Leu)	HRAS|LRRC56	M67L	Prostate cancer, hereditary, 1	VCV001711130	11	533857	11	533857	1711130	1709541		NC_000011.10:533856:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	no assertion criteria provided						
NM_005343.4(HRAS):c.198C>T (p.Ala66=)	HRAS|LRRC56		Costello syndrome	VCV001111529	11	533858	11	533858	1111529	1100063	rs1851279330	NC_000011.10:533857:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 23, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.197C>T (p.Ala66Val)	HRAS|LRRC56	A66V	Costello syndrome	VCV002850846	11	533859	11	533859	2850846	3013202		NC_000011.10:533858:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 30, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.195C>T (p.Ser65=)	HRAS|LRRC56		Costello syndrome	VCV001554193	11	533861	11	533861	1554193	1588277	rs898057728	NC_000011.10:533860:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 17, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.194G>A (p.Ser65Asn)	HRAS|LRRC56	S65N	Costello syndrome	VCV002146410	11	533862	11	533862	2146410	1873513		NC_000011.10:533861:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.191dup (p.Tyr64Ter)	HRAS|LRRC56	Y64*	Costello syndrome	VCV002034877	11	533864 - 533865	11	533864 - 533865	2034877	2100536		NC_000011.10:533864:T:TT	Duplication	nonsense|5 prime UTR variant	Uncertain significance	Oct 8, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.192C>T (p.Tyr64=)	HRAS|LRRC56		not specified|Costello syndrome	VCV001126862	11	533864	11	533864	1126862	1121547	rs2133990881	NC_000011.10:533863:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 21, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.174_192del (p.Gly60fs)	LRRC56|HRAS	G60fs	Costello syndrome	VCV000240133	11	533864 - 533882	11	533864 - 533882	240133	241157	rs878854757	NC_000011.10:533863:GTACTCCTCCTGGCCGGCGGTA:GTA	Deletion	frameshift variant|5 prime UTR variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.189G>A (p.Glu63=)	HRAS|LRRC56		Costello syndrome	VCV002727378	11	533867	11	533867	2727378	2882696		NC_000011.10:533866:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.189G>C (p.Glu63Asp)	HRAS|LRRC56	E63D	Costello syndrome	VCV001954526	11	533867	11	533867	1954526	2018541		NC_000011.10:533866:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.187G>A (p.Glu63Lys)	HRAS|LRRC56	E63K	not provided|Costello syndrome	VCV000012608	11	533869	11	533869	12608	27647	rs121917756	NC_000011.10:533868:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 2, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.171_185dup (p.Asp57_Gln61dup)	HRAS|LRRC56		Costello syndrome	VCV001478514	11	533870 - 533871	11	533870 - 533871	1478514	1429750	rs2133990973	NC_000011.10:533870:TCCTGGCCGGCGGTATCC:TCCTGGCCGGCGGTATCCTGGCCGGCGGTATCC	Duplication	inframe_insertion|5 prime UTR variant	Likely pathogenic	Dec 29, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.183G>A (p.Gln61=)	HRAS|LRRC56		Costello syndrome	VCV001956880	11	533873	11	533873	1956880	2011852		NC_000011.10:533872:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.183G>T (p.Gln61His)	LRRC56|HRAS	Q61H	Noonan syndrome 3	VCV000376318	11	533873	11	533873	376318	363197	rs121913496	NC_000011.10:533872:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 22, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.182A>T (p.Gln61Leu)	HRAS|LRRC56	Q61L	Costello syndrome|Neoplasm	VCV000376033	11	533874	11	533874	376033	362912	rs121913233	NC_000011.10:533873:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 6, 2020	criteria provided, single submitter				Oncogenic	Jul 31, 2024	criteria provided, single submitter
NM_005343.4(HRAS):c.182A>G (p.Gln61Arg)	HRAS|LRRC56	Q61R	Costello syndrome|Thyroid cancer, nonmedullary, 2|Linear nevus sebaceous syndrome|Large congenital melanocytic nevus|Epidermal nevus|Malignant tumor of urinary bladder|not provided|Noonan syndrome and Noonan-related syndrome	VCV000160364	11	533874	11	533874	160364	170209	rs121913233	NC_000011.10:533873:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 5, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)	HRAS|LRRC56	Q61K	not provided|Noonan syndrome 3|Epidermal nevus	VCV000012601	11	533875	11	533875	12601	27640	rs28933406	NC_000011.10:533874:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.179G>T (p.Gly60Val)	HRAS|LRRC56	G60V	Malignant tumor of urinary bladder|Costello syndrome|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Linear nevus sebaceous syndrome|not provided	VCV000391700	11	533877	11	533877	391700	374144	rs730880460	NC_000011.10:533876:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 13, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.179G>A (p.Gly60Asp)	HRAS|LRRC56	G60D	Costello syndrome|not provided	VCV000040436	11	533877	11	533877	40436	48906	rs730880460	NC_000011.10:533876:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 29, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.178G>C (p.Gly60Arg)	HRAS|LRRC56	G60R	Costello syndrome	VCV002164941	11	533878	11	533878	2164941	1895080		NC_000011.10:533877:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 20, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.178G>A (p.Gly60Ser)	HRAS|LRRC56	G60S	Costello syndrome	VCV000660897	11	533878	11	533878	660897	640156	rs1589792804	NC_000011.10:533877:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.177C>G (p.Ala59=)	HRAS|LRRC56		Costello syndrome	VCV001125878	11	533879	11	533879	1125878	1121548	rs730880456	NC_000011.10:533878:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.172_177delinsGTCCTGGATGTT (p.Thr58_Ala59delinsValLeuAspVal)	HRAS|LRRC56		Arteriovenous malformation	VCV000690298	11	533879 - 533884	11	533879 - 533884	690298	677975	rs1589792836	NC_000011.10:533878:GGCGGT:AACATCCAGGAC	Indel	inframe_indel|5 prime UTR variant	Pathogenic		no assertion criteria provided						
NM_005343.4(HRAS):c.177C>T (p.Ala59=)	HRAS|LRRC56		Costello syndrome|Hereditary cancer-predisposing syndrome|not provided|Noonan syndrome and Noonan-related syndrome|not specified|Cardiovascular phenotype	VCV000180847	11	533879	11	533879	180847	179418	rs730880456	NC_000011.10:533878:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Jun 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.176C>G (p.Ala59Gly)	HRAS|LRRC56	A59G	RASopathy	VCV001810343	11	533880	11	533880	1810343	1867353		NC_000011.10:533879:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jan 5, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.175_176delinsCT (p.Ala59Leu)	LRRC56|HRAS	A59L	Costello syndrome	VCV000179260	11	533880 - 533881	11	533880 - 533881	179260	174803	rs727504747	NC_000011.10:533879:GC:AG	Indel	missense variant|5 prime UTR variant	Likely pathogenic	Aug 14, 2014	criteria provided, single submitter						
NM_005343.4(HRAS):c.175G>T (p.Ala59Ser)	HRAS|LRRC56	A59S	Costello syndrome|Noonan syndrome and Noonan-related syndrome	VCV001334242	11	533881	11	533881	1334242	1325102	rs727503093	NC_000011.10:533880:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 16, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.175G>A (p.Ala59Thr)	HRAS|LRRC56	A59T	RASopathy	VCV000040435	11	533881	11	533881	40435	48905	rs727503093	NC_000011.10:533880:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 17, 2024	reviewed by expert panel						
NM_005343.4(HRAS):c.174C>T (p.Thr58=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV000697806	11	533882	11	533882	697806	687787	rs746639086	NC_000011.10:533881:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Aug 25, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.173C>T (p.Thr58Ile)	HRAS|LRRC56	T58I	Costello syndrome	VCV000012610	11	533883	11	533883	12610	27649	rs121917758	NC_000011.10:533882:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 3, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.171T>C (p.Asp57=)	HRAS|LRRC56		Costello syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000259746	11	533885	11	533885	259746	254210	rs776105083	NC_000011.10:533884:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 8, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.170A>C (p.Asp57Ala)	HRAS|LRRC56	D57A	Prostate cancer, hereditary, 1	VCV001711128	11	533886	11	533886	1711128	1709539		NC_000011.10:533885:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	no assertion criteria provided						
NM_005343.4(HRAS):c.166C>T (p.Leu56=)	HRAS|LRRC56		Costello syndrome	VCV001619760	11	533890	11	533890	1619760	1527775	rs2133991227	NC_000011.10:533889:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 28, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.165_166insTCCGGAAGCAGGTGGTCATTGATGGGGAGACGTGCCTGTTGGACATC (p.Leu56fs)	HRAS|LRRC56	L56fs	not specified	VCV000929128	11	533890 - 533891	11	533890 - 533891	929128	917090	rs1851284408	NC_000011.10:533890:GATGTCCAACAGGCACGTCTCCCCATCAATGACCACCTGCTTCCGG:GATGTCCAACAGGCACGTCTCCCCATCAATGACCACCTGCTTCCGGAGATGTCCAACAGGCACGTCTCCCCATCAATGACCACCTGCTTCCGG	Insertion	frameshift variant|5 prime UTR variant	Uncertain significance	Dec 31, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.165C>T (p.Ile55=)	HRAS|LRRC56		Costello syndrome	VCV001137813	11	533891	11	533891	1137813	1121549	rs1261188136	NC_000011.10:533890:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 12, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.162C>T (p.Asp54=)	HRAS|LRRC56		not specified|Costello syndrome	VCV000378924	11	533894	11	533894	378924	372462	rs1057520410	NC_000011.10:533893:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 8, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.159G>A (p.Leu53=)	HRAS|LRRC56		Costello syndrome	VCV001086607	11	533897	11	533897	1086607	1078343	rs1205035369	NC_000011.10:533896:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Mar 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.158T>A (p.Leu53Ter)	HRAS|LRRC56	L53*	Costello syndrome	VCV002837680	11	533898	11	533898	2837680	2996237		NC_000011.10:533897:A:T	single nucleotide variant	nonsense|5 prime UTR variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.158T>G (p.Leu53Trp)	HRAS|LRRC56	L53W	Costello syndrome	VCV002767695	11	533898	11	533898	2767695	2932307		NC_000011.10:533897:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.157T>C (p.Leu53=)	HRAS|LRRC56		Costello syndrome	VCV001951253	11	533899	11	533899	1951253	2013982		NC_000011.10:533898:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.156G>T (p.Leu52=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV000462148	11	533900	11	533900	462148	461207	rs1060504681	NC_000011.10:533899:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 22, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.156G>A (p.Leu52=)	HRAS|LRRC56		not provided|Costello syndrome	VCV000415882	11	533900	11	533900	415882	398227	rs1060504681	NC_000011.10:533899:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Feb 6, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.153C>T (p.Cys51=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV000531195	11	533903	11	533903	531195	526264	rs759482455	NC_000011.10:533902:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 23, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.151T>C (p.Cys51Arg)	HRAS|LRRC56	C51R	Costello syndrome	VCV002129189	11	533905	11	533905	2129189	2175438		NC_000011.10:533904:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.150G>C (p.Thr50=)	HRAS|LRRC56		Costello syndrome	VCV002023601	11	533906	11	533906	2023601	2084082		NC_000011.10:533905:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 27, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.150G>T (p.Thr50=)	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype	VCV001610884	11	533906	11	533906	1610884	1585702	rs1057520421	NC_000011.10:533905:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 16, 2021	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.150G>A (p.Thr50=)	HRAS|LRRC56		not provided|Costello syndrome	VCV000378937	11	533906	11	533906	378937	371492	rs1057520421	NC_000011.10:533905:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 13, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.149delinsGA (p.Thr50fs)	HRAS|LRRC56	T50fs	Prostate cancer, hereditary, 1	VCV001711125	11	533907	11	533907	1711125	1709536		NC_000011.10:533906:G:TC	Indel	frameshift variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	no assertion criteria provided						
NM_005343.4(HRAS):c.147G>A (p.Glu49=)	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype	VCV001119010	11	533909	11	533909	1119010	1100064	rs2133991462	NC_000011.10:533908:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.146A>G (p.Glu49Gly)	HRAS|LRRC56	E49G	Costello syndrome	VCV002754318	11	533910	11	533910	2754318	2913760		NC_000011.10:533909:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 22, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.146del (p.Glu49fs)	HRAS|LRRC56	E49fs	Prostate cancer, hereditary, 1	VCV001711126	11	533910	11	533910	1711126	1709537		NC_000011.10:533909:T:	Deletion	frameshift variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	no assertion criteria provided						
NM_005343.4(HRAS):c.144_145insC (p.Glu49fs)	HRAS|LRRC56	E49fs	Prostate cancer, hereditary, 1	VCV001711127	11	533911 - 533912	11	533911 - 533912	1711127	1709538		NC_000011.10:533911::G	Insertion	frameshift variant|5 prime UTR variant	Uncertain significance	Jul 29, 2022	no assertion criteria provided						
NM_005343.4(HRAS):c.145G>C (p.Glu49Gln)	HRAS|LRRC56	E49Q	Costello syndrome	VCV001523510	11	533911	11	533911	1523510	1346807	rs1277340795	NC_000011.10:533910:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 31, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.145G>A (p.Glu49Lys)	HRAS|LRRC56	E49K	Costello syndrome	VCV000548638	11	533911	11	533911	548638	539145	rs1277340795	NC_000011.10:533910:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.144G>A (p.Gly48=)	LRRC56|HRAS		Costello syndrome	VCV000783204	11	533912	11	533912	783204	712873	rs1589792926	NC_000011.10:533911:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 7, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.141T>C (p.Asp47=)	HRAS|LRRC56		Cardiovascular phenotype|not specified|Costello syndrome	VCV000531193	11	533915	11	533915	531193	526298	rs765092617	NC_000011.10:533914:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 9, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.138T>C (p.Ile46=)	HRAS|LRRC56		Costello syndrome	VCV001664653	11	533918	11	533918	1664653	1557016	rs1851286467	NC_000011.10:533917:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 9, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.138T>G (p.Ile46Met)	HRAS|LRRC56	I46M	Costello syndrome	VCV001001274	11	533918	11	533918	1001274	994571	rs1851286467	NC_000011.10:533917:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 14, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.137T>C (p.Ile46Thr)	HRAS|LRRC56	I46T	not provided|Costello syndrome	VCV000561731	11	533919	11	533919	561731	552663	rs1564789700	NC_000011.10:533918:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 29, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.136A>G (p.Ile46Val)	HRAS|LRRC56	I46V	not provided|Costello syndrome	VCV001509551	11	533920	11	533920	1509551	1365172	rs2133991578	NC_000011.10:533919:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.135C>T (p.Val45=)	HRAS|LRRC56		Costello syndrome	VCV002778774	11	533921	11	533921	2778774	2943811		NC_000011.10:533920:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 27, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.134T>A (p.Val45Asp)	HRAS|LRRC56	V45D	Costello syndrome|Cardiovascular phenotype	VCV001032989	11	533922	11	533922	1032989	1020875	rs1028352031	NC_000011.10:533921:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 28, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.133G>A (p.Val45Ile)	HRAS|LRRC56	V45I	Costello syndrome	VCV000842180	11	533923	11	533923	842180	838565	rs1564789708	NC_000011.10:533922:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.131T>C (p.Val44Ala)	HRAS|LRRC56	V44A	Costello syndrome	VCV002747523	11	533925	11	533925	2747523	2904416		NC_000011.10:533924:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.129G>C (p.Gln43His)	HRAS|LRRC56	Q43H	Costello syndrome	VCV002766820	11	533927	11	533927	2766820	2926265		NC_000011.10:533926:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.127C>T (p.Gln43Ter)	LRRC56|HRAS	Q43*	Costello syndrome	VCV001465356	11	533929	11	533929	1465356	1511180	rs2133991697	NC_000011.10:533928:G:A	single nucleotide variant	nonsense|5 prime UTR variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.126G>A (p.Lys42=)	HRAS|LRRC56		Costello syndrome	VCV001563448	11	533930	11	533930	1563448	1619952	rs775378080	NC_000011.10:533929:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 2, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.123G>C (p.Arg41=)	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype	VCV001118560	11	533933	11	533933	1118560	1100065	rs762706292	NC_000011.10:533932:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 16, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.122G>A (p.Arg41Gln)	HRAS|LRRC56	R41Q	Costello syndrome	VCV002763385	11	533934	11	533934	2763385	2925424		NC_000011.10:533933:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.122G>C (p.Arg41Pro)	HRAS|LRRC56	R41P	Costello syndrome	VCV001987678	11	533934	11	533934	1987678	2040325		NC_000011.10:533933:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.120C>T (p.Tyr40=)	HRAS|LRRC56		Costello syndrome|not provided	VCV000415880	11	533936	11	533936	415880	398679	rs763920334	NC_000011.10:533935:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 2, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.115T>A (p.Ser39Thr)	HRAS|LRRC56	S39T	Costello syndrome	VCV001437577	11	533941	11	533941	1437577	1514193	rs2133991854	NC_000011.10:533940:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 19, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-4G>A	HRAS|LRRC56		not specified|Costello syndrome	VCV000751337	11	533948	11	533948	751337	775857	rs1589792986	NC_000011.10:533947:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 8, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.112-7_112-5del	HRAS|LRRC56		Costello syndrome	VCV000835984	11	533949 - 533951	11	533949 - 533951	835984	852362	rs1347169680	NC_000011.10:533948:AGGAGGA:AGGA	Microsatellite	intron variant	Likely benign	Sep 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-6C>T	HRAS|LRRC56		Costello syndrome	VCV001083518	11	533950	11	533950	1083518	1078344	rs2133991944	NC_000011.10:533949:G:A	single nucleotide variant	intron variant	Likely benign	Jun 20, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-7C>T	HRAS|LRRC56		Costello syndrome	VCV000779508	11	533951	11	533951	779508	779544	rs756348934	NC_000011.10:533950:G:A	single nucleotide variant	intron variant	Likely benign	Apr 5, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-9C>G	LRRC56|HRAS		HRAS-related disorder	VCV003345790	11	533953	11	533953	3345790	3505460		NC_000011.10:533952:G:C	single nucleotide variant	intron variant	Likely benign	Jun 24, 2024	no assertion criteria provided						
NM_005343.4(HRAS):c.112-9C>T	HRAS|LRRC56		Costello syndrome	VCV001587143	11	533953	11	533953	1587143	1629083	rs1851288449	NC_000011.10:533952:G:A	single nucleotide variant	intron variant	Likely benign	Nov 16, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-10C>A	HRAS|LRRC56		Costello syndrome	VCV001476781	11	533954	11	533954	1476781	1416846	rs727503092	NC_000011.10:533953:G:T	single nucleotide variant	intron variant	Uncertain significance	Nov 5, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-10C>T	HRAS|LRRC56		Costello syndrome|not specified	VCV000163689	11	533954	11	533954	163689	175215	rs727503092	NC_000011.10:533953:G:A	single nucleotide variant	intron variant	Likely benign	Nov 10, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.112-11T>A	HRAS|LRRC56		Costello syndrome	VCV002155439	11	533955	11	533955	2155439	1892920		NC_000011.10:533954:A:T	single nucleotide variant	intron variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-12G>A	HRAS|LRRC56		Costello syndrome	VCV001582120	11	533956	11	533956	1582120	1654081	rs1851288777	NC_000011.10:533955:C:T	single nucleotide variant	intron variant	Likely benign	May 18, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-13T>C	HRAS|LRRC56		Costello syndrome	VCV001421809	11	533957	11	533957	1421809	1337424	rs766582484	NC_000011.10:533956:A:G	single nucleotide variant	intron variant	Likely benign	Jan 23, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-13T>A	HRAS|LRRC56		not specified|not provided|Costello syndrome	VCV000987825	11	533957	11	533957	987825	975806	rs766582484	NC_000011.10:533956:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 10, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.112-14C>G	HRAS|LRRC56		Costello syndrome	VCV002162179	11	533958	11	533958	2162179	1884567		NC_000011.10:533957:G:C	single nucleotide variant	intron variant	Likely benign	Jan 18, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-14C>T	HRAS|LRRC56		Costello syndrome	VCV001551479	11	533958	11	533958	1551479	1551258	rs753906417	NC_000011.10:533957:G:A	single nucleotide variant	intron variant	Likely benign	Oct 13, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-17G>T	HRAS|LRRC56		Costello syndrome	VCV002079997	11	533961	11	533961	2079997	2139217		NC_000011.10:533960:C:A	single nucleotide variant	intron variant	Likely benign	May 13, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-18A>T	HRAS|LRRC56		Costello syndrome	VCV002091540	11	533962	11	533962	2091540	2155923		NC_000011.10:533961:T:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-20dup	HRAS|LRRC56		Costello syndrome	VCV001671326	11	533963 - 533964	11	533963 - 533964	1671326	1530216	rs2133992078	NC_000011.10:533963:A:AA	Duplication	intron variant	Likely benign	Jun 29, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-19G>C	HRAS|LRRC56		Costello syndrome	VCV001644590	11	533963	11	533963	1644590	1522637	rs755577443	NC_000011.10:533962:C:G	single nucleotide variant	intron variant	Likely benign	Jul 27, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.112-19G>A	HRAS|LRRC56		Costello syndrome	VCV001557968	11	533963	11	533963	1557968	1540987	rs755577443	NC_000011.10:533962:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+75C>G	HRAS|LRRC56		not provided	VCV001251912	11	534137	11	534137	1251912	48904	rs1228359974	NC_000011.10:534136:G:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+50C>G	HRAS|LRRC56		not provided	VCV001291000	11	534162	11	534162	1291000	48903	rs375249516	NC_000011.10:534161:G:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+18G>A	HRAS|LRRC56		Costello syndrome	VCV001625905	11	534194	11	534194	1625905	1575120	rs759743352	NC_000011.10:534193:C:T	single nucleotide variant	intron variant	Likely benign	Jul 15, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+18G>C	HRAS|LRRC56		Squamous cell lung carcinoma	VCV000873192	11	534194	11	534194	873192	861318	rs759743352	NC_000011.10:534193:C:G	single nucleotide variant	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided						
NM_005343.4(HRAS):c.111+17C>T	HRAS|LRRC56		Costello syndrome	VCV001556122	11	534195	11	534195	1556122	1529506	rs1851313358	NC_000011.10:534194:G:A	single nucleotide variant	intron variant	Likely benign	Aug 11, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+15G>C	HRAS|LRRC56		Costello syndrome	VCV002812496	11	534197	11	534197	2812496	2965888		NC_000011.10:534196:C:G	single nucleotide variant	intron variant	Likely benign	Dec 13, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+15G>A	LRRC56|HRAS		not specified|Costello syndrome|not provided	VCV000040432	11	534197	11	534197	40432	48902	rs41258054	NC_000011.10:534196:C:T	single nucleotide variant	intron variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.111+14C>T	HRAS|LRRC56		Costello syndrome|not specified	VCV000515847	11	534198	11	534198	515847	503878	rs372917082	NC_000011.10:534197:G:A	single nucleotide variant	intron variant	Likely benign	Nov 14, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.111+12G>A	HRAS|LRRC56		Costello syndrome	VCV002134939	11	534200	11	534200	2134939	2190347		NC_000011.10:534199:C:T	single nucleotide variant	intron variant	Likely benign	May 10, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+11C>T	HRAS|LRRC56		Costello syndrome	VCV001501214	11	534201	11	534201	1501214	1401962	rs758933104	NC_000011.10:534200:G:A	single nucleotide variant	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+10G>A	LRRC56|HRAS		Costello syndrome	VCV000756122	11	534202	11	534202	756122	775739	rs1401412098	NC_000011.10:534201:C:T	single nucleotide variant	intron variant	Likely benign	Jul 17, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+8T>C	HRAS|LRRC56		Costello syndrome	VCV001661733	11	534204	11	534204	1661733	1608094	rs2133994019	NC_000011.10:534203:A:G	single nucleotide variant	intron variant	Likely benign	Dec 17, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+7C>T	HRAS|LRRC56		Costello syndrome	VCV000751869	11	534205	11	534205	751869	775696	rs374130868	NC_000011.10:534204:G:A	single nucleotide variant	intron variant	Likely benign	Sep 20, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.111+6C>T	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV000240132	11	534206	11	534206	240132	241158	rs377130570	NC_000011.10:534205:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.110_111+5del	HRAS|LRRC56		Costello syndrome	VCV001400189	11	534207 - 534213	11	534207 - 534213	1400189	1444278	rs1564790048	NC_000011.10:534206:CTCACCTCT:CT	Deletion	splice donor variant	Uncertain significance	Aug 18, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.110_111+1dup	HRAS|LRRC56		Costello syndrome	VCV000029911	11	534210 - 534211	11	534210 - 534211	29911	38866	rs398122808	NC_000011.10:534210:CCTC:CCTCCTC	Duplication	splice donor variant	Pathogenic	Mar 1, 2010	no assertion criteria provided						
NM_005343.4(HRAS):c.108_110dup (p.Glu37dup)	HRAS|LRRC56		Costello syndrome	VCV000029912	11	534212 - 534213	11	534212 - 534213	29912	38867	rs398122809	NC_000011.10:534212:TCT:TCTTCT	Duplication	inframe_insertion|5 prime UTR variant	Pathogenic	Mar 1, 2010	no assertion criteria provided						
NM_005343.4(HRAS):c.108dup (p.Glu37fs)	HRAS|LRRC56	E37fs	Costello syndrome	VCV001062119	11	534214 - 534215	11	534214 - 534215	1062119	1047288	rs2133994149	NC_000011.10:534214:T:TT	Duplication	frameshift variant|5 prime UTR variant	Uncertain significance	May 13, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.107T>C (p.Ile36Thr)	HRAS|LRRC56	I36T	Costello syndrome	VCV001355749	11	534216	11	534216	1355749	1509500	rs775056058	NC_000011.10:534215:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.106A>G (p.Ile36Val)	HRAS|LRRC56	I36V	Costello syndrome	VCV000409947	11	534217	11	534217	409947	398682	rs1060502663	NC_000011.10:534216:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.105T>C (p.Thr35=)	HRAS|LRRC56		Costello syndrome	VCV002828298	11	534218	11	534218	2828298	2990236		NC_000011.10:534217:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Sep 12, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.104C>T (p.Thr35Ile)	HRAS|LRRC56	T35I	not provided	VCV003373486	11	534219	11	534219	3373486	3532675		NC_000011.10:534218:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.103A>G (p.Thr35Ala)	HRAS|LRRC56	T35A	Costello syndrome	VCV001463197	11	534220	11	534220	1463197	1511634	rs2133994194	NC_000011.10:534219:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 16, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.102C>G (p.Pro34=)	HRAS|LRRC56		not provided|Costello syndrome	VCV000700253	11	534221	11	534221	700253	687788	rs149199691	NC_000011.10:534220:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.102C>T (p.Pro34=)	HRAS|LRRC56		Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|Costello syndrome	VCV000531197	11	534221	11	534221	531197	526306	rs149199691	NC_000011.10:534220:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.101C>T (p.Pro34Leu)	HRAS|LRRC56	P34L	Costello syndrome	VCV001052630	11	534222	11	534222	1052630	1047289	rs2133994210	NC_000011.10:534221:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 21, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.100C>T (p.Pro34Ser)	HRAS|LRRC56	P34S	Vascular Tumors Including Pyogenic Granuloma	VCV000548640	11	534223	11	534223	548640	539146	rs1348427922	NC_000011.10:534222:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 19, 2015	no assertion criteria provided						
NM_005343.4(HRAS):c.99C>A (p.Asp33Glu)	HRAS|LRRC56	D33E	Costello syndrome	VCV001388881	11	534224	11	534224	1388881	1384111	rs756934316	NC_000011.10:534223:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 23, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.99C>T (p.Asp33=)	HRAS|LRRC56		Costello syndrome	VCV001093653	11	534224	11	534224	1093653	1078345	rs756934316	NC_000011.10:534223:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 2, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.97G>A (p.Asp33Asn)	HRAS|LRRC56	D33N	Costello syndrome	VCV000948198	11	534226	11	534226	948198	926275	rs1851315835	NC_000011.10:534225:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 6, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.96C>T (p.Tyr32=)	HRAS|LRRC56		not provided|Costello syndrome|Cardiovascular phenotype|not specified	VCV000531196	11	534227	11	534227	531196	526310	rs369039481	NC_000011.10:534226:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 6, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.91G>C (p.Glu31Gln)	HRAS|LRRC56	E31Q	Costello syndrome	VCV002827173	11	534232	11	534232	2827173	2983125		NC_000011.10:534231:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 9, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.90C>T (p.Asp30=)	HRAS|LRRC56		Costello syndrome	VCV000704664	11	534233	11	534233	704664	693060	rs745489020	NC_000011.10:534232:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 14, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.88G>A (p.Asp30Asn)	HRAS|LRRC56	D30N	Costello syndrome	VCV001497843	11	534235	11	534235	1497843	1376363	rs1226305644	NC_000011.10:534234:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 25, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.84T>C (p.Phe28=)	HRAS|LRRC56		not specified|Costello syndrome	VCV000518011	11	534239	11	534239	518011	503881	rs915086641	NC_000011.10:534238:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 8, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.81T>C (p.His27=)	HRAS|LRRC56		RASopathy	VCV000040431	11	534242	11	534242	40431	48901	rs12628	NC_000011.10:534241:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign	Apr 3, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.74A>G (p.Gln25Arg)	HRAS|LRRC56	Q25R	Costello syndrome	VCV002966734	11	534249	11	534249	2966734	3127988		NC_000011.10:534248:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.69G>A (p.Leu23=)	HRAS|LRRC56		not specified|Costello syndrome	VCV000702191	11	534254	11	534254	702191	693061	rs1589793671	NC_000011.10:534253:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 23, 2022	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.67C>T (p.Leu23=)	HRAS|LRRC56		Costello syndrome	VCV002917594	11	534256	11	534256	2917594	3074836		NC_000011.10:534255:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 2, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.64C>T (p.Gln22Ter)	HRAS|LRRC56	Q22*	not provided	VCV000279996	11	534259	11	534259	279996	264487	rs121917757	NC_000011.10:534258:G:A	single nucleotide variant	nonsense|5 prime UTR variant	Likely benign	Jan 30, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.64C>A (p.Gln22Lys)	HRAS|LRRC56	Q22K	Costello syndrome|not provided	VCV000012609	11	534259	11	534259	12609	27648	rs121917757	NC_000011.10:534258:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Dec 6, 2018	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.60C>T (p.Thr20=)	HRAS|LRRC56		Costello syndrome	VCV000704043	11	534263	11	534263	704043	693062	rs774042283	NC_000011.10:534262:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 2, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.59C>T (p.Thr20Ile)	HRAS|LRRC56	T20I	Costello syndrome	VCV002692872	11	534264	11	534264	2692872	2863699		NC_000011.10:534263:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.57G>C (p.Leu19=)	HRAS|LRRC56		Costello syndrome|Cardiovascular phenotype|not specified	VCV000259749	11	534266	11	534266	259749	254211	rs761648389	NC_000011.10:534265:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 12, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.55C>A (p.Leu19Met)	HRAS|LRRC56	L19M	Costello syndrome	VCV002416979	11	534268	11	534268	2416979	1944138		NC_000011.10:534267:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 2, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.55C>T (p.Leu19=)	HRAS|LRRC56		Costello syndrome	VCV001115701	11	534268	11	534268	1115701	1100066	rs2133994674	NC_000011.10:534267:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 5, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.54G>C (p.Ala18=)	HRAS|LRRC56		Costello syndrome	VCV000779092	11	534269	11	534269	779092	701803	rs148380285	NC_000011.10:534268:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Mar 18, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.54G>A (p.Ala18=)	HRAS|LRRC56		Cardiovascular phenotype|not specified|not provided|Costello syndrome	VCV000380392	11	534269	11	534269	380392	372233	rs148380285	NC_000011.10:534268:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Jan 18, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.45C>G (p.Gly15=)	HRAS|LRRC56		Costello syndrome	VCV002694362	11	534278	11	534278	2694362	2860501		NC_000011.10:534277:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 8, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.45C>T (p.Gly15=)	HRAS|LRRC56		not provided|Hereditary cancer-predisposing syndrome|not specified|Costello syndrome	VCV000179085	11	534278	11	534278	179085	174804	rs727504614	NC_000011.10:534277:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.44G>T (p.Gly15Val)	HRAS|LRRC56	G15V	Costello syndrome	VCV002129194	11	534279	11	534279	2129194	2175443		NC_000011.10:534278:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.44G>C (p.Gly15Ala)	HRAS|LRRC56	G15A	Costello syndrome	VCV001381958	11	534279	11	534279	1381958	1341917	rs1554885139	NC_000011.10:534278:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.44G>A (p.Gly15Asp)	HRAS|LRRC56	G15D	Vascular Tumors Including Pyogenic Granuloma	VCV000548639	11	534279	11	534279	548639	539147	rs1554885139	NC_000011.10:534278:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 19, 2015	no assertion criteria provided						
NM_005343.4(HRAS):c.42G>A (p.Val14=)	HRAS|LRRC56		not specified|Costello syndrome|Cardiovascular phenotype|not provided	VCV000259748	11	534281	11	534281	259748	254212	rs777038147	NC_000011.10:534280:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 17, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.41T>G (p.Val14Gly)	HRAS|LRRC56	V14G	Costello syndrome	VCV000654373	11	534282	11	534282	654373	640157	rs1589793707	NC_000011.10:534281:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 17, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.37_38inv (p.Gly13Pro)	HRAS|LRRC56	G13P	not specified	VCV001677304	11	534285 - 534286	11	534285 - 534286	1677304	1668962		NC_000011.10:534284:CC:GG	Inversion	missense variant|5 prime UTR variant	Uncertain significance		no assertion criteria provided						
NM_005343.4(HRAS):c.38G>T (p.Gly13Val)	HRAS|LRRC56	G13V	Large congenital melanocytic nevus|not provided|Costello syndrome	VCV000180848	11	534285	11	534285	180848	179419	rs104894226	NC_000011.10:534284:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jan 15, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.38G>A (p.Gly13Asp)	HRAS|LRRC56	G13D	Costello syndrome|Non-immune hydrops fetalis|Malignant tumor of urinary bladder|Epidermal nevus|Large congenital melanocytic nevus|Thyroid cancer, nonmedullary, 2|Costello syndrome|Linear nevus sebaceous syndrome|HRAS-related disorder|Noonan syndrome and Noonan-related syndrome|RASopathy|not provided	VCV000012604	11	534285	11	534285	12604	27643	rs104894226	NC_000011.10:534284:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 28, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.37G>A (p.Gly13Ser)	HRAS|LRRC56	G13S	Costello syndrome	VCV000376323	11	534286	11	534286	376323	363202	rs104894228	NC_000011.10:534285:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 18, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.37G>C (p.Gly13Arg)	HRAS|LRRC56	G13R	Noonan syndrome and Noonan-related syndrome|Costello syndrome|Epidermolytic nevus|Non-immune hydrops fetalis	VCV000035554	11	534286	11	534286	35554	44227	rs104894228	NC_000011.10:534285:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 16, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.37G>T (p.Gly13Cys)	HRAS|LRRC56	G13C	Noonan syndrome	VCV000012606	11	534286	11	534286	12606	27645	rs104894228	NC_000011.10:534285:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 3, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.35_36delinsTT (p.Gly12Val)	LRRC56|HRAS	G12V	Costello syndrome|not provided	VCV001209208	11	534287 - 534288	11	534287 - 534288	1209208	613672	rs727503094	NC_000011.10:534286:GC:AA	Indel	missense variant|5 prime UTR variant	Pathogenic	Jun 9, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.35_36delinsTA (p.Gly12Val)	HRAS|LRRC56	G12V	not provided	VCV000279921	11	534287 - 534288	11	534287 - 534288	279921	264557	rs727503094	NC_000011.10:534286:GC:TA	Indel	missense variant|5 prime UTR variant	Pathogenic	Apr 26, 2016	criteria provided, single submitter						
NM_005343.4(HRAS):c.36C>T (p.Gly12=)	HRAS|LRRC56		RASopathy	VCV000222076	11	534287	11	534287	222076	223774	rs727504424	NC_000011.10:534286:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Apr 18, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.35_36delinsAT (p.Gly12Asp)	LRRC56|HRAS	G12D	not provided	VCV000180854	11	534287 - 534288	11	534287 - 534288	180854	179420	rs727503094	NC_000011.10:534286:GC:AT	Indel	missense variant|5 prime UTR variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.36C>A (p.Gly12=)	HRAS|LRRC56		not specified	VCV000177957	11	534287	11	534287	177957	175216	rs727504424	NC_000011.10:534286:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant	not provided	May 5, 2011	no classification provided						
NM_005343.4(HRAS):c.35_36delinsAA (p.Gly12Glu)	HRAS|LRRC56	G12E	not provided|Costello syndrome	VCV000163690	11	534287 - 534288	11	534287 - 534288	163690	174805	rs727503094	NC_000011.10:534286:GC:TT	Indel	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 31, 2017	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.35_36delinsCT (p.Gly12Ala)	HRAS|LRRC56	G12A	not provided	VCV000040430	11	534287 - 534288	11	534287 - 534288	40430	48900	rs727503094	NC_000011.10:534286:GC:AG	Indel	missense variant|5 prime UTR variant	Pathogenic	Apr 28, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.35G>A (p.Gly12Asp)	HRAS|LRRC56	G12D	Costello syndrome|RASopathy|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|not provided	VCV000012612	11	534288	11	534288	12612	27651	rs104894230	NC_000011.10:534287:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 17, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.35G>C (p.Gly12Ala)	HRAS|LRRC56	G12A	Costello syndrome|Malignant tumor of urinary bladder|Epidermal nevus|Large congenital melanocytic nevus|Thyroid cancer, nonmedullary, 2|Costello syndrome|Linear nevus sebaceous syndrome|Noonan syndrome and Noonan-related syndrome|not provided|Inborn genetic diseases	VCV000012603	11	534288	11	534288	12603	27642	rs104894230	NC_000011.10:534287:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 24, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.35G>T (p.Gly12Val)	HRAS|LRRC56	G12V	not provided|Costello syndrome|HRAS-related disorder|Cardiovascular phenotype	VCV000012600	11	534288	11	534288	12600	27639	rs104894230	NC_000011.10:534287:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jun 3, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.34G>C (p.Gly12Arg)	HRAS|LRRC56	G12R	Costello syndrome	VCV000375961	11	534289	11	534289	375961	362840	rs104894229	NC_000011.10:534288:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 25, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	G12C	Costello syndrome|Malignant tumor of urinary bladder|Epidermal nevus|Large congenital melanocytic nevus|Thyroid cancer, nonmedullary, 2|Costello syndrome|Linear nevus sebaceous syndrome|not provided	VCV000012613	11	534289	11	534289	12613	27652	rs104894229	NC_000011.10:534288:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 9, 2024	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS|LRRC56	G12S	Costello syndrome	VCV000012602	11	534289	11	534289	12602	27641	rs104894229	NC_000011.10:534288:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 3, 2017	reviewed by expert panel						
NM_005343.4(HRAS):c.33C>T (p.Ala11=)	HRAS|LRRC56		Costello syndrome	VCV001133421	11	534290	11	534290	1133421	1121550	rs1162804656	NC_000011.10:534289:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 7, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.31G>A (p.Ala11Thr)	HRAS|LRRC56	A11T	Costello syndrome|Cardiovascular phenotype|not specified	VCV000178860	11	534292	11	534292	178860	175217	rs727504496	NC_000011.10:534291:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 28, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.30C>T (p.Gly10=)	HRAS|LRRC56		Costello syndrome	VCV001122633	11	534293	11	534293	1122633	1121551	rs752765965	NC_000011.10:534292:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 4, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.27_29dup (p.Gly10dup)	HRAS|LRRC56		not provided	VCV000496287	11	534293 - 534294	11	534293 - 534294	496287	487315	rs1554885154	NC_000011.10:534293:CCC:CCCCCC	Duplication	inframe_insertion|5 prime UTR variant	Uncertain significance	Mar 8, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.17TGG[3] (p.Val9del)	HRAS|LRRC56	V9del	Costello syndrome	VCV000861048	11	534295 - 534297	11	534295 - 534297	861048	838566	rs1164486792	NC_000011.10:534294:CCACCACCACCA:CCACCACCA	Microsatellite	inframe_deletion|5 prime UTR variant	Uncertain significance	Jan 29, 2019	criteria provided, single submitter						
NM_005343.4(HRAS):c.25dup (p.Val9fs)	HRAS|LRRC56	V9fs	Costello syndrome	VCV002172864	11	534297 - 534298	11	534297 - 534298	2172864	1904226		NC_000011.10:534297:CC:CCC	Duplication	frameshift variant|5 prime UTR variant	Uncertain significance	May 10, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.16_24del (p.Leu6_Val8del)	HRAS|LRRC56		Costello syndrome	VCV002024247	11	534299 - 534307	11	534299 - 534307	2024247	2077024		NC_000011.10:534298:CACCACCAGC:C	Deletion	inframe_deletion|5 prime UTR variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.24G>C (p.Val8=)	HRAS|LRRC56		not provided|Costello syndrome	VCV001200713	11	534299	11	534299	1200713	1191238	rs1451160542	NC_000011.10:534298:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 15, 2021	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.21G>C (p.Val7=)	HRAS|LRRC56		not provided|Costello syndrome|Cardiovascular phenotype	VCV001787611	11	534302	11	534302	1787611	1850591		NC_000011.10:534301:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 21, 2022	criteria provided, conflicting classifications						
NM_005343.4(HRAS):c.19G>T (p.Val7Leu)	HRAS|LRRC56	V7L	Costello syndrome	VCV001718940	11	534304	11	534304	1718940	1776444		NC_000011.10:534303:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.16C>T (p.Leu6=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV000415884	11	534307	11	534307	415884	398321	rs763376142	NC_000011.10:534306:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 8, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.15G>A (p.Lys5=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV001095613	11	534308	11	534308	1095613	1078346	rs1368820132	NC_000011.10:534307:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Nov 14, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.12T>C (p.Tyr4=)	HRAS|LRRC56		Costello syndrome	VCV001565760	11	534311	11	534311	1565760	1590349	rs2133995153	NC_000011.10:534310:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 13, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.11A>C (p.Tyr4Ser)	HRAS|LRRC56	Y4S	Costello syndrome	VCV001398020	11	534312	11	534312	1398020	1353219	rs764622691	NC_000011.10:534311:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 17, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.11A>G (p.Tyr4Cys)	HRAS|LRRC56	Y4C	Malignant tumor of urinary bladder|Epidermal nevus|Costello syndrome|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Linear nevus sebaceous syndrome|Costello syndrome|not specified	VCV000503537	11	534312	11	534312	503537	494970	rs764622691	NC_000011.10:534311:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 20, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.10T>C (p.Tyr4His)	HRAS|LRRC56	Y4H	not provided	VCV000496286	11	534313	11	534313	496286	487541	rs1554885164	NC_000011.10:534312:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 6, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.6G>A (p.Thr2=)	HRAS|LRRC56		Cardiovascular phenotype|Costello syndrome	VCV001655853	11	534317	11	534317	1655853	1529100	rs751944063	NC_000011.10:534316:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 24, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.5C>G (p.Thr2Arg)	HRAS|LRRC56	T2R	Costello syndrome	VCV001400061	11	534318	11	534318	1400061	1444150	rs1447218022	NC_000011.10:534317:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter						
NM_005343.4(HRAS):c.5C>T (p.Thr2Met)	HRAS|LRRC56	T2M	Costello syndrome	VCV000659504	11	534318	11	534318	659504	640158	rs1447218022	NC_000011.10:534317:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 20, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.4A>G (p.Thr2Ala)	HRAS|LRRC56	T2A	Costello syndrome	VCV000240137	11	534319	11	534319	240137	241159	rs878854761	NC_000011.10:534318:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 7, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.-2C>A	HRAS|LRRC56		not specified	VCV001027582	11	534324	11	534324	1027582	1015371	rs757657838	NC_000011.10:534323:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Mar 15, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.-5G>A	HRAS|LRRC56		not specified	VCV000975012	11	534327	11	534327	975012	963282	rs879083675	NC_000011.10:534326:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jul 27, 2020	criteria provided, single submitter						
NM_005343.4(HRAS):c.-10C>T	HRAS|LRRC56		not provided|not specified|Noonan syndrome and Noonan-related syndrome|Costello syndrome	VCV000137556	11	534332	11	534332	137556	141259	rs41294870	NC_000011.10:534331:G:A	single nucleotide variant	5 prime UTR variant	Benign	Nov 29, 2023	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.-17C>T	HRAS|LRRC56		not specified	VCV003069045	11	534339	11	534339	3069045	3228370		NC_000011.10:534338:G:A	single nucleotide variant	5 prime UTR variant	Benign	Feb 19, 2024	criteria provided, single submitter						
NM_005343.4(HRAS):c.-19C>T	HRAS|LRRC56		not provided	VCV000561775	11	534341	11	534341	561775	552664	rs1187467800	NC_000011.10:534340:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	Mar 20, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.-33G>A	HRAS|LRRC56		not provided	VCV001226379	11	534355	11	534355	1226379	1217633	rs2133995685	NC_000011.10:534354:C:T	single nucleotide variant	5 prime UTR variant	Benign	Mar 3, 2015	criteria provided, single submitter						
NM_005343.4(HRAS):c.-53-5G>A	HRAS|LRRC56		not provided	VCV002572953	11	534380	11	534380	2572953	2737895		NC_000011.10:534379:C:T	single nucleotide variant	intron variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.-53-10T>C	HRAS|LRRC56		not provided	VCV001290991	11	534385	11	534385	1290991	48899	rs2133995919	NC_000011.10:534384:A:G	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter						
NM_005343.4(HRAS):c.-53-17A>G	LRRC56|HRAS		not provided	VCV000381164	11	534392	11	534392	381164	374147	rs544830383	NC_000011.10:534391:T:C	single nucleotide variant	intron variant	Benign	Mar 5, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.-53-40_-53-29del	LRRC56|HRAS		not provided	VCV000561357	11	534404 - 534415	11	534404 - 534415	561357	552665	rs146677294	NC_000011.10:534403:CCCAGGCCCAGCCCCAGGCCC:CCCAGGCCC	Deletion	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.-53-40_-53-35del	HRAS|LRRC56		not provided	VCV000561359	11	534410 - 534415	11	534410 - 534415	561359	552666	rs544630615	NC_000011.10:534409:CCCAGCCCCAG:CCCAG	Deletion	intron variant	Benign	Jun 16, 2018	criteria provided, single submitter						
NM_005343.4(HRAS):c.-54+103CGG[6]	HRAS|LRRC56		not provided	VCV001302776	11	535290 - 535295	11	535290 - 535295	1302776	1293057	rs113931482	NC_000011.10:535289:CCGCCGCCGCCGCCGCCGCCGCCGC:CCGCCGCCGCCGCCGCCGC	Microsatellite	intron variant	Benign	Jul 8, 2021	criteria provided, single submitter						
NM_005343.4(HRAS):c.-54+47C>T	HRAS|LRRC56		not provided	VCV001247504	11	535369	11	535369	1247504	1234883	rs111720508	NC_000011.10:535368:G:A	single nucleotide variant	intron variant	Benign	Sep 2, 2020	criteria provided, multiple submitters, no conflicts						
NM_005343.4(HRAS):c.-54+7G>A	HRAS|LRRC56		not specified	VCV000508418	11	535409	11	535409	508418	503299	rs1183370084	NC_000011.10:535408:C:T	single nucleotide variant	intron variant	Likely benign	Mar 24, 2017	criteria provided, single submitter						
NM_005343.4(HRAS):c.-54+3G>A	HRAS|LRRC56		Costello syndrome	VCV002665082	11	535413	11	535413	2665082	2832651		NC_000011.10:535412:C:T	single nucleotide variant	intron variant	Uncertain significance	May 30, 2023	criteria provided, single submitter						
NM_005343.4(HRAS):c.-95CGGCCC[1]	LRRC56|HRAS		not specified	VCV000418632	11	535446 - 535451	11	535446 - 535451	418632	408385	rs112488103	NC_000011.10:535445:GGGCCGGGGCCG:GGGCCG	Microsatellite	5 prime UTR variant	Benign	Sep 10, 2015	criteria provided, single submitter						
NM_005343.4(HRAS):c.-101C>T	HRAS|LRRC56		not provided|Noonan syndrome and Noonan-related syndrome	VCV001226590	11	535463	11	535463	1226590	1217844	rs8176336	NC_000011.10:535462:G:A	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 27, 2020	criteria provided, conflicting classifications						
NC_000011.10:g.535596C>T	HRAS|LRRC56		not provided	VCV001291288	11	535596	11	535596	1291288	1281103	rs8176335	NC_000011.10:535595:C:T	single nucleotide variant		Benign	Jun 23, 2018	criteria provided, single submitter						
NC_000011.10:g.535603G>A	HRAS|LRRC56		not provided	VCV001279995	11	535603	11	535603	1279995	1269860	rs8176334	NC_000011.10:535602:G:A	single nucleotide variant		Benign	Jun 23, 2018	criteria provided, single submitter						
NC_000011.10:g.535649C>T	HRAS|LRRC56		not provided	VCV001259531	11	535649	11	535649	1259531	1250294	rs8176333	NC_000011.10:535648:C:T	single nucleotide variant		Benign	Jun 23, 2018	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(644674_?)dup	CDHR5|DEAF1|DRD4|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|RASSF7|SCT		not provided	VCV003244779	11	532636 - 644674			3244779	3402142			Duplication		Uncertain significance	Jan 10, 2024	criteria provided, single submitter						
NC_000011.9:g.(?_216698)_(679836_?)del	ANO9|B4GALNT4|CDHR5|DEAF1|DRD4|HRAS|IFITM1|IFITM2|IFITM3|IFITM5|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|NLRP6|PGGHG|PHRF1|PKP3|PSMD13|PTDSS2|RASSF7|RNH1|SCT|SIGIRR|SIRT3		not provided	VCV003244777	11	216698 - 679836			3244777	3402140			Deletion		Uncertain significance	Oct 27, 2022	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(533632_?)dup	HRAS		Costello syndrome	VCV003244592	11	532636 - 533632			3244592	3403514			Duplication		Uncertain significance	Dec 18, 2023	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(824862_?)dup	EPS8L2|CDHR5|CEND1|DEAF1|DRD4|GATD1|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|PIDD1|PNPLA2|RASSF7|RPLP2|SCT|SLC25A22|TALDO1|TMEM80		Costello syndrome	VCV003244591	11	532636 - 824862			3244591	3403513			Duplication		Uncertain significance	Dec 29, 2023	criteria provided, single submitter						
NC_000011.10:g.(?_532636)_(534322_?)dup	HRAS		Costello syndrome	VCV003244590	11	532636 - 534322			3244590	820387			Duplication		Uncertain significance	Dec 23, 2023	criteria provided, single submitter						
NC_000011.9:g.(?_216698)_(2906719_?)dup	ANO9|AP2A2|ASCL2|B4GALNT4|BRSK2|C11orf21|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|GATD1|H19|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LRRC56|LSP1|MIR210|MIR210HG|MOB2|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NLRP6|PGGHG|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RNH1|RPLP2|SCT|SIGIRR|SIRT3|SLC25A22|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TRPM5|TSPAN32|TSPAN4|TSSC4		Beckwith-Wiedemann syndrome	VCV003244518	11	216698 - 2906719			3244518	3403444			Duplication		Uncertain significance	Nov 19, 2023	criteria provided, single submitter						
GRCh37/hg19 11p15.5(chr11:372929-762338)x3	HRAS|IRF7|ANO9|B4GALNT4|CDHR5|DEAF1|DRD4|EPS8L2|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|PKP3|PTDSS2|RASSF7|RNH1|SCT|SIGIRR|TALDO1|TMEM80		not specified	VCV003063193	11	372929 - 762338			3063193	3223409			copy number gain		Uncertain significance		criteria provided, single submitter						
GRCh37/hg19 11p15.5-15.4(chr11:192764-3362853)x3	CARS1|CD151|CD81|TNNT3|TOLLIP|TRPM5|TSPAN32|TSPAN4|TSSC4|LRRC56|LSP1|DEAF1|DRD4|CDHR5|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|LMNTD2|LMNTD2-AS1|ANO9|AP2A2|ASCL2|B4GALNT4|BET1L|BRSK2|C11orf21|CDKN1C|CEND1|CHID1|CIMAP1A|CRACR2B|CTSD|DUSP8|EPS8L2|GATD1|H19|HRAS|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|MIR210|MIR210HG|MOB2|MRGPRE|MRGPRG|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP6|OSBPL5|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RIC8A|RNH1|RPLP2|SCGB1C1|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SYT8|TALDO1|TH|TMEM80|TNNI2		not provided	VCV002684632	11	192764 - 3362853			2684632	2845667			copy number gain		Pathogenic	Sep 20, 2022	criteria provided, single submitter						
GRCh37/hg19 11p15.5(chr11:268586-748873)	CDHR5|MIR210HG|EPS8L2|LMNTD2|DRD4|LMNTD2-AS1|LRRC56|MIR210|DEAF1|ANO9|B4GALNT4|HRAS|IFITM1|IFITM2|IFITM3|IFITM5|IRF7|NLRP6|PGGHG|PHRF1|PKP3|PTDSS2|RASSF7|RNH1|SCT|SIGIRR|TALDO1|TMEM80		Beckwith-Wiedemann syndrome due to 11p15 microdeletion	VCV002574690	11	268586 - 748873			2574690	2739626			copy number loss		Pathogenic		no assertion criteria provided						
GRCh37/hg19 11p15.5-15.4(chr11:230615-8821443)x3	ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|C11orf42|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FHIP1B|GATD1|HPX|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RNH1|RPL27A|RPLP2|RRM1|RRP8|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|STIM1|STK33|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM80|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|ZNF195|ZNF214|ZNF215		Russell-Silver syndrome	VCV002503522	11	230615 - 8821443			2503522	2668708			copy number gain		Pathogenic	May 25, 2023	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(819925_?)dup	CDHR5|CEND1|DEAF1|DRD4|EPS8L2|GATD1|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|PIDD1|PNPLA2|RASSF7|RPLP2|SCT|SLC25A22|TALDO1|TMEM80		Neutral lipid storage myopathy	VCV002426546	11	532636 - 819925			2426546	1946455			Duplication		Uncertain significance	Dec 6, 2022	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(554276_?)dup	HRAS|LRRC56		not provided	VCV002425339	11	532636 - 554276			2425339	1943063			Duplication		Uncertain significance	Feb 3, 2022	criteria provided, single submitter						
GRCh37/hg19 11p15.5(chr11:461373-2157956)x4	GATD1|IRF7|LSP1|MUC5B|MUC6|MUC5AC|MOB2|MRPL23|PHRF1|MIR210HG|MIR210|MUC2|AP2A2|BRSK2|CD151|CDHR5|CEND1|CHID1|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|H19|HRAS|IFITM10|IGF2|INS-IGF2|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LRRC56|PIDD1|PNPLA2|POLR2L|PTDSS2|RASSF7|RNH1|RPLP2|SCT|SLC25A22|SYT8|TALDO1|TMEM80|TNNI2|TNNT3|TOLLIP|TSPAN4		not provided	VCV001808628	11	461373 - 2157956			1808628	1865632			copy number gain		Pathogenic	Apr 13, 2022	criteria provided, single submitter						
GRCh37/hg19 11p15.5-15.4(chr11:230616-8250724)x3	CAVIN3|CCKBR|CD151|CD81|CDHR5|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|C11orf42|CARS1|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FHIP1B|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RNH1|RPLP2|RRM1|RRP8|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|STIM1|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM80|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|ZNF195|ZNF214|ZNF215		not provided	VCV001807629	11	230616 - 8250724			1807629	1864633			copy number gain		Pathogenic	Dec 23, 2021	criteria provided, single submitter						
GRCh37/hg19 11p15.5-14.2(chr11:230615-26881146)x3	CYP2R1|DBX1|DRD4|AMPD3|ANO3|ANO5|ANO9|AP2A2|ABCC8|ADM|AKIP1|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CARS1|CAVIN3|CCDC179|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CSRP3|CTR9|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DENND5A|DKK3|DNHD1|DUSP8|E2F8|EIF3F|EIF4G2|EPS8L2|FANCF|FAR1|FHIP1B|GALNT18|GAS2|GATD1|GTF2H1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPS5|HPX|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|IGSF22|ILK|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNC1|KCNJ11|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LDHAL6A|LDHC|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MYOD1|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PARVA|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PRMT3|PSMA1|PSMD13|PTDSS2|PTH|PTPN5|RASSF10|RASSF7|RBMXL2|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SERGEF|SIGIRR|SIRT3|SLC17A6|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SYT8|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A|TMEM9B|TNNI2|TNNT3|TOLLIP|TPH1|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|UEVLD|USH1C|USP47|WEE1|ZBED5|ZDHHC13|ZNF143|ZNF195|ZNF214|ZNF215		See cases	VCV001707435	11	230615 - 26881146			1707435	1705743			copy number gain		Pathogenic		no assertion criteria provided						
NC_000011.9:g.(?_532636)_(695047_?)dup	CDHR5|DEAF1|DRD4|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|RASSF7|SCT		not provided	VCV001443721	11	532636 - 695047			1443721	1487722			Duplication		Uncertain significance	Sep 12, 2022	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(533328_?)del	HRAS		Costello syndrome	VCV001429506	11	532636 - 533328			1429506	1477239			Deletion		Uncertain significance	Jul 18, 2021	criteria provided, single submitter						
NC_000011.9:g.(?_216698)_(720766_?)dup	ANO9|B4GALNT4|CDHR5|DEAF1|DRD4|EPS8L2|HRAS|IFITM1|IFITM2|IFITM3|IFITM5|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|NLRP6|PGGHG|PHRF1|PKP3|PSMD13|PTDSS2|RASSF7|RNH1|SCT|SIGIRR|SIRT3|TMEM80		Immunodeficiency 39	VCV001421885	11	216698 - 720766			1421885	1337500			Duplication		Uncertain significance	Nov 18, 2020	criteria provided, single submitter						
NC_000011.9:g.(?_533443)_(534322_?)dup	HRAS		Costello syndrome	VCV001418514	11	533443 - 534322			1418514	1490110			Duplication		Uncertain significance	May 24, 2021	criteria provided, single submitter						
GRCh37/hg19 11p15.5-15.4(chr11:230615-5525355)x3	IFITM5|SIGIRR|TH|TNNT3|SIRT3|TMEM80|TNNI2|TOLLIP|LMNTD2|MOB2|MRGPRE|MRGPRG|MRPL23|LMNTD2-AS1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|ANO9|AP2A2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|CARS1|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP6|NUP98|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B4|OR52D1|OR52E2|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52M1|OR52R1|OSBPL5|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RHOG|RNH1|RPLP2|RRM1|SCT|SLC22A18|SLC22A18AS|SLC25A22|STIM1|SYT8|TALDO1|TRIM21|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195		not provided	VCV001339886	11	230615 - 5525355			1339886	1331096			copy number gain		not provided		no classification provided						
GRCh37/hg19 11p15.5(chr11:528484-534377)x1	HRAS		not provided	VCV001298529	11	528484 - 534377			1298529	1288391			copy number loss		Uncertain significance	Jul 1, 2021	criteria provided, single submitter						
NC_000011.9:g.(?_532636)_(533622_?)dup	HRAS		Costello syndrome	VCV001056195	11	532636 - 533622			1056195	1039155			Duplication		Uncertain significance	Jul 14, 2021	criteria provided, single submitter						
NC_000011.9:g.(?_532630)_(532761_?)dup	HRAS		Costello syndrome	VCV001047136	11	532630 - 532761			1047136	1022324			Duplication		Uncertain significance	Aug 12, 2021	criteria provided, single submitter						
NC_000011.9:g.(?_298501)_(4113028_?)dup	DEAF1|MIR210|NAP1L4|NUP98|TH|TMEM80|TSPAN4|TSSC4|ZNF195|PKP3|RPLP2|PNPLA2|POLR2L|PTDSS2|MUC5AC|MUC5B|MUC6|RASSF7|RHOG|RNH1|SCT|SIGIRR|TNNI2|TNNT3|TOLLIP|DRD4|IFITM10|LMNTD2|LMNTD2-AS1|IFITM1|IFITM2|CARS1|CD151|CD81|CDHR5|IFITM3|IFITM5|LRRC56|LSP1|TRPM5|TSPAN32|MIR210HG|MRGPRG|MRPL23|MUC2|ANO9|MOB2|MRGPRE|AP2A2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|CDKN1C|CEND1|CHID1|CHRNA10|CRACR2B|CTSD|DUSP8|EPS8L2|GATD1|H19|HRAS|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|OSBPL5|PGAP2|PHLDA2|PHRF1|PIDD1|SLC22A18|SLC22A18AS|SLC25A22|STIM1|SYT8|TALDO1		Early infantile epileptic encephalopathy with suppression bursts	VCV001017523	11	298501 - 4113028			1017523	1001671			Duplication		Uncertain significance	Sep 10, 2020	criteria provided, single submitter						
NC_000011.9:g.(?_532631)_(534375_?)dup	HRAS		Costello syndrome	VCV000989468	11	532631 - 534375			989468	977406			Duplication		Uncertain significance	Oct 16, 2016	criteria provided, single submitter						
GRCh37/hg19 11p15.5-15.4(chr11:230615-4851537)x3	ANO9|AP2A2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|CARS1|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|GATD1|H19|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LRRC56|LSP1|MIR210|MIR210HG|MOB2|MRGPRE|MRGPRG|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP6|NUP98|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR52B4|OR52I1|OR52I2|OR52K1|OR52K2|OR52M1|OR52R1|OSBPL5|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RHOG|RNH1|RPLP2|RRM1|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|STIM1|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TRIM21|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195		See cases	VCV000983191	11	230615 - 4851537			983191	971276			copy number gain		Pathogenic	Sep 10, 2020	no assertion criteria provided						
GRCh37/hg19 11p15.5-15.4(chr11:210300-8664358)x3	CHRNA10|CNGA4|CRACR2B|OR52B2|OR52B4|OR52B6|TPP1|OR52D1|OR52E2|CTSD|CYB5R2|TRIM21|TRIM22|EIF3F|OR52E4|OR52E6|TRIM3|TRIM34|ZNF195|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|OR52E8|OR52H1|OR52M1|OR52I1|OR52I2|OR52K1|OR52N1|OR52N2|OR52N4|LMNTD2|LMNTD2-AS1|FHIP1B|GATD1|LMO1|LRRC56|LSP1|OR52J3|OR52K2|OR52L1|MIR210|MIR210HG|MMP26|MOB2|HPX|IRF7|EPS8L2|TRIM5|TRIM6|TRIM66|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|C11orf42|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|DCHS1|DEAF1|DNHD1|DRD4|DUSP8|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RIC8A|RNH1|RPLP2|RRM1|RRP8|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|STIM1|STK33|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM80|TNNI2|TNNT3|TOLLIP|ZNF214|ZNF215		Silver-Russell syndrome 1	VCV000981209	11	210300 - 8664358			981209	969295			copy number gain		Pathogenic		no assertion criteria provided						
GRCh37/hg19 11p15.5(chr11:230615-1150353)x3	ANO9|AP2A2|B4GALNT4|CD151|CDHR5|CEND1|CHID1|CRACR2B|DEAF1|DRD4|EPS8L2|GATD1|HRAS|IFITM1|IFITM2|IFITM3|IFITM5|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|MUC2|MUC5AC|MUC6|NLRP6|PGGHG|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RNH1|RPLP2|SCT|SIGIRR|SIRT3|SLC25A22|TALDO1|TMEM80|TSPAN4		not provided	VCV000980416	11	230615 - 1150353			980416	968494			copy number gain		Uncertain significance	Jul 16, 2019	no assertion criteria provided						
NC_000011.10:g.(?_534206)_(534328_?)dup	HRAS		Costello syndrome	VCV000833484	11	534206 - 534328			833484	820388			Duplication		Uncertain significance	May 27, 2020	criteria provided, single submitter						
NC_000011.9:g.(?_532616)_(2906985_?)dup	C11orf21|AP2A2|ASCL2|BRSK2|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CRACR2B|CTSD|DEAF1|DRD4|DUSP8|EPS8L2|GATD1|H19|HRAS|IFITM10|LMNTD2|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2-AS1|LRRC56|LSP1|MIR210|MIR210HG|MOB2|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|PHRF1|PIDD1|PNPLA2|POLR2L|RASSF7|RPLP2|SCT|SLC25A22|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TRPM5|TSPAN32|TSPAN4|TSSC4		Neuronal ceroid lipofuscinosis	VCV000832038	11	532616 - 2906985			832038	820432			Duplication		Uncertain significance	Jan 31, 2019	criteria provided, single submitter						
NC_000011.10:g.(?_532616)_(534342_?)dup	HRAS		Costello syndrome	VCV000831988	11	532616 - 534342			831988	820384			Duplication		Uncertain significance	Jul 25, 2019	criteria provided, single submitter						
NC_000011.10:g.(?_532636)_(534322_?)del	HRAS		Costello syndrome	VCV000831687	11	532636 - 534322			831687	820386			Deletion		Uncertain significance	Dec 19, 2023	criteria provided, single submitter						
NC_000011.10:g.(?_532616)_(795026_?)dup	CDHR5|CEND1|DEAF1|DRD4|EPS8L2|GATD1|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|RASSF7|SCT|SLC25A22|TALDO1|TMEM80		Early infantile epileptic encephalopathy with suppression bursts	VCV000830507	11	532616 - 795026			830507	820385			Duplication		Uncertain significance	Apr 27, 2019	criteria provided, single submitter						
GRCh37/hg19 11p15.5-13(chr11:235934-33826995)x3	CALCB|CARS1|FSHB|GALNT18|GAS2|MRGPRG|MRGPRX1|OR2D2|OR2D3|OR51A2|OR51A4|OR52E6|PIK3C2A|PKP3|SAA2|SAA2-SAA4|TMEM86A|TMEM9B|ZNF143|ZNF195|ZNF214|ZNF215|TRIM34|TRIM5|TRIM6|TNNT3|TOLLIP|TPH1|SAA4|SCT|SCUBE2|SERGEF|SIGIRR|SIRT3|SLC17A6|SAAL1|SBF2|TNNI2|TPP1|TRIM21|TRIM22|TRIM3|PLEKHA7|PNPLA2|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|PPFIBP2|OR52H1|PRMT3|PRRG4|PSMD13|PTDSS2|POLR2L|PSMA1|OR52E8|OR52I1|OR52I2|OR52J3|OR51E2|OR51F1|OR51A7|OR51B4|MRPL17|MYOD1|MRPL23|MTRNR2L8|MUC15|MUC2|OR51B6|OR51D1|OR51E1|OR51F2|OR51B2|GATD1|GTF2H1|IFITM5|KCNC1|HPS5|KCNJ11|LGR4|LIN7C|HIPK3|HPX|OR51B5|MRGPRX2|MUC5AC|MUC5B|MUC6|CAVIN3|CCDC73|CCKBR|CD151|CD59|CD81|CDHR5|ADM|AKIP1|AMPD3|ANO3|CSTF3|CTR9|CTSD|CYB5R2|CRACR2B|CSNK2A3|CSRP3|CCDC179|CCDC34|MRGPRX3|MRGPRX4|ABCC8|ANO5|ANO9|AP2A2|APBB1|ARFIP2|ARL14EP|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BBOX1|BDNF|BDNF-AS|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|C11orf91|CALCA|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CYP2R1|DBX1|DCDC1|DCHS1|DEAF1|DENND2B|DENND5A|DEPDC7|DKK3|DNAJC24|DNHD1|DRD4|DUSP8|E2F8|EIF3F|EIF3M|EIF4G2|ELP4|EPS8L2|FANCF|FAR1|FBXO3|FHIP1B|FIBIN|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|IGSF22|ILK|IMMP1L|KCNA4|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KIAA1549L|KIF18A|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LDHAL6A|LDHC|LINC00294|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|METTL15|MICAL2|MICALCL|MIR210|MIR210HG|MIR610|MMP26|MOB2|MPPED2|MRGPRE|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PARVA|PAX6|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PTH|PTPN5|QSER1|RASSF10|RASSF7|RBMXL2|RCN1|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SYT8|SYT9|TAF10|TALDO1|TCP11L1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|UEVLD|USH1C|USP47|WEE1|WT1|WT1-AS|ZBED5|ZDHHC13		not provided	VCV000815395	11	235934 - 33826995			815395	803604			copy number gain		Pathogenic	Oct 24, 2018	no assertion criteria provided						
GRCh37/hg19 11p15.5-15.3(chr11:193146-12643136)	C11orf40|C11orf42|MRPL17|MRPL23|OR10A3|OR10A4|MUC5AC|MUC5B|NRIP3|NUP98|MUC2|OLFML1|OR10A2|OR52E6|DRD4|DUSP8|CTR9|CTSD|CAVIN3|CCKBR|CD151|CRACR2B|CD81|CDHR5|CARS1|ADM|AKIP1|AMPD3|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BET1L|BRSK2|C11orf16|C11orf21|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CNGA4|CSNK2A3|MTRNR2L8|CYB5R2|DCHS1|DEAF1|DENND2B|DENND5A|DKK3|DNHD1|EIF3F|EIF4G2|EPS8L2|FHIP1B|GALNT18|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IPO7|IRAG1|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PARVA|PGAP2|PGGHG|PPFIBP2|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RIC8A|RNF141|RNH1|RPL27A|RPLP2|RRM1|RRP8|SBF2|SCGB1C1|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|STIM1|STK33|SWAP70|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|USP47|WEE1|ZBED5|ZNF143|ZNF195|ZNF214|ZNF215		Silver-Russell syndrome 1	VCV000625559	11	193146 - 12643136			625559	613863			copy number gain		Pathogenic	Nov 1, 2018	criteria provided, single submitter						
GRCh37/hg19 11p15.5-15.1(chr11:230615-17099213)x3	ADM|AKIP1|AMPD3|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CTR9|CTSD|CYB5R2|CYP2R1|DCHS1|DEAF1|DENND2B|DENND5A|DKK3|DNHD1|DRD4|DUSP8|EIF3F|EIF4G2|EPS8L2|FAR1|FHIP1B|GALNT18|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|LMNTD2|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2-AS1|LMO1|LRRC56|LSP1|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MTRNR2L8|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NRIP3|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PARVA|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PSMA1|PSMD13|PTDSS2|PTH|RASSF10|RASSF7|RBMXL2|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SBF2|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|SOX6|SPON1|STIM1|STK33|SWAP70|SYT8|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|USP47|WEE1|ZBED5|ZNF143|ZNF195|ZNF214|ZNF215		not provided	VCV000563883	11	230615 - 17099213			563883	555067			copy number gain		Pathogenic	Nov 13, 2017	no assertion criteria provided						
GRCh37/hg19 11p15.5-15.4(chr11:230615-9704511)x3	AKIP1|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BRSK2|C11orf16|C11orf21|C11orf40|C11orf42|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DENND5A|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FHIP1B|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IPO7|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NRIP3|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PPFIBP2|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RNH1|RPL27A|RPLP2|RRM1|RRP8|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|STIM1|STK33|SWAP70|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|WEE1|ZNF143|ZNF195|ZNF214|ZNF215		not provided	VCV000563880	11	230615 - 9704511			563880	555064			copy number gain		Pathogenic	Mar 30, 2018	no assertion criteria provided						
GRCh37/hg19 11p15.5-13(chr11:230615-31995219)x3	DEAF1|DENND2B|DENND5A|DKK3|DNAJC24|DNHD1|DRD4|DUSP8|E2F8|EIF3F|EIF4G2|ELP4|EPS8L2|FANCF|FAR1|FHIP1B|FIBIN|FSHB|GALNT18|GAS2|GATD1|GTF2H1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPS5|HPX|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|IGSF22|ILK|IMMP1L|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNA4|KCNC1|KCNJ11|KCNQ1|KCNQ1DN|KCNQ1OT1|KIF18A|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LDHAL6A|LDHC|LGR4|LIN7C|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|METTL15|MICAL2|MICALCL|MIR210|MIR210HG|MIR610|MMP26|MOB2|MPPED2|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MYOD1|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PARVA|PAX6|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PRMT3|PSMA1|PSMD13|PTDSS2|PTH|PTPN5|RASSF10|RASSF7|RBMXL2|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SERGEF|SIGIRR|SIRT3|SLC17A6|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SYT8|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A|TMEM9B|TNNI2|TNNT3|TOLLIP|TPH1|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|UEVLD|USH1C|USP47|WEE1|ZBED5|ZDHHC13|ZNF143|ZNF195|ZNF214|ZNF215|ABCC8|ADM|AKIP1|AMPD3|ANO3|ANO5|ANO9|AP2A2|APBB1|ARFIP2|ARL14EP|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BBOX1|BDNF|BDNF-AS|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CARS1|CAVIN3|CCDC179|CCDC34|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CSRP3|CTR9|CTSD|CYB5R2|CYP2R1|DBX1|DCDC1|DCHS1		See cases	VCV000441985	11	230615 - 31995219			441985	435647			copy number gain		Pathogenic	May 16, 2014	no assertion criteria provided						
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)	AAMDC|AASDHPPT|ABCC8|ABCG4|ABTB2|ACAD8|ACAT1|ACCS|ACCSL|ACER3|ACP2|ACRV1|ACTN3|ACY3|ADAMTS15|ADAMTS8|ADM|AGBL2|AHNAK|AIP|AKIP1|ALDH3B1|ALDH3B2|ALG8|ALG9|ALKBH3|ALKBH8|ALX4|AMBRA1|AMOTL1|AMPD3|ANAPC15|ANGPTL5|ANKK1|ANKRD13D|ANKRD42|ANKRD49|ANO1|ANO3|ANO5|ANO9|AP2A2|AP5B1|APBB1|API5|APIP|APLNR|APLP2|APOA1|APOA4|APOA5|APOC3|AQP11|ARAP1|ARAP1-AS2|ARCN1|ARFGAP2|ARFIP2|ARHGAP1|ARHGAP20|ARHGAP32|ARHGAP42|ARHGEF12|ARHGEF17|ARHGEF17-AS1|ARL14EP|ARL2|ARRB1|ART1|ART5|ASCL2|ASCL3|ASRGL1|ATG13|ATG16L2|ATG2A|ATL3|ATM|ATP5MG|B3GAT1|B3GAT3|B3GNT6|B4GALNT4|B4GAT1|BACE1|BACE1-AS|BAD|BANF1|BARX2|BATF2|BBOX1|BBS1|BCL9L|BCO2|BDNF|BDNF-AS|BEST1|BIRC2|BIRC3|BLID|BMAL1|BRMS1|BRSK2|BSCL2|BSX|BTBD10|BTBD18|BTG4|BUD13|C11orf16|C11orf21|C11orf24|C11orf40|C11orf42|C11orf52|C11orf54|C11orf58|C11orf65|C11orf68|C11orf71|C11orf86|C11orf87|C11orf91|C11orf96|C1QTNF4|C1QTNF5|C2CD2L|C2CD3|CABP2|CABP4|CADM1|CALCA|CALCB|CAPN1|CAPN5|CAPRIN1|CARD16|CARD17|CARD18|CARNS1|CARS1|CASP1|CASP12|CASP4|CASP5|CAT|CATSPER1|CATSPERZ|CAVIN3|CBL|CBLIF|CCDC15|CCDC179|CCDC34|CCDC73|CCDC81|CCDC82|CCDC83|CCDC85B|CCDC86|CCDC87|CCDC88B|CCDC89|CCDC90B|CCKBR|CCND1|CCS|CD151|CD248|CD3D|CD3E|CD3G|CD44|CD5|CD59|CD6|CD81|CD82|CDC42BPG|CDC42EP2|CDCA5|CDHR5|CDK2AP2|CDKN1C|CDON|CELF1|CENATAC|CEND1|CEP126|CEP164|CEP295|CEP57|CFAP300|CFAP68|CFL1|CHEK1|CHID1|CHKA|CHORDC1|CHRDL2|CHRM1|CHRM4|CHRNA10|CHST1|CKAP5|CLCF1|CLDN25|CLMP|CLNS1A|CLP1|CLPB|CNGA4|CNIH2|CNTF|CNTN5|COA4|COMMD9|COPB1|CORO1B|COX8A|CPSF7|CPT1A|CRACR2B|CREB3L1|CREBZF|CRTAM|CRY2|CRYAB|CSKMT|CSNK2A3|CSRP3|CST6|CSTF3|CSTPP1|CTNND1|CTR9|CTSC|CTSD|CTSF|CTSW|CTTN|CUL5|CWC15|CWF19L2|CXCR5|CYB561A3|CYB5R2|CYP2R1|DAGLA|DBX1|DCDC1|DCHS1|DCPS|DCUN1D5|DDB1|DDB2|DDI1|DDIAS|DDX10|DDX25|DDX6|DEAF1|DEFB108B|DENND2B|DENND5A|DEPDC7|DEUP1|DGAT2|DGKZ|DHCR7|DIXDC1|DKK3|DLAT|DLG2|DNAJB13|DNAJC24|DNAJC4|DNHD1|DPAGT1|DPF2|DPP3|DRAP1|DRC12|DRD2|DRD4|DSCAML1|DTX4|DUSP8|DYNC2H1|E2F8|EED|EEF1G|EFEMP2|EHBP1L1|EHD1|EHF|EI24|EIF1AD|EIF3F|EIF3M|EIF4G2|ELF5|ELMOD1|ELP4|EML3|EMSY|ENDOD1|EPS8L2|ESAM|ESRRA|ETS1|EXPH5|EXT2|F2|FADD|FADS1|FADS2|FADS3|FAM111A|FAM111B|FAM118B|FAM168A|FAM180B|FAM181B|FAM76B|FAM86C1P|FAM89B|FANCF|FAR1|FAT3|FAU|FBXO3|FCHSD2|FDX1|FDXACB1|FEN1|FERMT3|FEZ1|FGF19|FGF3|FGF4|FHIP1B|FIBIN|FIBP|FJX1|FKBP2|FLI1|FLRT1|FNBP4|FOLH1|FOLH1B|FOLR1|FOLR2|FOLR3|FOSL1|FOXR1|FOXRED1|FREY1|FRMD8|FSHB|FTH1|FUT4|FXYD2|FXYD6|FXYD6-FXYD2|FZD4|GAB2|GAL|GAL3ST3|GALNT18|GANAB|GAS2|GATD1|GDPD4|GDPD5|GLB1L2|GLB1L3|GLYAT|GLYATL1|GLYATL2|GNG3|GPHA2|GPR137|GPR152|GPR83|GRAMD1B|GRIA4|GRIK4|GRK2|GRM5|GSTP1|GTF2H1|GUCY1A2|H19|H2AX|HARBI1|HBB|HBD|HBE1|HBG1|HBG2|HEPACAM|HEPHL1|HEPN1|HIKESHI|HINFP|HIPK3|HMBS|HNRNPUL2|HOATZ|HPS5|HPX|HRAS|HSD17B12|HSPA8|HSPB2|HTATIP2|HTR3A|HTR3B|HYLS1|HYOU1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IFT46|IFTAP|IGF2|IGF2-AS|IGHMBP2|IGSF22|IGSF9B|IL10RA|IL18|IL18BP|ILK|IMMP1L|INCENP|INPPL1|INS|INS-IGF2|INSC|INTS4|INTS5|IPO7|IRAG1|IRF7|IZUMO1R|JAM3|JAML|JHY|JRKL|KAT5|KBTBD3|KBTBD4|KCNA4|KCNC1|KCNE3|KCNJ1|KCNJ11|KCNJ5|KCNJ5-AS1|KCNK4|KCNK7|KCNQ1|KCNQ1DN|KCNQ1OT1|KCTD14|KCTD21|KDM2A|KDM4D|KDM4E|KIAA1549L|KIF18A|KIRREL3|KLC2|KLHL35|KMT2A|KMT5B|KRTAP5-1|KRTAP5-10|KRTAP5-11|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-7|KRTAP5-8|KRTAP5-9|LAMTOR1|LARGE2|LAYN|LBHD1|LDHA|LDHAL6A|LDHC|LDLRAD3|LGALS12|LGR4|LIN7C|LINC00294|LINC02714|LINC02743|LINC02873|LIPT2|LMNTD2|LMNTD2-AS1|LMO1|LMO2|LOC100132686|LOC101929473|LPXN|LRFN4|LRP4|LRP5|LRRC10B|LRRC32|LRRC4C|LRRC55|LRRC56|LRRN4CL|LRTOMT|LSP1|LTBP3|LTO1|LUZP2|LYVE1|MACROD1|MADD|MADD-AS1|MAJIN|MALAT1|MAML2|MAP3K11|MAP4K2|MAP6|MAPK8IP1|MARK2|MCAM|MDK|ME3|MED17|MED19|MEN1|METTL15|MFRP|MICAL2|MICALCL|MIR100|MIR125B1|MIR130A|MIR139|MIR192|MIR194-2|MIR210|MIR210HG|MIR326|MIR34B|MIR34BHG|MIR34C|MIR610|MIRLET7A2|MMP1|MMP10|MMP12|MMP13|MMP20|MMP26|MMP27|MMP3|MMP7|MMP8|MOB2|MOGAT2|MPEG1|MPPED2|MPZL2|MPZL3|MRE11|MRGPRD|MRGPRE|MRGPRF|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL11|MRPL16|MRPL17|MRPL21|MRPL23|MRPL48|MRPL49|MS4A1|MS4A10|MS4A12|MS4A13|MS4A14|MS4A15|MS4A18|MS4A2|MS4A3|MS4A4A|MS4A4E|MS4A5|MS4A6A|MS4A6E|MS4A7|MS4A8|MSANTD2|MSANTD4|MTA2|MTCH2|MTMR2|MTNR1B|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MUS81|MYBPC3|MYEOV|MYO7A|MYOD1|MYRF|NAA40|NAALAD2|NAALADL1|NADSYN1|NAP1L4|NARS2|NAT10|NAV2|NCAM1|NCAPD3|NCR3LG1|NDUFC2|NDUFC2-KCTD14|NDUFS3|NDUFS8|NDUFV1|NDUFV1-DT|NEAT1|NECTIN1|NELL1|NEU3|NFRKB|NHERF4|NKAPD1|NLRP10|NLRP14|NLRP6|NLRX1|NNMT|NOX4|NPAS4|NPAT|NR1H3|NRGN|NRIP3|NRXN2|NTM|NUCB2|NUDT22|NUDT8|NUMA1|NUP160|NUP98|NXF1|NXPE1|NXPE2|NXPE4|OAF|OLFML1|OMP|OOSP2|OPCML|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR10AG1|OR10G4|OR10G7|OR10G8|OR10G9|OR10Q1|OR10S1|OR10V1|OR10W1|OR1S1|OR1S2|OR2AG1|OR2AG2|OR2AT4|OR2D2|OR2D3|OR4A15|OR4A16|OR4A47|OR4A5|OR4B1|OR4C11|OR4C12|OR4C13|OR4C15|OR4C16|OR4C3|OR4C46|OR4C6|OR4D10|OR4D11|OR4D5|OR4D6|OR4D9|OR4P4|OR4S1|OR4S2|OR4X1|OR4X2|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5A1|OR5A2|OR5AK2|OR5AN1|OR5AP2|OR5AR1|OR5AS1|OR5B12|OR5B17|OR5B2|OR5B21|OR5B3|OR5D13|OR5D14|OR5D16|OR5D18|OR5F1|OR5I1|OR5J2|OR5L1|OR5L2|OR5M1|OR5M10|OR5M11|OR5M3|OR5M8|OR5M9|OR5P2|OR5P3|OR5T1|OR5T2|OR5T3|OR5W2|OR6A2|OR6M1|OR6Q1|OR6T1|OR6X1|OR8A1|OR8B12|OR8B2|OR8B3|OR8B4|OR8B8|OR8D1|OR8D2|OR8D4|OR8G1|OR8G5|OR8H1|OR8H2|OR8H3|OR8I2|OR8J1|OR8J3|OR8K1|OR8K3|OR8K5|OR8U1|OR8U3|OR9G1|OR9G4|OR9I1|OR9Q1|OR9Q2|OSBP|OSBPL5|OTOG|OTUB1|OVCH2|OVOL1|P2RX3|P2RY2|P2RY6|P4HA3|PAAF1|PACS1|PACSIN3|PAFAH1B2|PAK1|PAMR1|PANX1|PANX3|PARVA|PATE1|PATE2|PATE3|PATE4|PATL1|PAX6|PC|PCF11|PCNX3|PCSK7|PDE2A|PDE3B|PDGFD|PDHX|PELI3|PEX16|PGA3|PGA4|PGA5|PGAP2|PGGHG|PGM2L1|PGR|PHF21A|PHLDA2|PHLDB1|PHOX2A|PHRF1|PICALM|PIDD1|PIH1D2|PIK3C2A|PITPNM1|PIWIL4|PKNOX2|PKP3|PLAAT2|PLAAT3|PLAAT4|PLAAT5|PLCB3|PLEKHA7|PLEKHB1|PLET1|PNPLA2|POGLUT3|POLA2|POLD3|POLD4|POLR2G|POLR2L|POU2AF1|POU2AF2|POU2AF3|POU2F3|PPFIA1|PPFIBP2|PPME1|PPP1CA|PPP1R14B|PPP2R1B|PPP2R5B|PPP6R3|PRCP|PRDM10|PRDM11|PRDX5|PRG2|PRG3|PRMT3|PRPF19|PRR5L|PRRG4|PRSS23|PSMA1|PSMC3|PSMD13|PTDSS2|PTGDR2|PTH|PTPMT1|PTPN5|PTPRCAP|PTPRJ|PTS|PUS3|PYGM|QSER1|RAB1B|RAB30|RAB38|RAB39A|RAB3IL1|RAB6A|RAD9A|RAG1|RAG2|RAPSN|RASGRP2|RASSF10|RASSF7|RBM14|RBM14-RBM4|RBM4|RBM4B|RBM7|RBMXL2|RCE1|RCN1|RCOR2|RDX|RELA|RELT|REXO2|RHOD|RHOG|RIC3|RIN1|RNASEH2C|RNF121|RNF141|RNF169|RNF214|RNF26|RNH1|ROBO3|ROBO4|ROM1|RPL27A|RPLP2|RPS13|RPS25|RPS3|RPS6KA4|RPS6KB2|RPUSD4|RRAS2|RRM1|RRP8|RSF1|RTN3|RTN4RL2|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SAC3D1|SART1|SAXO4|SBF2|SC5D|SCGB1A1|SCGB1D1|SCGB1D2|SCGB1D4|SCGB2A1|SCGB2A2|SCN2B|SCN3B|SCN4B|SCT|SCUBE2|SCYL1|SDHAF2|SDHD|SELENOH|SERGEF|SERPING1|SERPINH1|SESN3|SF1|SF3B2|SHANK2|SIAE|SIDT2|SIGIRR|SIK2|SIK3|SIPA1|SIRT3|SLC15A3|SLC17A6|SLC1A2|SLC22A10|SLC22A11|SLC22A12|SLC22A18|SLC22A18AS|SLC22A24|SLC22A25|SLC22A6|SLC22A8|SLC22A9|SLC25A22|SLC25A45|SLC29A2|SLC35C1|SLC35F2|SLC36A4|SLC37A2|SLC37A4|SLC39A13|SLC3A2|SLC43A1|SLC43A3|SLC5A12|SLC6A5|SLCO2B1|SLN|SMCO4|SMPD1|SMTNL1|SNHG1|SNORA3B|SNORD15A|SNORD22|SNORD25|SNORD26|SNORD27|SNORD28|SNORD29|SNORD30|SNORD31|SNX15|SNX19|SNX32|SORL1|SOX6|SPA17|SPATA19|SPCS2|SPDYC|SPI1|SPINDOC|SPON1|SPTBN2|SPTY2D1|SRPRA|SRSF8|SSH3|SSRP1|ST14|ST3GAL4|STARD10|STIM1|STIP1|STK33|STT3A|STX3|STX5|SVIP|SWAP70|SYT12|SYT13|SYT7|SYT8|SYT9|SYTL2|SYVN1|TAF10|TAF1D|TAF6L|TAGLN|TALDO1|TBC1D10C|TBCEL|TBRG1|TBX10|TCIRG1|TCN1|TCP11L1|TEAD1|TECTA|TENM4|TESMIN|TEX12|TH|THAP12|THRSP|THY1|THYN1|TIGD3|TIMM10|TIMM10B|TIMM8B|TIRAP|TKFC|TLCD5|TM7SF2|TMEM109|TMEM123|TMEM126A|TMEM126B|TMEM132A|TMEM133|TMEM134|TMEM135|TMEM138|TMEM151A|TMEM179B|TMEM216|TMEM218|TMEM223|TMEM225|TMEM25|TMEM258|TMEM41B|TMEM45B|TMEM80|TMEM86A|TMEM9B|TMPRSS13|TMPRSS4|TMPRSS5|TMX2|TNKS1BP1|TNNI2|TNNT3|TOLLIP|TOP6BL|TP53AIP1|TP53I11|TPBGL|TPCN2|TPH1|TPP1|TRAF6|TRAPPC4|TREH|TRIM21|TRIM22|TRIM29|TRIM3|TRIM34|TRIM44|TRIM48|TRIM49|TRIM49B|TRIM49C|TRIM49D1|TRIM49D2|TRIM5|TRIM51|TRIM6|TRIM64|TRIM64B|TRIM64C|TRIM66|TRIM68|TRIM77|TRMT112|TRPC6|TRPM5|TRPT1|TSG101|TSGA10IP|TSKU|TSPAN18|TSPAN32|TSPAN4|TSSC4|TTC12|TTC17|TTC36|TTC9C|TUB|TUT1|TYR|UBASH3B|UBE2L6|UBE4A|UBQLN3|UBQLNL|UBTFL1|UBXN1|UCP2|UCP3|UEVLD|UNC93B1|UPK2|UQCC3|USH1C|USP2|USP28|USP35|USP47|UVRAG|VEGFB|VPS11|VPS26B|VPS37C|VPS51|VSIG2|VSTM5|VWA5A|VWCE|WDR74|WEE1|WNT11|WT1|WT1-AS|XRRA1|YAP1|YIF1A|YPEL4|ZBED5|ZBTB16|ZBTB3|ZBTB44|ZC3H12C|ZDHHC13|ZDHHC24|ZDHHC5|ZFP91|ZFPL1|ZFTA|ZNF143|ZNF195|ZNF202|ZNF214|ZNF215|ZNF408|ZNF705E|ZNHIT2|ZNRD2|ZP1|ZPR1|ZW10		See cases	VCV000441904	11	230616 - 134938470			441904	435566			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided						
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)x3	SLC37A4|SNORD26|SNORD27|ST3GAL4|TAGLN|TALDO1|TBC1D10C|TBCEL|TBRG1|TBX10|TCIRG1|SYT12|SYT13|SYT7|SYT8|SNORD31|SNX15|SNX19|SNX32|SORL1|SOX6|SPA17|SPATA19|SPI1|SPINDOC|SPON1|SPTBN2|SPCS2|SPDYC|STARD10|STIM1|STT3A|SWAP70|STIP1|STK33|STX3|STX5|SLC39A13|SLC43A3|SLC43A1|SLC5A12|SLC6A5|ACCS|ACCSL|ACER3|ACP2|ACAD8|ACAT1|SLCO2B1|SLN|SMCO4|SMPD1|SLC3A2|SVIP|SNORD28|SNORD29|SNORD30|ACRV1|AAMDC|AASDHPPT|ABCC8|ABCG4|ABTB2|ACTN3|ACY3|ADAMTS15|SLC35F2|SLC36A4|SLC37A2|SMTNL1|SNHG1|SNORA3B|SNORD15A|SNORD22|SNORD25|SPTY2D1|SRPRA|SRSF8|SSH3|SSRP1|ST14|SYT9|SYTL2|SYVN1|TAF10|TAF1D|TAF6L|TCN1|TCP11L1|TEAD1|TECTA|TENM4|TESMIN|TEX12|TH|THAP12|THRSP|THY1|THYN1|TIGD3|TIMM10|TIMM10B|TIMM8B|TIRAP|TKFC|TLCD5|TM7SF2|TMEM109|TMEM123|TMEM126A|TMEM126B|TMEM132A|TMEM133|TMEM134|TMEM135|TMEM138|TMEM151A|TMEM179B|TMEM216|TMEM218|TMEM223|TMEM225|TMEM25|TMEM258|TMEM41B|TMEM45B|TMEM80|TMEM86A|TMEM9B|TMPRSS13|TMPRSS4|TMPRSS5|TMX2|TNKS1BP1|TNNI2|TNNT3|TOLLIP|TOP6BL|TP53AIP1|TP53I11|TPBGL|TPCN2|TPH1|TPP1|TRAF6|TRAPPC4|TREH|TRIM21|TRIM22|TRIM29|TRIM3|TRIM34|TRIM44|TRIM48|TRIM49|TRIM49B|TRIM49C|TRIM49D1|TRIM49D2|TRIM5|TRIM51|TRIM6|TRIM64|TRIM64B|TRIM64C|TRIM66|TRIM68|TRIM77|TRMT112|TRPC6|TRPM5|TRPT1|TSG101|TSGA10IP|TSKU|TSPAN18|TSPAN32|TSPAN4|TSSC4|TTC12|TTC17|TTC36|TTC9C|TUB|TUT1|TYR|UBASH3B|UBE2L6|UBE4A|UBQLN3|UBQLNL|UBTFL1|UBXN1|UCP2|UCP3|UEVLD|UNC93B1|UPK2|UQCC3|USH1C|USP2|USP28|USP35|USP47|UVRAG|VEGFB|VPS11|VPS26B|VPS37C|VPS51|VSIG2|VSTM5|VWA5A|VWCE|WDR74|WEE1|WNT11|WT1|WT1-AS|XRRA1|YAP1|YIF1A|YPEL4|ZBED5|ZBTB16|ZBTB3|ZBTB44|ZC3H12C|ZDHHC13|ZDHHC24|ZDHHC5|ZFP91|ZFPL1|ZFTA|ZNF143|ZNF195|ZNF202|ZNF214|ZNF215|ZNF408|ZNF705E|ZNHIT2|ZNRD2|ZP1|ZPR1|ZW10|ADM|ADAMTS8|AGBL2|AHNAK|AIP|AKIP1|ALDH3B1|ALDH3B2|ALG8|ALG9|ALKBH3|ALKBH8|ALX4|AMBRA1|AMOTL1|AMPD3|ANAPC15|ANGPTL5|ANKK1|ANKRD13D|ANKRD42|ANKRD49|ANO1|ANO3|ANO5|ANO9|AP2A2|AP5B1|APBB1|API5|APIP|APLNR|APLP2|APOA1|APOA4|APOA5|APOC3|AQP11|ARAP1|ARAP1-AS2|ARCN1|ARFGAP2|ARFIP2|ARHGAP1|ARHGAP20|ARHGAP32|ARHGAP42|ARHGEF12|ARHGEF17|ARHGEF17-AS1|ARL14EP|ARL2|ARRB1|ART1|ART5|ASCL2|ASCL3|ASRGL1|ATG13|ATG16L2|ATG2A|ATL3|ATM|ATP5MG|B3GAT1|B3GAT3|B3GNT6|B4GALNT4|B4GAT1|BACE1|BACE1-AS|BAD|BANF1|BARX2|BATF2|BBOX1|BBS1|BCL9L|BCO2|BDNF|BDNF-AS|BEST1|BIRC2|BIRC3|BLID|BMAL1|BRMS1|BRSK2|BSCL2|BSX|BTBD10|BTBD18|BTG4|BUD13|C11orf16|C11orf21|C11orf24|C11orf40|C11orf42|C11orf52|C11orf54|C11orf58|C11orf65|C11orf68|C11orf71|C11orf86|C11orf87|C11orf91|C11orf96|C1QTNF4|C1QTNF5|C2CD2L|C2CD3|CABP2|CABP4|CADM1|CALCA|CALCB|CAPN1|CAPN5|CAPRIN1|CARD16|CARD17|CARD18|CARNS1|CARS1|CASP1|CASP12|CASP4|CASP5|CAT|CATSPER1|CATSPERZ|CAVIN3|CBL|CBLIF|CCDC15|CCDC179|CCDC34|CCDC73|CCDC81|CCDC82|CCDC83|CCDC85B|CCDC86|CCDC87|CCDC88B|CCDC89|CCDC90B|CCKBR|CCND1|CCS|CD151|CD248|CD3D|CD3E|CD3G|CD44|CD5|CD59|CD6|CD81|CD82|CDC42BPG|CDC42EP2|CDCA5|CDHR5|CDK2AP2|CDKN1C|CDON|CELF1|CENATAC|CEND1|CEP126|CEP164|CEP295|CEP57|CFAP300|CFAP68|CFL1|CHEK1|CHID1|CHKA|CHORDC1|CHRDL2|CHRM1|CHRM4|CHRNA10|CHST1|CKAP5|CLCF1|CLDN25|CLMP|CLNS1A|CLP1|CLPB|CNGA4|CNIH2|CNTF|CNTN5|COA4|COMMD9|COPB1|CORO1B|COX8A|CPSF7|CPT1A|CRACR2B|CREB3L1|CREBZF|CRTAM|CRY2|CRYAB|CSKMT|CSNK2A3|CSRP3|CST6|CSTF3|CSTPP1|CTNND1|CTR9|CTSC|CTSD|CTSF|CTSW|CTTN|CUL5|CWC15|CWF19L2|CXCR5|CYB561A3|CYB5R2|CYP2R1|DAGLA|DBX1|DCDC1|DCHS1|DCPS|DCUN1D5|DDB1|DDB2|DDI1|DDIAS|DDX10|DDX25|DDX6|DEAF1|DEFB108B|DENND2B|DENND5A|DEPDC7|DEUP1|DGAT2|DGKZ|DHCR7|DIXDC1|DKK3|DLAT|DLG2|DNAJB13|DNAJC24|DNAJC4|DNHD1|DPAGT1|DPF2|DPP3|DRAP1|DRC12|DRD2|DRD4|DSCAML1|DTX4|DUSP8|DYNC2H1|E2F8|EED|EEF1G|EFEMP2|EHBP1L1|EHD1|EHF|EI24|EIF1AD|EIF3F|EIF3M|EIF4G2|ELF5|ELMOD1|ELP4|EML3|EMSY|ENDOD1|EPS8L2|ESAM|ESRRA|ETS1|EXPH5|EXT2|F2|FADD|FADS1|FADS2|FADS3|FAM111A|FAM111B|FAM118B|FAM168A|FAM180B|FAM181B|FAM76B|FAM86C1P|FAM89B|FANCF|FAR1|FAT3|FAU|FBXO3|FCHSD2|FDX1|FDXACB1|FEN1|FERMT3|FEZ1|FGF19|FGF3|FGF4|FHIP1B|FIBIN|FIBP|FJX1|FKBP2|FLI1|FLRT1|FNBP4|FOLH1|FOLH1B|FOLR1|FOLR2|FOLR3|FOSL1|FOXR1|FOXRED1|FREY1|FRMD8|FSHB|FTH1|FUT4|FXYD2|FXYD6|FXYD6-FXYD2|FZD4|GAB2|GAL|GAL3ST3|GALNT18|GANAB|GAS2|GATD1|GDPD4|GDPD5|GLB1L2|GLB1L3|GLYAT|GLYATL1|GLYATL2|GNG3|GPHA2|GPR137|GPR152|GPR83|GRAMD1B|GRIA4|GRIK4|GRK2|GRM5|GSTP1|GTF2H1|GUCY1A2|HBG1|H19|H2AX|HARBI1|HBB|HBD|HBE1|HBG2|HEPACAM|HEPHL1|HEPN1|HIKESHI|HINFP|HIPK3|HMBS|HNRNPUL2|HOATZ|HPS5|HPX|HRAS|HSD17B12|HSPA8|HSPB2|HTATIP2|HTR3A|HTR3B|HYLS1|HYOU1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IFT46|IFTAP|IGF2|IGF2-AS|IGHMBP2|IGSF22|IGSF9B|IL10RA|IL18|IL18BP|ILK|IMMP1L|INCENP|INPPL1|INS|INS-IGF2|INSC|INTS4|INTS5|IPO7|IRAG1|IRF7|IZUMO1R|JAM3|JAML|JHY|JRKL|KAT5|KBTBD3|KBTBD4|KCNA4|KCNC1|KCNE3|KCNJ1|KCNJ11|KCNJ5|KCNJ5-AS1|KCNK4|KCNK7|KCNQ1|KCNQ1DN|KCNQ1OT1|KCTD14|KCTD21|KDM2A|KDM4D|KDM4E|KIAA1549L|KIF18A|KIRREL3|KLC2|KLHL35|KMT2A|KMT5B|KRTAP5-1|KRTAP5-10|KRTAP5-11|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-7|KRTAP5-8|KRTAP5-9|LAMTOR1|LARGE2|LAYN|LBHD1|LDHA|LDHAL6A|LDHC|LDLRAD3|LGALS12|LGR4|LIN7C|LINC00294|LINC02714|LINC02743|LINC02873|LIPT2|LMNTD2|LMNTD2-AS1|LMO1|LMO2|LOC100132686|LOC101929473|LPXN|LRFN4|LRP4|LRP5|LRRC10B|LRRC32|LRRC4C|LRRC55|LRRC56|LRRN4CL|LRTOMT|LSP1|LTBP3|LTO1|LUZP2|LYVE1|MACROD1|MADD|MADD-AS1|MAJIN|MALAT1|MAML2|MAP3K11|MAP4K2|MAP6|MAPK8IP1|MARK2|MCAM|MDK|ME3|MED17|MED19|MEN1|METTL15|MFRP|MICAL2|MICALCL|MIR100|MIR125B1|MIR130A|MIR139|MIR192|MIR194-2|MIR210|MIR210HG|MIR326|MIR34B|MIR34BHG|MIR34C|MIR610|MIRLET7A2|MMP1|MMP10|MMP12|MMP13|MMP20|MMP26|MMP27|MMP3|MMP7|MMP8|MOB2|MOGAT2|MPEG1|MPPED2|MPZL2|MPZL3|MRE11|MRGPRD|MRGPRE|MRGPRF|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL11|MRPL16|MRPL17|MRPL21|MRPL23|MRPL48|MRPL49|MS4A1|MS4A10|MS4A12|MS4A13|MS4A14|MS4A15|MS4A18|MS4A2|MS4A3|MS4A4A|MS4A4E|MS4A5|MS4A6A|MS4A6E|MS4A7|MS4A8|MSANTD2|MSANTD4|MTA2|MTCH2|MTMR2|MTNR1B|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MUS81|MYBPC3|MYEOV|MYO7A|MYOD1|MYRF|NAA40|NAALAD2|NAALADL1|NADSYN1|NAP1L4|NARS2|NAT10|NAV2|NCAM1|NCAPD3|NCR3LG1|NDUFC2|NDUFC2-KCTD14|NDUFS3|NDUFS8|NDUFV1|NDUFV1-DT|NEAT1|NECTIN1|NELL1|NEU3|NFRKB|NHERF4|NKAPD1|NLRP10|NLRP14|NLRP6|NLRX1|NNMT|NOX4|NPAS4|NPAT|NR1H3|NRGN|NRIP3|NRXN2|NTM|NUCB2|NUDT22|NUDT8|NUMA1|NUP160|NUP98|NXF1|NXPE1|NXPE2|NXPE4|OAF|OLFML1|OMP|OOSP2|OPCML|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR10AG1|OR10G4|OR10G7|OR10G8|OR10G9|OR10Q1|OR10S1|OR10V1|OR10W1|OR1S1|OR1S2|OR2AG1|OR2AG2|OR2AT4|OR2D2|OR2D3|OR4A15|OR4A16|OR4A47|OR4A5|OR4B1|OR4C11|OR4C12|OR4C13|OR4C15|OR4C16|OR4C3|OR4C46|OR4C6|OR4D10|OR4D11|OR4D5|OR4D6|OR4D9|OR4P4|OR4S1|OR4S2|OR4X1|OR4X2|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5A1|OR5A2|OR5AK2|OR5AN1|OR5AP2|OR5AR1|OR5AS1|OR5B12|OR5B17|OR5B2|OR5B21|OR5B3|OR5D13|OR5D14|OR5D16|OR5D18|OR5F1|OR5I1|OR5J2|OR5L1|OR5L2|OR5M1|OR5M10|OR5M11|OR5M3|OR5M8|OR5M9|OR5P2|OR5P3|OR5T1|OR5T2|OR5T3|OR5W2|OR6A2|OR6M1|OR6Q1|OR6T1|OR6X1|OR8A1|OR8B12|OR8B2|OR8B3|OR8B4|OR8B8|OR8D1|OR8D2|OR8D4|OR8G1|OR8G5|OR8H1|OR8H2|OR8H3|OR8I2|OR8J1|OR8J3|OR8K1|OR8K3|OR8K5|OR8U1|OR8U3|OR9G1|OR9G4|OR9I1|OR9Q1|OR9Q2|OSBP|OSBPL5|OTOG|OTUB1|OVCH2|OVOL1|P2RX3|P2RY2|P2RY6|P4HA3|PAAF1|PACS1|PACSIN3|PAFAH1B2|PAK1|PAMR1|PANX1|PANX3|PARVA|PATE1|PATE2|PATE3|PATE4|PATL1|PAX6|PC|PCF11|PCNX3|PCSK7|PDE2A|PDE3B|PDGFD|PDHX|PELI3|PEX16|PGA3|PGA4|PGA5|PGAP2|PGGHG|PGM2L1|PGR|PHF21A|PHLDA2|PHLDB1|PHOX2A|PHRF1|PICALM|PIDD1|PIH1D2|PIK3C2A|PITPNM1|PIWIL4|PKNOX2|PKP3|PLAAT2|PLAAT3|PLAAT4|PLAAT5|PLCB3|PLEKHA7|PLEKHB1|PLET1|PNPLA2|POGLUT3|POLA2|POLD3|POLD4|POLR2G|POLR2L|POU2AF1|POU2AF2|POU2AF3|POU2F3|PPFIA1|PPFIBP2|PPME1|PPP1CA|PPP1R14B|PPP2R1B|PPP2R5B|PPP6R3|PRCP|PRDM10|PRDM11|PRDX5|PRG2|PRG3|PRMT3|PRPF19|PRR5L|PRRG4|PRSS23|PSMA1|PSMC3|PSMD13|PTDSS2|PTGDR2|PTH|PTPMT1|PTPN5|PTPRCAP|PTPRJ|PTS|PUS3|PYGM|QSER1|RAB1B|RAB30|RAB38|RAB39A|RAB3IL1|RAB6A|RAD9A|RAG1|RAG2|RAPSN|RASGRP2|RASSF10|RASSF7|RBM14|RBM14-RBM4|RBM4|RBM4B|RBM7|RBMXL2|RCE1|RCN1|RCOR2|RDX|RELA|RELT|REXO2|RHOD|RHOG|RIC3|RIN1|RNASEH2C|RNF121|RNF141|RNF169|RNF214|RNF26|RNH1|ROBO3|ROBO4|ROM1|RPL27A|RPLP2|RPS13|RPS25|RPS3|RPS6KA4|RPS6KB2|RPUSD4|RRAS2|RRM1|RRP8|RSF1|RTN3|RTN4RL2|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SAC3D1|SART1|SAXO4|SBF2|SC5D|SCGB1A1|SCGB1D1|SCGB1D2|SCGB1D4|SCGB2A1|SCGB2A2|SCN2B|SCN3B|SCN4B|SCT|SCUBE2|SCYL1|SDHAF2|SDHD|SELENOH|SERGEF|SERPING1|SERPINH1|SESN3|SF1|SF3B2|SHANK2|SIAE|SIDT2|SIGIRR|SIK2|SIK3|SIPA1|SIRT3|SLC15A3|SLC17A6|SLC1A2|SLC22A10|SLC22A11|SLC22A12|SLC22A18|SLC22A18AS|SLC22A24|SLC22A25|SLC22A6|SLC22A8|SLC22A9|SLC25A22|SLC25A45|SLC29A2|SLC35C1		See cases	VCV000441903	11	230616 - 134938470			441903	435565			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided						
GRCh37/hg19 11p15.5-14.3(chr11:230615-25584362)x3	ASCL3|CEND1|CHID1|EIF3F|EIF4G2|EPS8L2|FANCF|LDHAL6A|MRGPRX4|MRPL17|OR10A2|OR51E2|OR51F1|OR52E2|OR52E4|OR52E6|OR56A4|OR56A5|PTPN5|RASSF10|SERGEF|SIGIRR|TRIM34|ZNF195|TRIM5|TSG101|TSPAN32|TSPAN4|TSSC4|TRIM68|TRPM5|TUB|UBQLN3|UBQLNL|UEVLD|TRIM6|TRIM66|ZNF214|ZNF215|SIRT3|SLC17A6|TMEM9B|SWAP70|SYT8|RRAS2|RRM1|RRP8|SAA1|SAA2|RHOG|RIC3|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TNNI2|TNNT3|TMEM41B|TMEM80|TMEM86A|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PARVA|PDE3B|PGAP2|PGGHG|PNPLA2|POLR2L|OTOG|RASSF7|RPL27A|RPLP2|RPS13|RBMXL2|RNF141|RNH1|OR52E8|OR52H1|OR52I1|OR51I2|OR51L1|OR51M1|OR51T1|OR51V1|OR51I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR10A3|OR2AG1|OR2AG2|OR2D3|OR51A2|OR10A4|OR10A5|OR10A6|OR2D2|MUC2|MUC5AC|OR51A4|OR51A7|OR52N2|OR51F2|OR51Q1|OR51S1|OR51G1|OR51G2|MRPL23|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MUC5B|MUC6|MTRNR2L8|MYOD1|IFITM5|INSC|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|LDHC|LMNTD2|GATD1|DEAF1|COPB1|CRACR2B|CSNK2A3|CTSD|CYB5R2|CYP2R1|DBX1|DCHS1|DENND2B|GTF2H1|FAR1|FHIP1B|GALNT18|GAS2|B4GALNT4|BMAL1|C11orf16|C11orf21|HPS5|HPX|BRSK2|C11orf40|C11orf42|C11orf58|CALCA|CALCB|AMPD3|ANO5|ANO9|CARS1|CAVIN3|BTBD10|CHRNA10|CNGA4|CSRP3|CTR9|ABCC8|ADM|AKIP1|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|CCDC179|CCKBR|CD151|CD81|CDHR5|CDKN1C|DENND5A|DKK3|DNHD1|DRD4|DUSP8|E2F8|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|IGSF22|ILK|INS|INS-IGF2|IPO7|IRAG1|IRF7|KCNC1|KCNJ11|LDHA|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|MOB2|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PPFIBP2|PRMT3|PSMA1|PSMD13|PTDSS2|PTH|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SLC22A18|SLC22A18AS|SLC25A22|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|TOLLIP|TPH1|TPP1|TRIM21|TRIM22|TRIM3|USH1C|USP47|WEE1|ZBED5|ZDHHC13|ZNF143		See cases	VCV000441787	11	230615 - 25584362			441787	435449			copy number gain		Pathogenic	Dec 31, 2014	no assertion criteria provided						
GRCh37/hg19 11p15.5-12(chr11:230615-37698540)x3	ART5|CCDC34|CCDC73|DNAJC24|HBG2|HIPK3|LUZP2|LYVE1|MUC2|OR51A4|OR51A7|OR51B2|OR52D1|OR52E2|OR52E4|OR56B1|OR56B4|RBMXL2|RCN1|SERGEF|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|USH1C|USP47|WEE1|ZNF214|ZNF215|TRIM3|TRIM34|TRIM44|TRIM5|TMEM9B|TNNI2|UEVLD|TRIM22|TNNT3|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SLC17A6|SLC1A2|TOLLIP|TPH1|TPP1|TRAF6|TRIM21|RRAS2|RRM1|RRP8|RIC3|RPL27A|RPLP2|RPS13|SAA1|SAA2|RNF141|RNH1|SIGIRR|SIRT3|OR5P2|OR5P3|OR6A2|PRRG4|PSMA1|PSMD13|POLR2L|PPFIBP2|PRMT3|PRR5L|PTDSS2|PTH|SNORA3B|SOX6|RHOG|OR52E6|OR52E8|OR52H1|OR52J3|OR52K1|OR52N2|OR52N4|OR52N5|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR52K2|OR52L1|OR52M1|OR52N1|OR52I1|OR52I2|OR51B4|OR51B5|OR51I2|OR51B6|OR51D1|OR51E1|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|NELL1|NLRP10|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|MUC5AC|MOB2|MPPED2|MICAL2|MICALCL|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MIR610|MMP26|MUC5B|NLRP14|NLRP6|HPS5|HPX|LIN7C|LINC00294|IFITM5|IFTAP|KCNC1|KCNJ11|KCNQ1|KCNQ1DN|LDHAL6A|LDHC|LDLRAD3|LGR4|NRIP3|NUCB2|METTL15|DNHD1|DRD4|ELF5|ELP4|EPS8L2|FANCF|FAR1|FBXO3|FHIP1B|FIBIN|CSTF3|FJX1|FSHB|GALNT18|GAS2|GATD1|MIR210|MIR210HG|CCKBR|CD151|CD81|CD44|CD59|CDHR5|BDNF|BDNF-AS|BMAL1|BRSK2|C11orf21|C11orf40|C11orf42|COPB1|CRACR2B|CSNK2A3|CSRP3|ASCL2|ASCL3|B4GALNT4|BBOX1|BTBD10|C11orf16|C11orf58|C11orf91|CALCA|ABCC8|ABTB2|ADM|AKIP1|AMPD3|ANO3|ANO5|ANO9|AP2A2|APBB1|APIP|ARFIP2|ARL14EP|ART1|CALCB|CAPRIN1|CARS1|CAT|CAVIN3|CCDC179|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COMMD9|CTR9|CTSD|CYB5R2|CYP2R1|DBX1|DCDC1|DCHS1|DEAF1|DENND2B|DENND5A|DEPDC7|DKK3|DUSP8|E2F8|EHF|EIF3F|EIF3M|EIF4G2|GTF2H1|H19|HBB|HBD|HBE1|HBG1|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|IGSF22|ILK|IMMP1L|KCNA4|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNQ1OT1|KIAA1549L|KIF18A|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LMNTD2|LMNTD2-AS1|LMO1|LMO2|LRRC56|LSP1|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MTRNR2L8|MUC15|MUC6|MYOD1|NAP1L4|NAT10|NAV2|NCR3LG1|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OSBPL5|OTOG|OVCH2|PAMR1|PARVA|PNPLA2|PAX6|PDE3B|PDHX|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PTPN5|QSER1|RAG1|RAG2|RASSF10|RASSF7|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SYT8|SYT9|TAF10|TALDO1|TCP11L1|TEAD1|TRIM6|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|WT1|WT1-AS|ZBED5|ZDHHC13|ZNF143|ZNF195		See cases	VCV000441715	11	230615 - 37698540			441715	435377			copy number gain		Pathogenic	Jun 23, 2014	no assertion criteria provided						
GRCh37/hg19 11p15.5(chr11:494540-616565)x3	CDHR5|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|RASSF7|RNH1		See cases	VCV000394738	11	494540 - 616565			394738	381631			copy number gain		Uncertain significance		no assertion criteria provided						
GRCh37/hg19 11p15.5(chr11:532230-699404)x3	CDHR5|DEAF1|DRD4|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|RASSF7|SCT|TMEM80		See cases	VCV000394279	11	532230 - 699404			394279	381172			copy number gain		Uncertain significance		no assertion criteria provided						
GRCh37/hg19 11p15.5-15.4(chr11:193187-5291338)x3	OR51G2|OR51L1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B4|OR52E2|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52M1|OR52R1|OSBPL5|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RHOG|RIC8A|RNH1|RPLP2|RRM1|SCGB1C1|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|STIM1|SYT8|TALDO1|TH|TMEM80|TNNI2|TNNT3|TOLLIP|TRIM21|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|ZNF195|ANO9|AP2A2|ART1|ART5|ASCL2|B4GALNT4|BET1L|BRSK2|C11orf21|C11orf40|CARS1|CD151|CD81|CDHR5|CTSD|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CRACR2B|DEAF1|DRD4|DUSP8|EPS8L2|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP6|NUP98|OR51A2|OR51A4|OR51A7|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1		See cases	VCV000394007	11	193187 - 5291338			394007	380900			copy number gain		Pathogenic		no assertion criteria provided						
GRCh37/hg19 11p15.5(chr11:532230-699463)x3	CDHR5|DEAF1|DRD4|HRAS|IRF7|LMNTD2|LMNTD2-AS1|LRRC56|MIR210|MIR210HG|PHRF1|RASSF7|SCT|TMEM80		See cases	VCV000253876	11	532230 - 699463			253876	248324			copy number gain		Uncertain significance	Jan 20, 2016	criteria provided, single submitter						
NM_005343.4(HRAS):c.195C>G (p.Ser65Arg)	HRAS	S65R	not provided	VCV003361451					3361451	3520661			single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 20, 2023	criteria provided, single submitter						
